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Mitosis is a highly regulated process by which a cell duplicates and distributes its 
chromosomal DNA into two identical daughter cells equally. Equal distribution of the 
chromosomes is crucial for accurate propagation of genetic information. This is 
essential for maintaining viability and preventing genomic instability that can 
potentially lead to cancer. In order to avoid unequal distribution of chromosomes, cells 
employ a surveillance mechanism called the spindle assembly checkpoint (SAC). The 
SAC is an inhibitory signalling network, which delays segregation of chromosomes, 
until they have stably attached to spindle microtubules through their multi-protein 
platforms, known as kinetochores. The main target of the SAC is the anaphase 
promoter complex/ cyclosome (APC/C), an E3 ubiquitin ligase. Specifically APC/C 
and its activator Cdc20 are inhibited by the main effector of the SAC, called the mitotic 
checkpoint complex (MCC). The MCC consists of Cdc20, Mad2, Mad3 and Bub3 
(except S. pombe) proteins, which are recruited to the unattached kinetochores to 
promote MCC assembly. Once the chromosomes stably attach to the spindle, the SAC 
is turned off, MCC disassembles, and APC/CCdc20 is released from the inhibition. 
Activated APC/CCdc20 then targets its two main substrates, securin and cyclin B, for 
proteasomal degradation, and thereby triggers anaphase onset and mitotic exit. 
SAC signalling involves many protein components, whose activities are essentially 
regulated by direct protein-protein interactions and/ or post-translational 
modifications. One of these major modifications is phosphorylation, which is mediated 
by the SAC kinases such as Aurora B, Mps1 and Bub1. A number of studies have 
characterised SAC related substrates of Aurora B and Mps1 kinases in several model 
organisms. On the other hand, Bub1 kinase activity has been thought to play a key role 






The aim of this study is to investigate the importance of Bub1 kinase activity for SAC 
response in fission yeast Schizosaccharomyces pombe (S. pombe). SAC activation 
assays, using various degrees of spindle perturbation, have demonstrated that Bub1 
kinase activity plays an important role in SAC maintenance. In order to examine the 
pathways downstream of Bub1, we set out to indicate Bub1 substrates which may be 
involved in SAC signalling. According to studies in various species, Cdc20 appears to 
be a prominent candidate, whose phosphorylation by Cdk1 and Bub1 kinases has been 
reported to regulate its mitotic activity. 
To investigate whether Cdc20 is phosphorylated by Bub1 in vitro, we purified 
recombinant S. pombe proteins from insect cells. Subsequent kinase assays identified 
Cdc20 as an in vitro substrate of Bub1, and the phosphorylated sites in Cdc20 were 
mapped by mass spectrometry. To address if this phospho-modification is involved in 
SAC regulation, phosphorylation mutants of Cdc20 were analysed in terms of their 
abilities to activate and silence SAC in vivo. Results show that phosphorylation of 
Cdc20 C-terminus promotes SAC maintenance in response to spindle damage. 
Furthermore, the mutations mimicking Bub1-mediated phosphorylation of Cdc20 C-
terminus restore the SAC defects in the absence of Bub1 kinase activity. 
In addition, we purified S. pombe mitotic checkpoint complex (MCC) from insect 
cells, and analysed the interactions between its components (Cdc20, Mad2 and Mad3) 
by cross-linking mass spectrometry. Crystal structure of S.pombe MCC has been 
determined recently, which lacks Mad3 C-terminus and flexible C-terminal tail of 
Cdc20. Using an MCC with full length Mad3, we identified novel interactions between 
the C-terminal tails Mad3 and Cdc20, which are in close proximity to the identified 
Cdc20 phosphorylation sites. 
Briefly, in this study we confirm the previously known roles of Bub1 kinase activity 
(chromosome bi-orientation). Moreover, we propose a new pathway (in addition to the 
well-established H2A pathway) mediated by Cdc20, that may be important to maintain 
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Chapter 1: Introduction 
1.1 The cell division cycle 
To grow and proliferate, all organisms require to produce genetically identical 
daughter cells through a process known as cell division. To maintain genetic identity, 
accurate duplication of cell contents and an equal distribution of those contents into 
two daughter cells must be ensured during every cell division. The sequence of events 
between two successive cell divisions is called the cell cycle. 
The eukaryotic cell cycle can be split up into four distinct phases: G1, S, G2 and M 
(Hartwell & Weinert, 1989). Each cell division leads to G1 phase (gap 1), during which 
the cell monitors its mass and the environmental conditions before deciding whether 
to stay in the cell cycle or to enter a prolonged non-dividing phase (G0).  
Once the cell reaches a certain size in the availability of nutrients, it commits to a new 
cell cycle and progresses into S phase (synthesis) (Sherlock & Rosamond, 1993). In S 
phase, the genetic content of the cell is replicated through DNA synthesis and 
centrosomes are duplicated (Adams & Kilmartin, 2000), which is followed by G2 
phase. G1, S and G2 phases define interphase, which form the majority of the cell 
cycle. In G2 (gap 2) the cell prepares for the M phase, in which segregation of 
duplicated chromosomes and their distribution into two daughter cells take place. 
Transition between cell cycle phases is largely unidirectional. This requires the activity 
of a family of enzymes called cyclin-dependent kinases (Cdks), which regulate 
progression through the cell cycle (Hartwell, Culotti, Pringle, & Reid, 1974). Cdks are 
conserved serine/threonine protein kinases, which are present at constant levels 
throughout the cell cycle. Cdks are activated by binding to proteins called cyclins. The 
abundance of cyclins at a given time in the cell are tightly regulated by gene expression 
and proteolysis (Morgan 1997; Murray 2004). 
In higher eukaryotes, there are cyclins that activate different Cdks during particular 
phases of the cells cycle: G1 (cyclin D), S phase (cyclins E and A) and mitosis (cyclins 
B and A) (Diffley, 2004) (Figure 1.1A). On the other hand fission yeast 
Schizosaccharomyces pombe (S. pombe) has only one type of Cdk (Cdk1Cdc2) that is 
involved in G1/S and G2/M transition (Figure 1.1B) and three type of cyclins: G1 




1981). Although Cdc2 is constitutively expressed throughout the cell cycle, its activity 
is regulated by binding of cyclin BCdc13, phosphorylation by Wee1 kinase and 
dephosphorylation by Cdc25 phosphatase. Early in G2 phase, low levels of Cyclin B, 
and inhibitory phosphorylation by Wee1 keep Cdk1 inactive (Fattaey & Booher, 
1997). Towards the end of G2 phase, Cyclin B levels and Cdc25 phosphatase activity 
increase. Hence, binding of Cyclin B and reversal of Wee1 mediated inhibitory 
phosphorylation by Cdc25 phosphatase activate Cdk1, which leads to the entry into 
mitosis. Moreover, the active Cdk1-Cyclin B complex then phosphorylates Wee1 
kinase (to inhibit) and Cdc25 phosphatase (to further activate), in order to generate a 
positive-feedback loop for its own activation (Enoch & Nurse, 1990). In mitosis, 
Cdk1-Cyclin B complex catalyses the main events. Before the duplicated 
chromosomes separate, Cyclin B levels decrease through proteasomal degradation, 
thereby Cdk1 becomes inactive again (Sullivan & Morgan, 2007). 
 
1.2 Mitosis 
Mitosis is a short, but highly regulated process which results in the generation of two 
identical daughter cells. Mitosis comprises six stages in higher eukaryotes: prophase 
(not in yeast), pro-metaphase, metaphase, anaphase (anaphase A and anaphase B) and 
telophase/cytokinesis. 
After S phase, replicated chromosomes (sister chromatids) are linked together by sister 
DNA catenation and protein complexes called cohesin (Uhlmann, Wernic, Poupart, 
Koonin, & Nasmyth, 2000). Upon entry into prophase chromosomes condense. Then 
duplicated centrosomes (spindle pole bodies in yeast) move apart and nucleate the 
mitotic spindle. The mitotic spindle is a bipolar structure comprising microtubules, 
which rapidly polymerise and depolymerise until stabilised end-on attachments 
(microtubule plus ends) are formed with protein assemblies called kinetochores 
(Cheeseman and Desai, 2008). Kinetochores are protein complexes that are found on 
centromeric regions of chromosomes and connect with microtubules emanating from 
each of the two poles. In prometaphase, the nuclear envelope breaks down (unlike 
fission yeast that has a closed mitosis, in which contents of the nucleus remain 
compartmentalised from the cytoplasm throughout the cell cycle), thereby the mitotic 




Needleman, 2014). With this stabilised attachment, captured chromatids are tethered 
to the centrosomes/ spindle pole bodies. During metaphase, sister chromatids align at 
the metaphase plate. Once all sister chromatids are bi-oriented, they are captured by 
microtubules emanating from opposite spindle poles, the cell progresses into anaphase. 
In anaphase A, the cohesin complex that links sister-chromatids together disassembles. 
In anaphase B, centrosomes/spindle pole bodies move apart from each other. Thereby, 
sister-chromatids are pulled to opposite spindle poles, which results in their separation 
(Elmore, Beckley, Chen, & Gould, 2014). During telophase the spindle is 
disassembled, chromosomes de-condense and the nuclear envelope begins to reform. 
Finally in cytokinesis, the cell is divided into two daughter cells with identical genetic 
material (David, 2010). 
 
However, during prometaphase chromosomes are not bi-oriented straightaway. Until 
attaining bi-orientation, erroneous associations between microtubules and sister 
kinetochores occur, such as syntelic (kinetochores attach to microtubules from the 
same pole) and merotelic (a kinetochore attaches to microtubules from both poles) 
attachments (Musacchio & Salmon, 2007). If the cell fails to correct these attachment 
errors, chromosomes will segregate unequally, which results in aneuploidy (abnormal 
number of chromosomes). To establish bi-orientation, erroneous kinetochore-
microtubule attachments are destabilized (error correction) by Aurora B kinase 
(Kalantzaki et al., 2015), which leads to formation of unattached kinetochores. Then 
unattached kinetochores are detected by a surveillance mechanism called the spindle 
assembly checkpoint (SAC) that delays chromosome segregation (anaphase onset), 









Figure 1.1 The cell cycle of higher eukaryotes and fission yeast cell cycle
(A) An overview of the cell division cycle of higher eukaryotes controlled by multiple 
cyclin-dependent kinases (Cdk) and cyclins. Model was adapted from Hochegger, 
Takeda, & Hunt, 2008 (B) An overview of fission yeast (S. pombe) cell cycle, which is 
driven by the activity of a single Cdk (cdc2). Note that fission yeast G2 phase takes up
70 % of its cell cycle, which is not reflected in the model. (See the text for details on the 






1.3 Anaphase promoting complex/cyclosome (APC/C) 
The anaphase promoting complex/cyclosome (APC/C) is a large (1.5-MDa) multi-
subunit (13 subunits) E3 ubiquitin ligase (Figure 1.2A) that regulates progression 
through, and exit from mitosis. In the absence of APC/C activity, cells cannot separate 
their sister chromatids in anaphase, exit from mitosis or divide into two daughter cells 
(D. Barford, 2011).  The APC/C triggers anaphase onset by ubiquitinating two 
inhibitors of the transition to anaphase: securin and Cyclin B. Securin is a protein 
inhibitor of separase, a protease that cleaves the Cohesin subunit SCC1 (Uhlmann et 
al., 2000). Once securin is degraded, separase cleaves SCC1 which results in 
disassembly of Cohesin and sister chromatid segregation. Reduction in cyclin B levels 
are also required for entry into anaphase, (to relieve inhibition of separase by Cdk1) 
and exit from mitosis, that is maintained by Cyclin B- Cdk1 complex (Holland & 
Taylor, 2006).  
The temporal regulation of APC/C activity is achieved through a combination of two 
structurally related activator proteins, Cdc20 and Cdh1 (Kraft et al., 2003). Cdc20 
activates the APC/C during early mitosis, when APC/C is phosphorylated by Cdk1, 
which enhances its affinity for Cdc20 (Rudner & Murray, 2000). However, Cdk1-
mediated phosphorylation of Cdc20 prevents it from activating APC/C in a C-box 
dependent manner; therefore dephosphorylation of Cdc20 is required for its interaction 
with and activation of APC/C  (Labit et al., 2012). Cdh1 activity is low during mitosis 
due to its Cdk1 dependent phosphorylation. Cdh1 activates APC/C in late mitosis and 
G1 phase (Kramer, Scheuringer, Podtelejnikov, Mann, & Peters, 2000). APC/C 
activators utilise two conserved sequence motifs for APC/C binding: the C-box, 
located toward the N-terminus and a C-terminal IR motif (Figure 1.2A) (D. Barford, 
2011; Chang, Zhang, Yang, McLaughlin, & Barford, 2015; Thornton et al., 2006). 
Upon binding, the activators recruit APC/C substrates to the catalytic site of APC/C. 
The recognition of APC/C substrates by co-activators is predominantly achieved 
through two destructions motifs (degrons) found on the substrates: D-box and KEN-
boxes (J. L. Burton & Solomon, 2001). Cyclin B and securin are included in the APC/C 
substrates recognized through D-box and KEN-box, which is the reason for APC/C to 
be the main target of the SAC. 
A
Figure 1.2 EM reconstructions of the human APC/C and its interaction with the MCC
(A) Atomic structure of the human anaphase promoting complex (APC/C) interacting with 
Cdh1 (APC/C coactivator) and Emi1 (APC/C inhibitor), indicated by electron microscopy 
(EM). Large subunits are shown in cartoon, whereas the four small subunits, Emi1, 
Cdh1NTD, Cdh1IR and Apc10IR, are shown as surface representations. Emi1 interacts 
with the substrate-recognition and catalytic modules  Note that both Cdh1 and Apc10 
(APC/C subunit) contain the IR (isoleucine, arginine) motif. The figure was taken from 
(Chang, Zhang, Yang, McLaughlin, & Barford, 2015). (B) APC/C subunit topology and 
structural changes upon MCC binding indicated by electron microscopy (EM): (1) The 
apo-APC/C structure in its most open conformation; (2) The APC/C-MCC structure with a 
closed conformation; (3) Conformational changes induced by MCC binding to APC/C. The 








1.4 The spindle assembly checkpoint (SAC): overview 
Components of the spindle assembly checkpoint (SAC) were first identified in budding 
yeast (Saccharomyces cerevisiae) screens for mutants that failed to delay chromosome 
segregation upon treatment with a microtubule depolymerising drug, called benomyl 
(Hoyt et al., 1991; Li and Murray, 1991).  
Major components of the SAC are the Bub (budding uninhibited by benzimidazole) 
proteins: the kinase Bub1 (Bernard et al., 1998; Roberts et al., 1994) and Bub3 (Taylor 
et al., 1998; Vanoosthuyse et al., 2004) and the Mad (mitotic arrest deficient) proteins: 
Mad1 (Hardwick and Murray, 1995), Mad2 (Chen et al., 1999; He et al., 1997), Mad3 
(Hardwick et al., 2000; Millband and Hardwick, 2002). Another kinase component of 
the SAC is Mps1 (mono polar spindle 1) that was first identified in a budding yeast 
screen for mutants with spindle pole duplication defects (Winey et al., 1991). 
 
The SAC proteins are recruited to unattached kinetochores, where the assembly of a 
diffusible checkpoint effector, known as mitotic checkpoint complex (MCC), is 
catalysed (Sudakin, Chan, & Yen, 2001). MCC consists of Mad2, Mad3 (BubR1 in 
animals) and Cdc20 (Slp1 in S. pombe) (plus Bub3 in budding yeast and animals). 
Once assembled, MCC delays anaphase onset through the inhibition of Anaphase 
promoting complex/cyclosome (APC/C). APC/C mediates poly-ubiquitination of 
cyclin B and securin (inhibitors of anaphase onset and mitotic exit), and thereby 
targeting them for degradation by 26S proteasome. By inhibiting APC/C, the SAC 
delays anaphase onset, and provides time for the aberrant kinetochore-microtubule 
attachments to be corrected. When the last kinetochore is stably attached in a bi-
oriented manner, the SAC is satisfied, and the MCC disassembles (SAC silencing). 
Once the APC/C is active again, it targets cyclin B and securin for proteasomal 






1.4.1 Spindle assembly checkpoint activation at kinetochores 
Laser ablation studies have indicated that even a single unattached kinetochore is 
sufficient to activate the “wait anaphase” signal mediated by the SAC (C L Rieder, 
Cole, Khodjakov, & Sluder, 1995). Kinetochore localization of checkpoint proteins 
has been reported to be important for SAC activation by many studies (London & 
Biggins, 2014a; Mchedlishvili et al., 2012; Rischitor, May, & Hardwick, 2007; Sharp-
Baker & Chen, 2001; Taylor & McKeon, 1997; Vanoosthuyse, Valsdottir, Javerzat, & 
Hardwick, 2004). However, the precise mechanisms regulating their recruitment was 
unknown until recently. Recent studies have demonstrated that the core kinetochore 
protein KNL1 (Spc7 in fission yeast, Spc105 in budding yeast) recruits BUB proteins: 
Bub1, BubR1 (Mad3 in S. pombe) and Bub3 at unattached kinetochores (Kiyomitsu, 
Obuse, & Yanagida, 2007; London, Ceto, Ranish, & Biggins, 2012; Shepperd et al., 
2012a; Yamagishi, Yang, Tanno, & Watanabe, 2012).  
KNL1 contains conserved ‘MELT’- like ([M/I/ L/ V]-[E/D]-[M/I/L/V]-T) motifs. It 
has been shown that the phosphorylation of the threonine residues on the MELT-like 
motifs by Mps1 (and polo-like kinase 1, plk1, in humans (von Schubert et al., 2015)) 
is required for kinetochore localization of Bub3, Bub1 and Mad3 (London et al., 2012; 
Shepperd et al., 2012a; Yamagishi et al., 2012). Additional crystallisation studies 
revealed that this phosphorylation is required for a tight interaction between KNL1 
and Bub3, suggesting that Bub3 recruitment to KNL1 may be the key step in localizing 
Bub1-Bub3 complex at kinetochores (Primorac et al., 2013). Furthermore, Bub1 
contributes to stabilizing the KNL1-Bub3 interaction in vitro (Primorac et al., 2013), 
which is in line with the finding that Bub1 is important for in vivo localization of Bub3 
(Vanoosthuyse et al., 2004). 
On the other hand, the mechanism of BubR1 (Mad3 in yeast) kinetochore recruitment 
remains unsolved. BubR1 (Mad3) may not be localising through the Bub3-KNL1 
interaction, as it has not been found to stabilize the KNL1-Bub3 interaction (Krenn, 
Overlack, Primorac, Van Gerwen, & Musacchio, 2014). Instead, Mad3 recruitment 
has been demonstrated to depend on Bub1 in fission yeast (Millband & Hardwick, 
2002). This raises the possibility that Mad3 may be directly recruited by Bub1 through 




This is consistent with the observation that ectopically localized fission yeast Bub1 
recruits Mad3 (Rischitor et al., 2007). On the other hand, a Mad3-Bub3 complex at 
high levels has been observed in budding yeast (Hardwick, Johnston, Smith, & 
Murray, 2000). 
Even though Bub3–Bub1 recruitment to kinetochores is required for the spindle 
assembly checkpoint (except in fission yeast), this localization does not always 
correlate with SAC activation. For instance, Bub1 has been observed on early anaphase 
kinetochores, which do not signal the SAC anymore (Sharp-Baker & Chen, 2001). On 
the other hand, kinetochore recruitment of Mad1-Mad2 heterodimer has been reported 
to strictly correlate with the SAC signalling (Maldonado & Kapoor, 2011). This 
implies that association of Mad1-Mad2 heterodimer with kinetochores is an important 
step in the SAC activation.  
As for the kinetochore receptor of Mad1-Mad2, a budding yeast study reported that 
Mad1 interacts with Bub1, and is dependent on an RLK motif that is present in Mad1 
(Brady & Hardwick, 2000). Mutation of this Mad1 motif or Bub1 depletion abrogated 
kinetochore recruitment of Mad1 in budding yeast and Caenorhabditis elegans 
(London & Biggins, 2014a; Moyle et al., 2014). Moreover, in vitro association of 
budding yeast Mad1 with kinetochores was found to require Mps1-mediated 
phosphorylation of Bub1 (London & Biggins, 2014a). Taken together, these findings 
imply that Mps1-mediated phosphorylation of KNL1 (Spc7, Spc105) and Bub1 may 
be responsible for establishing a link between Bub (Bub1, Bub3, BubR1 – Mad3 -) 
and Mad (Mad1 and Mad2) proteins at unattached kinetochores in budding yeast. 
Once localized at unattached kinetochores, Mad1 recruits Mad2 and induces a 
conformational change; Mad1 converts it to closed Mad2 (C-Mad2), which is one of 
the two distinct conformations that Mad2 adopts. When unbound to Mad1, it adopts 
an open conformation (O-Mad2), whereas upon binding to Mad1 (or Cdc20) closed 
conformation (C-Mad2) is created through the movement of two β-sheets across the 
face of Mad2. Upon mitotic entry, Mad1-C-Mad2 complex localizes at kinetochores, 
recruits O-Mad2 from cytosol, and converts it to C-Mad2 that has a higher affinity for 
binding Cdc20 (De Antoni et al., 2005). This leads to the formation of C-Mad2-Cdc20 




recovery after photobleaching (FRAP) analysis in human cells has demonstrated that 
Cdc20 localizes at kinetochores with a fast turnover rate (Bonnie J Howell et al., 2004). 
1.4.2 Assembly of the mitotic checkpoint complex (MCC) 
MCC is the ultimate effector of the SAC that inhibits the APC/C in the cytoplasm 
(nucleoplasm in yeast which have closed mitosis). It has been suggested to be 
assembled from two sub-complexes, the C-Mad2-Cdc20 complex and the 
Mad3/BubR1-Bub3 complex (Musacchio & Salmon, 2007). While formation of C-
Mad2-Cdc20 complex is catalysed by unattached kinetochores, Mad3/BubR1-Bub3 
complex exists throughout the cell cycle in budding yeast (Hardwick et al., 2000). 
Recently, the crystal structure of the fission yeast MCC, that consists of Cdc20, Mad2 
and Mad3, has been solved (Chao, Kulkarni, Zhang, Kong, & Barford, 2012a). 
It has been established that Mad2 is essential for Cdc20 to bind Mad3/BubR1 (Janet 
L. Burton & Solomon, 2007; Hardwick et al., 2000; Nilsson, Yekezare, Minshull, & 
Pines, 2008). In addition, it has been demonstrated in yeast, flies and human cells that 
the N-terminal KEN box in Mad3/BubR1 (KEN20 in fission yeast) is necessary for 
MCC formation (King, van der Sar, & Hardwick, 2007; Pablo Lara-Gonzalez & 
Taylor, 2012; Sczaniecka et al., 2008).  
The MCC crystal structure has revealed that the N-terminal KEN box of Mad3 adopts 
a helix-loop-helix structure, and exhibits direct interactions with both Mad2 and Cdc20 
(Figure 1.3A and B) (Chao et al., 2012a). This is consistent with the findings that Mad2 
is required for the Mad3/BubR1-Cdc20 interaction. In addition, the N-terminal TPR 
domains in Mad3 also directly interact with Cdc20. This is in line with the observation 
that mutating these domains in Mad3/BubR1 abolishes its binding to Cdc20 (P. Lara-
Gonzalez, Scott, Diez, Sen, & Taylor, 2011). It was observed that only the closed 
conformation of Mad2 (C-Mad2) is capable of binding to Mad3. Intriguingly, the C-
Mad2 bound to Cdc20 interacts with Mad3 through the same surface that it dimerises 
with O-Mad2 (Chao et al., 2012a). In other words, when Mad2 incorporates into the 
MCC, it is not able to bind O-Mad2 anymore, as Mad3 competes for the same region 
of C-Mad2. This implies that, once formed part of the MCC, C-Mad2 is not likely to 




1.4.3 Is the SAC response dependent on kinetochores? 
Although the SAC signalling network is widely associated with unattached 
kinetochores, some observations argue against the strict requirement for kinetochore 
localization of checkpoint proteins for a SAC response. For instance, MCC can still 
assemble in budding yeast strains with mutated Ndc10, a protein necessary for 
kinetochore function (Fraschini et al., 2001). Moreover, in fission yeast although Bub3 
is required for kinetochore recruitment of Bub1, Mad3, Mad1 and Mad2, it is not 
essential for MCC-APC/C interaction in the presence of a microtubule depolymerising 
drug (S. Heinrich, Windecker, Hustedt, & Hauf, 2012; Vanoosthuyse, Meadows, van 
der Sar, Millar, & Hardwick, 2009; Windecker, Langegger, Heinrich, & Hauf, 2009). 
However, although SAC signals can be amplified without kinetochore recruitment of 
the checkpoint proteins, their kinetochore localisation is still required for a full SAC 
response, as 15% of bub3 null cells failed to maintain a robust SAC arrest upon 
complete microtubule depolymerization (Vanoosthuyse et al., 2009). On the other 
hand Bub3 is essential for the SAC signalling in budding yeast (Hardwick et al., 2000). 
Similar observations have been made in mammalian cells. Although BubR1 (Mad3) 
interacts with Bub3 throughout the cell cycle, Bub3 is not necessary either for the 
MCC assembly, or for the ability of Mad2 and BubR1 to inhibit APC/CCdc20 activity 
in vitro (P. Lara-Gonzalez et al., 2011; Tang, Bharadwaj, Li, & Yu, 2001). Even 
though Bub3 may not be essential for in vitro interaction of BubR1 (Mad3) with Mad2 
and Cdc20, or APC/C inhibition, in cellular context the ability of BubR1 to bind Bub3 
(and to localize at kinetochores) is required for an efficient SAC response (Elowe et 









Figure 1.3 Crystal structure of S. pombe MCC trimer
(A) Cartoon representation of the fission yeast mitotic checkpoint complex: Cdc20 
ΔN-term (yellow) lacking the first 86 amino acids; closed Mad2 (C-Mad2) (green) and 
Mad3 ΔC-term (blue) lacking last 87 amino acids, 224-310. The N-terminal KEN box is 
shown in red, located in the helix-loop-helix (HLH) motif of Mad3. The N-terminus of the 
WD40 domain is indicated. (B) Details of the Mad3 HLH interaction with Mad2 and Cdc20. 
(C) Mad2-binding motif (MB motif) of Cdc20 bound to the Mad2 safety belt. Cartoon 





1.5 Mechanisms underlying APC/CCdc20 inhibition by the SAC 
1.5.1 Inhibition of APC/CCdc20 through MCC 
According to the early observations Mad2 has been considered as a key inhibitor of 
anaphase onset, as it binds Cdc20 directly and prevents it from activating APC/C 
(Fang, Yu, & Kirschner, 1998; Li, Gorbea, Mahaffey, Rechsteiner, & Benezra, 1997). 
Consistent with this, Mad2 overexpression has been reported to activate the SAC in 
several model organisms (He, Patterson, & Sazer, 1997; Li et al., 1997). Indeed, a 
recent experiment in budding yeast has demonstrated that tethering Mad2 to Cdc20 
delayed anaphase onset, which was partially dependent on Mad3 (Lau & Murray, 
2012).  
On the other hand, recent investigations have indicated that Mad3/BubR1 may be the 
key APC/C inhibitor, instead of Mad2. First of all, Mad2 alone requires to be added in 
very high amounts with respect to Cdc20, to be able to inhibit the APC/C in vitro (Fang 
et al., 1998; Tang et al., 2001). Moreover, Mad2 has been observed to bind APC/CCdc20 
in vitro without significantly affecting its activity (P. Lara-Gonzalez et al., 2011). 
Importantly, Mad2 is not always present at the same amounts as the other components 
of the MCC (Mad3/ BubR1 and Cdc20) are under different mitotic conditions. For 
example, in the presence of nocodazole (many kinetochores are unattached in response 
to microtubule depolymerisation) Mad2 is easily detectable as an MCC component. 
Whereas in the presence of taxol (only a few kinetochores are activating the SAC in 
response to stabilized microtubules) much less Mad2 is detected in the MCC. This 
finding suggests that as well as the MCC (Mad2, Mad3/BubR1, Cdc20), the 
Mad3/BubR1-Cdc20 complex is also a viable APC/C inhibitor in human cells 
(Westhorpe, Tighe, Lara-Gonzalez, & Taylor, 2011). 
There is growing evidence that Mad3/BubR1 may be acting as a ‘pseudosubstrate’ to 
inhibit APC/CCdc20 (Janet L. Burton & Solomon, 2007). Recent structural studies have 
demonstrated that D-box substrates bind at the bi-partite D-box receptor formed 
between the activator (Cdc20 or Cdh1) and the small APC/C subunit Apc10 
(Buschhorn et al., 2011; da Fonseca et al., 2011). In addition, when the APC/C is 





These observations suggest that Mad3/BubR1 may inhibit substrate recruitment to the 
APC/C by either inducing a conformational change on the bi-partite D-box receptor of 
APC/C, or by directly occupying the substrate binding site, acting as a 
pseudosubstrate. This view has been supported by observations in yeast that Mad3 
binds to Mad2-Cdc20 via its N-terminal KEN box (KEN20 in fission yeast) (Janet L. 
Burton & Solomon, 2007; King et al., 2007; Sczaniecka et al., 2008). Accordingly, 
Mad3 has been reported to compete with Cdc20 for substrate binding, which is 
dependent on the N-terminal KEN box (Janet L. Burton & Solomon, 2007). In 
agreement with these findings, the fission yeast MCC structure has demonstrated that 
the N-terminal KEN box of Mad3 occupies the KEN-box receptor on the WD40 
domain of Cdc20 (Figure 1.3B) (Chao, Kulkarni, Zhang, Kong, & Barford, 2012b). 
This strengthens the possibility that Mad3 does indeed appear to act as a 
pseudosubstrate to block recognition of KEN box-containing substrates by 
APC/CCdc20.  
Intriguingly, Mad3/ BubR1 contains a second KEN box (KEN271 in fission yeast) 
(Janet L. Burton & Solomon, 2007; King et al., 2007), which is essential for SAC 
function, although is not required for MCC assembly (P. Lara-Gonzalez et al., 2011; 
Sczaniecka et al., 2008). Moreover, BubR1 inhibits the recruitment of D-box-
containing substrates to APC/CCdc20 in vitro, in a second KEN box dependent manner 
(P. Lara-Gonzalez et al., 2011). These observations imply that, while the N-terminal 
KEN box inhibits the recruitment of KEN-box containing substrates to APC/CCdc20, C-
terminal second KEN box might occupy the bi-partite D-box receptor. This possibility 
is supported by the MCC structure; docking of the fission yeast MCC structure onto 
that of the APC/C indicates that Mad3 binding displaces Cdc20 from Apc10, thus 
disrupting the bi-partite D-box receptor between them (Chao et al., 2012b). These data 
are in line with cryo-EM studies demonstrating that MCC binding changes the position 
of Cdc20 within the APC/C (Figure 1.2B) (Herzog, 2009). In addition, a study in 
human cells has demonstrated that Mad2 inhibits Cdc20 by binding directly to a site 
required to bind the APC/C (Izawa & Pines, 2012). This is consistent with the MCC 
crystal structure that safety belt domain of Mad2 sequesters the Mad2 binding domain 




Taken together, Mad2 and the two KEN boxes of Mad3/BubR1 appear to cooperate 
for inhibiting APC/CCdc20. 
1.5.2 Inhibition of APC/CCdc20 through Cdc20 turnover 
Cdc20 is an activator (along with Cdh1) of APC/C that associates with the APC/C in 
early mitosis and triggers anaphase onset by promoting the destruction of cyclin B and 
securin. Cdc20 is related to the β subunit of trimeric G proteins and contains seven 
WD40 repeats. These repeats form a seven-bladed β propeller structure which 
efficiently mediates protein-protein interactions (Chao et al., 2012b).  
Although Cdh1 protein and transcript levels are constitutive, both Cdc20 mRNA and 
protein levels oscillate throughout the cell cycle: absent in G1, begin to accumulate in 
S phase, and reach their peak levels in mitosis. (Pan & Chen, 2004) (Figure 1.4). 
During the normal cell cycle, Cdc20 levels are regulated both by transcription and 
proteolytic degradation. Expression of CDC20 gene is driven by a hybrid promoter 
that bears Yox1-, Mcm1- and Fkh-binding sites (Liang, Lim, Venkitaraman, & Surana, 
2011).  
Cdc20 is degraded by multiple APC/C-dependent mechanisms in budding yeast (Foe 
et al., 2011). It has been reported that late in mitosis and early in G1, Cdc20 
degradation is largely mediated by APC/CCdh1. On the other hand, even though Cdh1-
mediated degradation of Cdc20 is likely important, recent studies have proposed Cdh1-
independent mechanisms for Cdc20 turnover (Foe et al., 2011). Consistent with this, a 
budding yeast study has demonstrated that the majority of Cdc20 turnover does not 
involve a second activator molecule but instead is mediated by in cis Cdc20 auto-
ubiquitination while it binds to the activator binding site of the APC/C (Foe et al., 
2011). 
Studies in fission yeast, budding yeast and human cells have reported that Cdc20 
turnover is promoted by SAC activation, leading to lower Cdc20 levels (King et al., 
2007; Nilsson et al., 2008; Pan & Chen, 2004) to ensure that MCC (Mad2 and Mad3) 
levels are not overridden by Cdc20 hyper-accumulation.  
These data are in agreement with the recent findings in fission yeast that Cdc20Slp1 




rescues the SAC defects caused by lower abundance of Mad2 and Mad3 (Stephanie 
Heinrich et al., 2013).  
Interestingly, a budding yeast study has demonstrated that Cdk1 activity promotes 
recovery from SAC-induced mitotic arrest by sustaining Cdc20 expression during 
mitosis (Liang et al., 2011). It has been shown that Cdk1 activity silences Yox1, a 
transcription repressor of the CDC20 gene, and thereby maintains Cdc20 levels high 
enough during SAC recovery, which contributes to the rapid anaphase onset upon 
chromosome bi-orientation. 
Taken together, these observations suggest that the SAC keeps levels of Cdc20 low 
enough for its stoichiometric inhibition by the MCC until chromosome biorientation, 
yet high enough (by the indirect promotion of Cdk1 activity through stabilized Cyclin 
B) for APC/CCdc20 to start anaphase rapidly (recover from the SAC) once chromosomes 
are bioriented.  
1.5.3 Regulation of APC/CCdc20 activity through phosphorylation 
The association of APC/C and its activators is also subject to control by 
phosphorylation. Cdh1 can activate both interphase and mitotic APC/C, independent 
of APC/C phosphorylation, however its own activity is inhibited by Cdk1 mediated 
phosphorylation. On the other hand, Cdc20 binds and activates mitotically 
phosphorylated APC/C by Cdk1 (Kramer et al., 2000; Rudner & Murray, 2000; 
Yudkovsky, Shteinberg, Listovsky, Brandeis, & Hershko, 2000). This suggests that 
Cdc20 is the predominant activator of the APC/C when Cdk1 activity is high in 
mitosis. 
Phospho-regulation of Cdc20 by different kinases has also been reported in different 
model organisms. However, unlike the activating phosphorylation of APC/C, 
phosphorylation of Cdc20 has largely been suggested to inhibit its APC/C activator 
function.  
Studies in Xenopus egg extracts and human cells have reported that the SAC requires 
mitotic Cdk1 activity. Indeed, inhibition of Cdk1 activity disrupts the interaction of 
Cdc20 with other MCC components (Mad2 and Mad3/BubR1), and thereby overrides 




Yudkovsky et al., 2000). Moreover, the Cdc20 that is phosphorylated by Cdk1 in vitro 
has been shown to interact with Mad2 rather than APC/ C (D’Angiolella et al., 2003). 
Another Xenopus egg extract study has reported that Cdk1 does not account for all of 
the phosphorylation on Cdc20. Indeed, mitogen-activated protein kinase (MAPK) and 
Cdk1 mediated phosphorylation of Cdc20 is required for the interaction between MCC 
components (Cdc20, Mad2 and Mad3/BubR1) and a functional SAC response to 
spindle perturbation by nocodazole (Chung & Chen, 2003). It has been suggested that 
the SAC delays anaphase onset by inhibiting a fully-phosphorylated Cdc20. 
Consistent with these observations, a recent study in Xenopus egg extracts has 
demonstrated that the antagonistic activities of Cdk1 and protein phosphatase 2A 
(PP2A) regulate APC/CCdc20 in mitosis (Labit et al., 2012). Upon mitotic entry, both 
APC/C and N-terminus of Cdc20 are phosphorylated by Cdk1. Phosphorylation of 
APC/C increases its affinity for Cdc20, whereas Cdc20 phosphorylation has the 
opposite effect on its affinity for the APC/C. During the metaphase- anaphase 
transition, dephosphorylation of Cdc20 N-terminus by PP2A promotes the binding of 
its C-box to Apc8 and the subsequent APC/C activation. Importantly, when Cdc20 
remains hyper-phosphorylated through the inhibition of PP2A by ocadaic acid, it fails 
to activate APC/C-mediated ubiquitination. 
In addition to Cdk1 and MAPK mediated phosphorylation of Cdc20, Bub1 kinase has 
also been reported to regulate Cdc20 in human cells (Tang, Shu, Oncel, Chen, & Yu, 
2004). In vitro kinase assays have demonstrated that Bub1 directly phosphorylates 
Cdc20, which catalytically (at sub-stoichiometric amounts) inhibits APC/C. Moreover, 
in vivo phosphorylation of Cdc20 by Bub1 is required for a full SAC response, as the 
expression of a non-phosphorylatable Cdc20 mutant results in slippage from the SAC 
arrest upon spindle damage. Consequently, in addition to the APC/CCdc20 inhibition by 
MCC that is mediated by protein-protein interactions, a catalytic inhibition of Cdc20 







Figure 1.4 Expression of Cdc20 is dynamically regulated during the cell cycle 
Oscillations in protein levels of Cdc20 orthologs from fission yeast (Slp1) (S. pombe), 
budding yeast (S. cerevisiae) and humans (H. sapiens) during the cell cycle progression. 
Each curve represents results of an independent time course experiment from different 
research groups (or from the same group if labeled with the same name). Red dots 
indicate the cell cycle phase, in which a particular Cdc20 ortholog reaches its peak levels. 





1.6 Roles of Bub1 kinase in mitosis 
Bub1 (budding uninhibited by benzimidazole 1) is a serine/threonine-protein kinase 
containing a conserved kinase domain at its C-terminus. Bub1 is recruited to unattached 
kinetochores during mitosis, and its slow FRAP recovery rates suggest that it is a more 
stable component of kinetochores than the other two Bub proteins (Bub3 and 
BubR1/Mad3) (Bonnie J Howell et al., 2004). Bub1 has been reported to have multiple 
roles in mitosis, either performed by its non-kinase region (N-terminal and middle) or the 
kinase domain (C-terminal).  
1.6.1 Roles of Bub1 that do not require its kinase activity 
Non-kinase roles of Bub1, for which its kinase function is dispensable, were previously 
mentioned in the section we described the SAC activation at kinetochores (1.4.1). In 
brief, Bub1 is recruited to the phosphorylated (by Mps1) kinetochore protein KNL1 
(Spc7 in fission yeast) through Bub3, where it functions as a scaffold for the 
subsequent localization of downstream SAC proteins, such as Mad1, Mad2, Mad3 
(BubR1 in animals) and Cdc20 (Klebig, Korinth, & Meraldi, 2009; Rischitor et al., 
2007; Shepperd et al., 2012a; Vanoosthuyse et al., 2004; Mathijs Vleugel et al., 2013). 
In this way Bub1 significantly contributes to the activation and maintenance of a robust 
SAC response upon spindle damage. 
 
A recent study in human cells has proposed that although Bub1 promotes Mad1 
recruitment to unattached kinetochores, its ability to activate the SAC correlates more 
strongly with its ability to recruit Cdc20 (M. Vleugel et al., 2015). This function of 
Bub1 is dependent on its ABBA motif (A-box-like motif) and BubR1 (Mad3). 
Consequently, the kinetochore recruitment of Cdc20 by Bub1 has been suggested to 
activate the SAC by bringing the Cdc20 in close proximity to newly formed C-Mad2. 
In addition, Bub1 dependent kinetochore recruitment of Cdc20 may also promote the 
SAC response by mediating a kinetochore-driven modification of Cdc20 (such as 






1.6.2 Roles of Bub1 that require its kinase activity 
In this section we summarise observations in different model organisms which suggest 
two major roles for Bub1 kinase activity that are relevant to mitosis: (i) roles in 
maintaining accurate chromosome bi-orinetation; (ii) roles in the SAC signalling. 
1.6.2.1 Bub1 kinase activity for chromosome bi-orientation 
In mitosis, Bub1 kinase has been shown to recruit the Shugoshin protein (Sgo2 in 
fission yeast; Sgo1 in budding yeast and human cells) to inner centromere through 
direct phosphorylation of H2A (Kawashima, Yamagishi, Honda, Ishiguro, & 
Watanabe, 2010). By catalysing the centromere localization of Shugoshin, Bub1 
kinase contributes to ensuring chromosome bi-orientation through two downstream 
mechanisms: 
1. Sgo1 has been reported to protect centromere cohesion from premature 
separation by associating with PP2A phosphatase that counteracts kinases 
targeting the cohesin complex (Tang, Sun, Harley, Zou, & Yu, 2004). 
 
2. Sgo1 (in mammalian cells and budding yeast), and Sgo2 (in fission yeast) have 
been demonstrated to recruit Aurora B to the inner centromere, where it 
destabilizes erroneous kinetochore–microtubule attachments (error correction) 
(Ruchaud, Carmena, & Earnshaw, 2007). Through the disruption of aberrant 
attachments, Aurora B promotes SAC signalling by creating unattached 
kinetochores. In addition, Aurora B is required for the recruitment of Mps1Mph1 
to unattached kinetochores in fission yeast (S. Heinrich et al., 2012), which is 
of vital importance for a stable SAC response. These two observations suggest 
that Bub1 kinase activity appears to contribute to the SAC signalling through 
the H2A-Shugoshin-Aurora B pathway. In the next section, we summarise the 






1.6.2.2 Bub1 kinase activity for a robust SAC response 
Unlike its chromosome bi-orientation roles described above, requirement of the Bub1 
kinase activity for the SAC response is less well understood. Contribution of Bub 
kinase activity to delaying anaphase onset in response to spindle damage has been 
investigated in different model organisms (fission yeast, budding yeast, Xenopus egg 
extracts and cultured human cells) and under various experimental conditions (such as 
different levels of spindle perturbation to induce SAC activation). 
1.6.2.2.1 Bub1 kinase activity in budding yeast SAC 
An early study in budding yeast reported that Bub1 is a kinase protein that is able to 
autophosphorylate and to catalyze phosphorylation of Bub3 (Roberts, Farr, & Hoyt, 
1994). This study also suggested that the kinase activity of Bub1 is required for the 
SAC response, as a Bub1 kinase-dead mutant (bub1-K733R) fails to rescue the 
benomyl sensitivity exhibited by a bub1 null strain. However, bub1-K733R was later 
found to be less stable than the wild type Bub1 in mitotically arrested cells (Cheryl, 
Johnston, Joseph, Hardwick & Spencer, 2003), which might have caused the SAC 
deficiency observed previously (Roberts et al., 1994). 
Another budding yeast study investigated the kinase activity of Bub1 extensively, 
using a truncated Bub1 kinase allele (bub1ΔK) that lacks the whole kinase domain, yet 
is as stable as the wild type Bub1 (Fernius & Hardwick, 2007). Bub1ΔK was tested 
using different degrees of spindle perturbation. First, bub1ΔK cells were demonstrated 
to have growth defects when exposed to anti-microtubule drugs (benomyl); bub1ΔK 
cells are more sensitive than mad3Δ cells, but not as sensitive as bub1 null cells. 
Moreover, bub1ΔK cells die rapidly (at similar rates to bub1 null and mad2Δ cells) 
when they are first grown in the presence of nocodazole (microtubule 
depolymerisation), and then plated on a rich media. This sensitivity of bub1ΔK cells is 
not due to a defect in arresting at metaphase in the presence of unattached kinetochores. 
Instead, it is mainly caused by a defect in chromosome bi-orientation, as bub1ΔK cells 





Subsequent experiments demonstrated that whilst the Bub1 kinase domain is not 
essential for the SAC response to unattached or defective kinetochores, it is essential 
for the SAC response to lack of tension at sister kinetochores (Fernius & Hardwick, 
2007). 
1.6.2.2.2 Bub1 kinase activity in fission yeast SAC 
Fission yeast Bub1 has been reported to be hyperphosphorylated by Cdk1 in vitro and 
in cells arrested at metaphase upon spindle damage. This phosphorylation of Bub1 is 
required to activate the SAC (Yamaguchi, Decottignies, & Nurse, 2003). In addition, 
Bub1 kinase activity is also required for a complete SAC function, as both the bub1-
K762R allele (equivalent of the budding yeast bub1-K733R) and a Bub1 truncation 
allele lacking the entire kinase domain (both of them are as stable as the wild type 
Bub1) failed to delay anaphase onset in response to the anti-microtubule drug 
carbendazim (CBZ). Importantly, the double mutant Bub1 allele (bub1*P Cdk1, 
bub1Δkinase), which both lacks its kinase domain and is refractory to Cdk1 mediated 
phosphorylation, exhibits a more severe SAC defect than the single mutants. This 
suggests that Cdk1-mediated phosphorylation of Bub1 and the kinase activity of Bub1 
itself promote the SAC response non-redundantly, as losing them simultaneously 
results in an additive SAC defect (Yamaguchi et al., 2003). 
Another fission yeast study analysed Bub1 kinase activity by mutating the invariant 
lysine 762 into methionine to generate the bub1-K733M allele (Vanoosthuyse et al., 
2004). When the microtubules are depolymerized by the cold sensitive tubulin mutant 
nda3-KM311, bub1-K733M cells exhibit cut (cell untimely torn) phenotype more 
frequently than wild type, in which cells exit mitosis forming septa without equal 
chromosome segregation. This suggests that Bub1 kinase activity in response to 
unattached kinetochores is required for a complete SAC response. More importantly, 
upon recovery from the nda3-KM311 arrest, bub1-K733M cells exhibit lagging 
chromosomes very frequently, which suggests that Bub1 kinase activity is necessary 






Bub1 kinase activity was further investigated in a recent fission yeast study, in which 
a different kinase-dead Bub1 allele (bub1-K762R D900N) was constructed through 
two point mutations: one in its ATP binding motif (lysine 762 to arginine) and another 
in the catalytic site (aspartate 900 to asparagine) (Kawashima et al., 2010). This group 
generated the bub1-K762R D900N allele because they have demonstrated that the 
previously reported (Yamaguchi et al., 2003) canonical ‘kinase-dead’ protein (bub1-
K762R) still retains residual kinase activity in vitro (< 1/100 of wild type Bub1 
activity) and in vivo. On the other hand, the bub1-K762R D900N allele has been shown 
to have no kinase activity. In addition, wild type Bub1 was shown to 
autophosphorylate (in vitro) as well as it catalyses the phosphorylation of H2A (in 
vitro and in vivo). Experiments with the bub1-K762R D900N allele demonstrated that 
lack of Bub1 kinase activity only slightly impairs the SAC response to unattached 
kinetochores (through the nda3-KM311 mutation depolymerizing microtubules). 
However, when the tension between sister chromatids is lost, (through the psc3-1T 
temperature-sensitive cohesin mutation disrupting sister cohesion) Bub1 kinase 
activity is essential for a SAC response to delay anaphase. As described above, Bub1 
phosphorylates H2A, and thereby recruits Sgo2 to inner centromeres, which is mainly 
required for chromosome bi-orientation. Forced enrichment of Sgo2 at centromeres is 
able to rescue only half of the SAC defect observed in the absence of Bub1 kinase 
activity when the tension between chromatids is lost (Kawashima et al., 2010). 
1.6.2.2.3 Bub1 kinase activity in Xenopus SAC 
An early study in Xenopus egg extracts reported that Bub1 is a kinase protein that 
autophosphorylates as well as it catalyses phosphorylations of Bub3 and Mad1 in vitro 
(Sharp-Baker & Chen, 2001). In vivo immunoprecipitations show that Bub1 is 
phosphorylated during interphase, mitosis, and SAC mediated arrest. Sharp-Baker and 
colleagues constructed a kinase-dead Bub1 allele (K872R) by mutating the invariant 
lysine 872 to arginine, which does not autophosphorylate. Catalytically inactive Bub1 
K872R (transcribed in vitro and translated in egg extracts) was shown to be capable of 
restoring the SAC response and the kinetochore recruitment of Mad1, Mad2 and Bub3 
proteins in Bub1-depleted egg extracts in response to high density of sperm nuclei 




(10 ng/µl). (Sharp-Baker & Chen, 2001). However, it is worth noting that the kinase 
inactive Bub1 K872R mutant was translated at a noticeably higher level than the wild 
type Bub1. This might have accounted for the capability of the kinase inactive mutant 
in the SAC response. In other words, non-kinase SAC functions of the kinase-dead 
Bub1 mutant (that was more abundant than the wild type) might have compensated for 
its missing kinase activity. Importantly, to activate the SAC Sharp-Baker and 
colleagues perturbed spindle by exposing the egg extracts to high numbers of sperm 
nuclei and high dose nocodazole (10ng/µl) (optimal conditions to activate the SAC). 
Among components of the SAC machinery, the role of Bub1 kinase activity may be 
maintaining the SAC response by fine-tuning it, rather than being directly responsible 
for the assembly of the ultimate inhibitor of APC/C (mitotic checkpoint complex, 
MCC). During such severe spindle perturbation, Bub1 kinase activity may not be 
detectable; as cells are expected to assemble high amounts of MCC, which might delay 
anaphase onset regardless of Bub1 kinase activity. 
A similar Xenopus study from the same group has addressed this hypothesis (Chen, 
2004), that any subtle difference in the SAC function between wild type and kinase-
dead Bub1 may be revealed only under suboptimal conditions for the SAC activation. 
Chen tested this possibility by treating the egg extracts with lower concentrations of 
nocodazole (or sperm nuclei) to disrupt microtubule-kinetochore attachment to 
different degrees. First, they confirmed that Bub1 becomes hyperphosphorylated in 
mitosis; and demonstrated that Bub1 phosphorylation by MAPK promotes its further 
phosphorylation by other kinases, which collectively induce Bub1 kinase activity 
specifically on unattached chromosomes. Second, analysis of the kinase-dead Bub1 
mutant (Bub1 K872R) revealed that although the kinase-dead Bub1 is fully SAC 
proficient under optimal spindle perturbation conditions (high concentration of 
nocodazole, 10 ng/µl; and sperm nuclei 10000/ µl extract), it is compromised in the 
SAC function under sub-optimal spindle perturbation conditions (low concentration of 
nocodazole, 1 ng/µl; and sperm nuclei 7500/ µl extract). This suggests that the kinase 
activity of Bub1 does not function as an on-off switch of the SAC; instead, it modulates 
the strength of the SAC signal generated from each kinetochore, and appears to 
become more important for the maintenance of the SAC when the number of 




1.6.2.2.4 Bub1 kinase activity in human SAC 
As described in the previous sections, Bub1 kinase activity has been suggested to 
contribute to the SAC response in various species, by employing different methods/ 
conditions to activate the SAC. However, a substrate of Bub1 kinase, whose 
phosphorylation may directly promote the SAC signalling (other than H2A, as its role 
is indirect and mainly through the Aurora B recruitment to centromeres (S. Heinrich 
et al., 2012)), had not been implied until a report published in 2004 (Tang, Shu, et al., 
2004).  
Tang and colleagues demonstrate that six residues of human Cdc20 (N-terminal), 
phosphorylated in vitro by Bub1, are phosphorylated in vivo in a Bub1-dependent 
manner. In addition, expression of a Cdc20 mutant that is nonphosphorylatable on 
these residues has a dominant-negative effect, which results in 50% of the cells leaking 
through the SAC arrest in the lack of microtubule-kinetochore attachments (generated 
through nocodazole treatment) or the tension between chromatids (generated through 
taxol treatment). On the other hand, this mutation does not affect either Cdc20 
recruitment to kinetochores or its binding to the other components of mitotic 
checkpoint complex (Mad2 and BubR1). Moreover, both Mad2 and BubR1 are 
capable of inhibiting the Cdc20 mutant (nonphosphorylatable on the six N-terminal 
residues by Bub1) by direct binding at least in vitro (Tang, Shu, et al., 2004). 
It is worth noting that the mutation of the six serine/ threonine sites on Cdc20 does not 
completely abolish its Bub1 mediated phosphorylation in vitro. This residual 
phosphorylation of Cdc20 is not due to a co-purified kinase contaminant, as it is not 
observed in the presence of a kinase-inactive Bub1. This suggests that there may be 
other sites of Cdc20 which are likely to be phosphorylated by Bub1. On the basis of 
these findings, Tang and colleagues conclude that Bub1 kinase activity towards Cdc20 
is crucial for a complete SAC response and full inhibition of APC/C activity (Tang, 
Shu, et al., 2004). 
Another study from the same group addressed whether the Bub1 kinase activity is 
required for the SAC response to spindle damage (Kang et al., 2008). They showed 
that in Bub1 depleted HeLa cells (by Bub1 RNAi) exposed to nocodazole, expression 




delaying premature anaphase onset. This suggests that the kinase activity of Bub1 is 
required for a full SAC response in human cells.  
Kang and colleagues next solved the crystal structure of the C-terminal domain of 
Bub1, consisting of its kinase domain and a 60 residue fragment N-terminal to it. The 
structure reveals that the extension fragment organizes the activation segment and the 
ATP-binding pocket of Bub1 in a similar way to the activation of cyclin- dependent 
kinases (Cdks) by cyclins. Mutations in the N-terminal extension disrupt the kinase 
activity of Bub1 (Kang et al., 2008).  
Interestingly, compared to other kinases, Bub1 has an extended substrate recognition 
loop that limits the access of non-specific substrates by blocking the active site of 
Bub1. Bub1 contains two KEN boxes in its central region, which mediate its 
degradation by APC/CCdh1 in G1 phase (Qi & Yu, 2007). In addition, Kang and 
colleagues demonstrated that these KEN boxes of Bub1 are also required for Cdc20 
binding, efficient phosphorylation of Cdc20 by Bub1, and the SAC response (Kang et 
al., 2008). These data suggest that Bub1 has a considerable specificity toward Cdc20, 
because Cdc20 is one of only two known KEN box receptors. The other KEN box 
receptor is Cdh1 (the other activator of the APC/C); however, Cdh1 is not efficiently 
phosphorylated by Bub1 in vitro (Tang, Shu, et al., 2004) presumably because it lacks 












1.7 SAC silencing and recovery from a SAC mediated arrest 
While it is essential to inhibit APC/C when kinetochores are unattached, the ability to 
alleviate APC/C inhibition once the SAC is satisfied is equally crucial for mitotic 
progression. Once all sister kinetochores stably attach to microtubules emanating from 
opposite poles, the ‘wait anaphase’ signal mediated by the SAC is extinguished. The 
major downstream consequence of the SAC silencing is the disassembly of the mitotic 
checkpoint complex (MCC), and the subsequent activation of the APC/C by Cdc20. 
SAC silencing is regulated by multiple mechanisms. 
The most widely conserved silencing mechanism is the phosphatase activity of protein 
phosphatase 1 (PP1; Dis2 in S. pombe). PP1 is required for mitotic exit (Vanoosthuyse 
et al., 2009). KNL1 (Spc7 in fission yeast) cooperates with the kinesins Klp5/6 to 
recruit PP1/Dis2 to kinetochores (Meadows et al., 2011). In the absence of kinetochore 
tension, Aurora B phosphorylates KNL1, and inhibits it from recruiting PP1. Once 
kinetochores are under tension, KNL1 leaves the phosphorylation range of Aurora B, 
thus is relieved from the inhibitory phosphorylation (Liu et al., 2010). This enables the 
localisation of PP1 to the kinetochores, whereupon it counteracts the checkpoint kinase 
activity. PP1 activity removes Bub1-Bub3 from kinetochores, which subsequently 
removes Mad1 and Mad2 (London et al., 2012), yet direct targets (substrates) of PP1 
remain to be discovered. 
Another model for the SAC silencing suggests that a vertebrate protein known as 
p31comet interacts with closed Mad2 (C-Mad2; the only state of Mad2 that can 
recognize Mad3 in fission yeast (Chao et al., 2012a)) in a way similar to interactions 
of C-Mad2 with open Mad2 (O-Mad2), Cdc20 or Mad3. Binding of p31comet to Mad2 
has been found to promote MCC disassembly (Westhorpe et al., 2011). It has been 
suggested that binding of p31comet to MCC through Mad2 may trigger a conformational 
change in Cdc20, facilitating its phosphorylation by Cdk1, which subsequently 
promotes dissociation of Cdc20 from BubR1 (Miniowitz-Shemtov et al., 2012).  
Another SAC silencing mechanism is known as ‘dynein-mediated stripping’ of 
checkpoint proteins, albeit it has only been reported by vertebrate studies. Dynein 
localizes to kinetochores (not in all eukaryotes), and the attachment of microtubules to 
































In this study, we aim to further our understanding of the phospho-regulation of the 
spindle assembly checkpoint (SAC), specifically by investigating roles of Bub1 kinase 
activity in fission yeast SAC signalling. In order to investigate that: 
1. We examine roles of Bub1 kinase activity in: 
1.1 Maintaining a SAC mediated metaphase arrest in response to various 
degrees of spindle perturbation 
1.2 Recovering from the SAC arrest and progressing into anaphase, once 
spindle reforms and chromosomes are bioriented. 
2. We investigate the protein(s) downstream of Bub1 kinase activity by: 
2.1 Identifying the substrate(s) of Bub1 kinase (Cdc20) 
2.2 Mapping phosphorylated sites of Cdc20 by Bub1 
2.3 Analysing interactions between the MCC components by cross-linking 
mass spectrometry analysis (Cdc20, Mad2 and Mad3) to determine 
Cdc20 phosphorylation sites that may be important for SAC regulation. 
2.4 Engineering the cdc20+ gene at its endogenous locus (inserting an 
antibiotic resistance marker and an internal epitope tag) for using in 
subsequent experiments. 
2.5 Generating phosphorylation mutants of Cdc20 to analyse its regulation 
through putative Bub1-phosphorylated sites. 
3. We examine roles of Cdc20 phosphorylation (C-terminal) by analysing 
phospho-deficient or phospho-mimicking mutants of Cdc20 in: 
3.1 Unperturbed mitosis or various degrees of spindle perturbation in terms 
of their abilities to maintain a SAC response. 
3.2 Prolonged spindle destabilisation followed by re-polymerisation of 
microtubules, in terms of their abilities to recover from the SAC and 
progress into anaphase. 
3.3 The absence of Bub1 kinase activity to test whether Cdc20 phospho-
mimicking mutants can rescue the SAC defects exhibited by the Bub1 





Chapter 2: Materials and Methods 
2.1 Buffers and solutions 
10 x TBE 
Tris 445 mM 
Boric acid 445 mM 
EDTA (pH 8) 100 Mm 
SDS gel running buffer (1x) 
Tris 50 mM 
Glycine 384 mM 
SDS 2 % 
Coomassie Blue stain 
0.16 % Coomassie Blue in 4 volumes methanol 
4 volumes acetic acid 
5 volumes ddH20 
PonceauS stain 
PonceauS 0.25 g 
Acetic acid 12.5 ml 
ddH20 to 250 ml 
Semi-dry transfer buffer (1x) 
Tris-Cl 25 mM 
Glycine 129 mM 






2.2 Growth media 
Bacteria media (LB) 
Component Final conc. 
Bacto-tryptone 1 % (w/v) 
Bacto-yeast extract 0.5 % (w/v) 
NaCl 
pH adjusted to pH 7.2 with NaOH 
0.5 % (w/v) 
 
Yeast media 
Yeast extract supplemented (YES) 
Component Final conc. 
Yeast extract 0.5 % (w/v) 
D-glucose, anhydrous 0.5 % (w/v) 
Supplements mix 1x 
 
Pombe minimal medium (PMG) 
Component Final conc. 
Phtalic acid 14.7 mM 
Di-sodium hydrogen orthophosphate, 
anhydrous 
15.5 mM 
L-glutamic acid, monosodium salt 25.4 mM 




Vitamins mix 1x 
Minerals mix 1x 
Supplements mix 1x 
 
Supplements mix (20x) 
Component Mass 
Adenine 0.4 g 
Arginine 0.4 g 
Histindine 0.4 g 
Leucine 0.4 g 
Uracil 0.4 g 
Lysine 0.4 g 
Distilled water to 250 ml 
 
 
Vitamins mix (1000x) 
Component Final conc. 
Biotin 10 mg/l 
Pantothenic acid 1 g/l 
Nicotinic acid 10 g/l 




2.3 Insect cell methods 
This section describes the methods used in baculovirus/insect cell experiments. 
Expression and purification of protein complexes were carried out in five steps: 
 
2.3.1 Cloning target DNAs into a transfer vector 
Genes encoding the components of a protein complex were cloned into pFL using the 
multiple cloning site of the transfer vector. The efficiency of cloning was checked by 
analytical digestion and sequencing. 
 
2.3.2 Integration of the transfer vector into the baculoviral genome 
The Transfer vector carrying the insert was integrated into the baculovirus genome 
through transformation into engineered E.coli cells (DH10EMBacY) (a gift from Ken 
Sawin) containing this genome as a bacterial artificial chromosome (bacmid). This 
integration is performed using Tn7- dependent transposition. To enable the 
transposition, DH10EMBacY cells contain a helper plasmid (Tet resistant) that 
expresses the Tn7 transposon complex upon induction with IPTG. Selection of 
positive colonies occurs via blue-white screening. Insertions of the mini-Tn7 into the 
mini-attTn7 attachment site on the bacmid disrupt the expression of the LacZα peptide. 
Hence, colonies containing the recombinant bacmid are white and colonies that harbor 
the unaltered bacmid are blue. Moreover, DH10EMBacY cells are kanamycin resistant 
and the integrated part of transfer vector (pFL) carries a gentamicin resistance gene. 
Thus, to select for the right transformants, LB plates were prepared with the following 
markers: kanamycin (50 g/ml), gentamicin (7 g/ml), tetracycline (10 g/ml), bluo-
gal (100 g/ml), IPTG (40 g/ml). Furthermore, DH10EMBacY cells carry a YFP 
reporter gene in the bacmid that is expressed by the same promoter as the insert gene. 
This enabled us to screen the expression of our gene of interest by examining YFP 
expression under UV light.  Transformed cells were selected by blue/ white screening. 
Bacmid was isolated from white cells using PureLink HiPure Plasmid DNA Miniprep 




2.3.3 Initial insect cell infection with bacmid and generation of virus 
Recombinant bacmids containing the genes of interest were used to transfect insect 
cells in order to produce recombinant baculovirus. On the first day, an exponentially 
growing monolayer Sf9 culture (1-1.5 x 106 cells/ml) with 95% viability was diluted 
in serum and antibiotic free SF-900 II media (Invitrogen) to 0.4 x 106 cells/ml. One 
hour prior to transfection 2.5 ml cells (1 x 106) were added to each well of a 6- well 
plate. Cells were allowed to attach the plate for one hour at 27C. Meanwhile the 
transfection mixture was prepared. For each well to be transfected, 2 g bacmid DNA 
and 10 l transfection reagent (Insect GeneJuice, Novagen) were diluted with 100 l 
media (serum and antibiotic free) in separate tubes. The diluted DNA was added to the 
diluted transfection reagent and mixed. The mixture was incubated at room 
temperature for 30 minutes followed by addition of 0.8 ml media (serum and antibiotic 
free). After the cells attached the plate, media was aspirated from the cells and replaced 
with the transfection mixture (~1 ml). Cells were incubated at 27C for 5 hours and 
then the transfection media was replaced with 2 ml medium (serum and antibiotic free). 
Approximately in 48- 72 hours, transfected insect cells start to demonstrate 
characteristics of very late infection (cessation of cell growth, granular appearance and 
release from the plate) as well as a YFP expression. 2 ml media was collected from 
wells with visibly infected cells. This medium contains the released virus. This is the 
high quality budded virus (P1) that has not yet suffered from damage that can occur 
through over-amplification from successive infection cycles. P1 virus was 
supplemented with 2% fetal bovine serum (FBS) and stored at 4C, protected from 
light. 
2.3.4 Virus amplification and test expression 
Initial virus amplification was carried out using a 25 ml suspension culture (1.8 x 106 
cells/ml) infected with 3 ml of P1 virus. This culture was incubated in 2L roller bottles 
(Corning) on the green sticky pads of a shaking incubator (InFors, at Edinburgh Protein 
Purification Facility, EPPF) at 27C, 95 rpm for 48- 72 hours. Cells were spun (at 500 
rcf, for 5 minutes) and the media containing the P2 virus was collected when the cell 
viability was around 75- 80 %, which was indicated using an automated cell counter 




PAGE and revealed by western blot. Expression was also confirmed by observation of 
YFP activity in the cell cultures. P2 virus was then used to infect a larger culture to 
obtain a virus solution (P3) with a higher titer and volume to be used in the ultimate 
protein expression. 
 
2.3.5 Protein expression 
Sf9 cells were used during the bacmid transfection and virus amplifications since they 
tend to clump less than other cell lines (enabling better observation of the infection 
symptoms) and attach firmly to plate surfaces. Once we obtained the P1 virus, we 
switched to suspension culture that provides better aeration and reproduction rates. 
Although Sf9 cells are suitable for suspension cultures, they double only once in 72 
hours whereas another insect cell line called High Five (Invitrogen) (kindly provided 
by Bill Earnshaw) has a much shorter doubling time (~18 hours). High Five cells are 
maintained in another media (ExpressFive, Gibco), but still could be infected with the 
virus released into Sf9 media. When High Five cells were initially transferred from 
tissue culture flasks to suspension culture, they started to form large aggregates of 
cells. Thus, 10 units/ ml Heparin (Heparin sodium salt from porcine intestinal mucosa, 
Sigma) was initially included in High Five media to prevent them from clumping, but 
removed before protein expression once clumping affected less than 10% of the total 
population. 500 ml of exponentially growing High Five cells (1.8 x 106 cells/ml, 98% 
viable) were infected with 10 ml of P3 virus. The cell pellet was harvested (spun at 
5,000 rpm for 20 minutes) 48 – 60 hours after the infection (when 70-80 % of the cells 
appeared to express YFP) and washed with phosphate buffer saline (PBS) to remove 
insect cell media. Cell pellets were stored at – 20°C. In this way more than 20 g of 







2.3.6 Protein purification 
Recombinant proteins expressed in the baculovirus and insect cell system carried a tag 
with two Strep II sites. A Strep II site is a short peptide (WSHPQFEK), which binds 
with high selectivity to Strep-Tactin, an engineered streptavidin. A tag with Strep II 
sites (strep-tag) allows affinity purification on immobilized Strep-tactin. Strep-tagged 
proteins bind to Strep-Tactin with a 100 times higher affinity (Kd = 1 µM) than to 
streptavidin. Then bound proteins are eluted using biotin (for magnetic beads) or 
desthiobiotin (for liquid chromotography). Desthiobiotin is a stable, reversibly binding 
analog of biotin, the natural ligand of streptavidin. Thawed insect cell pellets were re-
suspended in 5x volume (v/w) of lysis buffer. Cells were lysed by sonication (8 
minutes, 20% amplitude, 10 seconds on, 10 seconds off) and lysis efficiency was 
confirmed by checking the lysate under a bright-field microscope. Cell lysate was 
clarified by centrifuging at 22,000 rpm, 4C for 40 minutes. Supernatant was collected 
and re-adjusted to pH 8.0 before filtering with a 4.5 m filter (Millipore). Finally, 
recombinant protein was purified using magnetic beads.Pilot purification experiments 
involving relatively small pellets (<5 g) were performed using Strep-Tactin magnetic 
beads (Qiagen). The purification was carried out in the cold room. Magnetic bead 
suspension (70ul/ 1 g of pellet) was added to the cleared lysate and mixed on an end-
over-end shaker for 2 hours at 4C. The cell lysate – bead mixture was briefly 
centrifuged and the tube was placed on a magnetic separator for 2 minutes. The 
supernatant (flow-through) was removed and the beads were washed three times with 
1 ml wash buffer in each time. A magnetic separator was used to remove supernatants. 
Then the beads were re-suspended in 100 µl elution buffer and incubated for 5 minutes. 
The tube was placed on a magnetic separator and the supernatant was transferred to a 
new tube. Beads were subjected to four rounds of elution and the supernatants 
collected. Finally samples from all steps were mixed with SDS sample buffer, boiled 





Buffers used in the Strep-tactin magnetic-bead purification: 
 
2.4 DNA methods 
Polymerase chain reaction  
For cloning work, Phusion® 2X Master Mix (New England Biolabs) was used in 
accordance with the manufacturer’s instructions. PCR products were visualised by 
agarose gel electrophoresis using ethidium bromide.  
Restriction endonuclease digestion 
All restriction enzymes were obtained from New England Biolabs and used in 
accordance with the manufacturer’s instructions.  
Ligation 
Ligations were carried out using T4 Quick Ligase (New England Biolabs) in 
accordance with the manufacturer’s instructions before transformation into E. coli 
Ethanol precipitation of DNA 
Three volumes of ice-cold 96 % ethanol and 1/10 volume 3 M sodium acetate solution 
was first added to one volume of DNA solution to precipitate DNA from aqueous 
solutions. After incubating on wet ice for 30 min., tubes were centrifuged at 14,000 





50 mM NaH2PO4 pH 8.0, 0.3 M NaCl, 10% glycerol, 
0.05% Tween 20, 10mM 2-mercaptoethanol, 1 
Complete-Mini Protease Inhibitor Cocktail Tablet 
(EDTA-free) per 10 ml buffer, 0.5 mM Pefabloc, 0.4 
ug/ml DNase 
 
Strep-Tactin magnetic beads 
wash buffer 
 
50 mM NaH2PO4 pH 8.0, 0.3 M NaCl, 10% glycerol, 
0.05% Tween 20, 10mM 2-mercaptoethanol 
 
Strep-Tactin magnetic beads 
elution buffer 
 
50 mM NaH2PO4 pH 8.0, 0.3 M NaCl, 10% glycerol, 






rpm at 4 oC for 15 min. Supernatant was aspirated and the pellet was washed with 500 
µl of 70 % ethanol solution. The tubes were spun at 14,000 rpm at 4 oC for 10 min. 
After removing the wash solution, tubes were air-dried for 5-10 min. before the pellet 
was re-suspended in TE buffer.  
Site directed mutagenesis 
Site-directed mutagenesis was carried out using the Quikchange II site-directed 
mutagenesis kit (Strategene) according to the manufacturer’s instructions. Reaction 
volumes were reduced to 10 µl/reaction.  
Gateway cloning 
Gateway-based cloning was performed using the kit (LR Clonase II Enzyme Mix, 
Invitrogen) in accordance with the manufacturer’s instructions. Reaction volumes 
were reduced to 5 µl/reaction. 
Ethanol precipitation of DNA 
Three volumes of ice-cold 100 % ethanol and 1/10 volume 3 M sodium acetate solution 
were added to one volume of DNA solution to precipitate DNA. After incubating it on 
ice for 30 min., tubes were centrifuged at 14,000 rpm at 4 oC for 15 minutes. Then the 
supernatant was aspirated and the pellet was washed with 500 µl of cold 70 % ethanol 
solution. The tubes were spun at 14,000 rpm at 4 oC for 10 minutes. After removing 
the wash solution, tubes were air-dried for 5-10 minutes, and the pellet was re-
suspended in TE buffer. 
 
2.4 Fission yeast methods 
2.4.1 Yeast transformation 
Electroporation 
Yeast cells to be transformed were grown to mid-exponential phase (OD600 = 0.5) in 
YES overnight. Next day, cells were harvested (spun at 3000 rpm for 3 minutes), 
transferred to a pre-chilled microfuge tube and placed on ice. Then cells were washed 




sorbitol to a final density of 1 x 109 cells/ml. 40 µl of the cell suspension was mixed 
with 10 µl of transforming DNA (~1-2 µg)  in a pre-chilled tube. The mixture was then 
transferred to a pre-chilled cuvette (0.2 cm gap) and incubated for 2 minutes on ice, 
followed by electroporation at 1.8 kV, 200 Ω, 25 µF capacitance using a BioRad 
electroporator. Immidiately after electroporation, 500 µl of ice-cold 1 M sorbitol was 
added onto the cells, incubated 2 minutes on ice and transferred to a sterile microfuge 
tube. Cells were then spun, washed with water and plated onto YES plates. Once a 
thick layer of cells appear on the YES plate (2-3 days), cells were replica plated onto 
selective plates. 
 
2.4.2 Yeast genomic DNA extraction 
Yeast was extracted using the single-tube LiOAc-SDS lysis method described in 
(Lõoke, Kristjuhan, & Kristjuhan, 2011).  
 
2.4.3 Mitotic arrests 
G2 arrests (cdc25-22) for synchronous mitotic time courses treated with 
microtubule depolymerizing drug carbendazim (CBZ) 
Cells bearing the cdc25-22 mutation were grown in YES medium at 25°C to mid-log 
phase and then shifted to 36°C for 4 hours to arrest them in G2 phase. Once all cells 
exhibited characteristics of G2 phase (long cells were checked under the microscope) 
they were released into a synchronous mitosis, by shifting the temperature back to 
25°C in ice-water and then incubated at 25°C for 120-150 minutes. 20 mins after the 
G2 release into mitosis, the CBZ solution was spun at room temperature for 1 min at 
4500 rpm, and the soluble phase added to liquid cultures at 100 µg/ml final 
concentration to activate the spindle assembly checkpoint (SAC). Cells were 
harvested, then either fixed in 100% methanol (to be stained with DAPI or calcofluor), 






Preparation of the carbendazim (CBZ) solution 
A carbendazim stock solution (3.75 mg/ml) was prepared by dissolving it in pre-
warmed DMSO. This solution was vortexed and heated in a water bath set to 55°C for 
3.5 hours. Then the solution was vortexed again and cooled down to room temperature 
before use.  
 
Prolonged microtubule depolymerization via nda3-KM311 block 
Cells bearing the nda3-KM311 cold sensitive tubulin mutation were grown at the 
permissive temperature (30°C) to mid-log phase and then shifted to the restrictive 
temperature (18°C) for 6-9 hours to depolymerize their microtubules and activate the 
spindle assembly checkpoint (SAC). Cells were harvested, fixed in 100% methanol 
and stained with DAPI (to detect DNA) or calcofluor (to detect septa). 
 
SAC recovery assay 
nda3-KM311 cells arrested at 18°C for 6 hours were shifted back to the permissive 
temperature (30°C), and incubated for 30 minutes to allow microtubule re-
polymerization. Cells were harvested, fixed in 100% methanol and stained with DAPI 














Table 2.1 Fission yeast strains used in this study 
Strain Genotype  Source 
OS118 nda3-KM311 GFP-plo1::ura4+  Hardwick lab 
OS165 nda3-KM311 GFP-plo1::ura4+ bub1Δ::NAT  Hardwick lab 
OS172 nda3-KM311 GFP-plo1::ura4+ bub1 K762R D900N  This work 
OS260 cdc25-22 lid1-TAP::kan’mad2-GFP::his3 mad3-
GFP::his3 
 Hardwick lab 
OS261 cdc25-22 lid1-TAP::kan’mad2-GFP::his3 mad3-
GFP::his3 bub1 K762R D900N 
 Hardwick lab 
OS216 cdc25-22 lid1-TAP::kan’mad2-GFP::his3 mad3-
GFP::his3 sgo2Δ::NAT 
 This work 
OS190 cdc25-22 slp1-FLAG::hyg mad2-GFP::his3 mad3-
GFP::his3 bub1 K762R D900N 
 This work 
OS20 cdc25-22 slp1-FLAG::hyg mad3-GFP::his3  This work 
OS246 cdc25-22 slp1-FLAG::hyg mad2-GFP::his3 mad3-
GFP::his3 mph1-kd::NAT 
 This work 
OS191 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 
slp1S482A::hyg 
 This work 
OS188 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 
slp1S482A S483A S484A::hyg 
 This work 
OS210 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 S482E 
S483E S484E::hyg 
 This work 
OS201 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 
mad2Δ::ura4+ leu1 
 This work 
OS213 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 S482E 
S483E S484E::hyg mad2Δ::ura4+ leu1 
 This work 
OS18 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 slp1-
FLAG::hyg 
 This work 
OS184 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 
slp1S482A-FLAG::hyg 






Strain Genotype  Source 
OS154 nda3-KM311 GFP-plo1::ura4+slp1S482A S483A 
S484A::hyg 
 This work 
OS123 nda3-KM311 GFP-plo1::ura4+slp1S482E S483E 
S484E::hyg 
 This work 
OS129 nda3-KM311 GFP-plo1::ura4+slp1R488E::hyg  This work 
OS119 nda3-KM311 lid1-TAP::kan’ mad3-GFP::his3  Hardwick lab 
OS134 nda3-KM311 lid1-TAP::kan’ mad3-GFP::his3 
slp1S482E S483E S484E::hyg 
 This work 
OS135 nda3-KM311 lid1-TAP::kan’ mad3-GFP::his3 
slp1R488E::hyg 
 This work 
OS287 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 
slp1S482D::hyg 
 This work 
OS286 cdc25-22 lid1-TAP::kan’ mad3-GFP::his3 
slp1S482D::hyg bub1 K762R D900N  
 This work 
 
 
Table 2.2 Plasmids used in this study 
Name Description Source 
OS11 pDONR201-Slp1-FLAG::hyg Gateway This work 
OS5 pFL-MCC-DN David Barford 
OS18 pFL-bub1 This work 
OS19 pFL-bub1-kd  This work 








Table 2.3 Primers used in this study 




























Internal tag This 
work. 





















Internal tag This 
work. 




S1D mutation This 
work. 




S1D mutation This 
work. 
OS39 IE FW CCCCGTCCAGCAGCATAAC
AATCgaaTGAACAACACC 
IE mutation. This 
work. 
OS40 IE REV GGTGTTGTTCAttcGATTGTT
ATGCTGCTGGACGGGG 
IE mutation. This 
work. 
OS41 S3A FW CCAAAACCCCGgcggctgccAT
AACAATCCG 
S3A mutation This 
work. 
OS42 S3A REV CGGATTGTTATggcagccgcCG
GGGTTTTGG 
S3A mutation This 
work. 
OS43 S3E FW CCAAAACCCCGgaggaagagAT
AACAATCCG 
 
S3E mutation This 
work. 
OS44 S3E REV CGGATTGTTATctcttcctcCGGG
GTTTTGG 
S3E mutation This 
work. 





2.5 Protein methods 
2.5.1 Immunoprecipitations 
Anaphase promoting complex/cyclosome (APC/C) interaction  
Proteins were extracted from harvested cells in lysis buffer (50 mM HEPES pH 7.5, 
75 mM KCl, 1 mM MgCl2, 1 mM EGTA, 0.1% TritonX-100, 1 mM sodium vanadate, 
0.1 μM microcystin, complete mini EDTA free, and 1 mM pefabloc). Cells were 
resuspended in lysis buffer and bead-beat twice for 30 seconds. Lysates were spun and 
cleared lysates were incubated for 45 min with IgG-coupled Dynabeads (Invitrogen), 
which bind to Apc4-TAP. The immunoprecipitated complexes were washed five times 
with lysis buffer and then analysed by immunoblotting with sheep anti-GFP antibody, 
sheep anti-Mad2 and Peroxidase anti-Peroxidase (PAP) antibodies. 
Cdc20Slp1 (mitotic checkpoint complex) interaction  
The same steps described above were followed, except cells expressing Cdc20Slp1-
FLAG (instead of Apc4-TAP) were used, and the lysates from these cells were 
incubated with anti-FLAG-coupled Dynabeads, which bind to Cdc20-FLAG. 
2.5.2 SDS-PAGE 
Resolving gels were made following the recipe below: 
  12.5 %  
40 % acrylamide  4.7 ml  
2 % Bis  0.75 ml  
1.5 M Tris-HCl pH 8.8                    3.75 ml 
Water                      to 15 ml 
 
150 µl of 10 % ammonium persulfate (APS) and 20 µl TEMED were added to 
catalyse the polymerization of resolving gel. Once the gel solution was added 




allowed to set for 20 minutes. Then ispropanol was decanted, the gel was quickly 
rinsed and stacking gel solution was added. 
 
Stacking gels were made following the recipe below: 
40 % acrylamide 6.25 ml 
2 % Bis 3.33 ml 
1.0 M Tris-HCl pH 6.8 6.25 ml 
Water to 50 ml 
 
Proteins were resolved for 60-120 minutes at a constant voltage (110-170 V) in SDS-
PAGE running buffer (2 % SDS, 50 mM Tris, 384 mM glycine). After SDS-PAGE, 
proteins were transferred unto a nitrocellulose membrane (GE Healthcare) using a 
TE77 semi-dry transfer unit (Hoefer) at 135 mA for 120 min in semi-dry transfer buffer 
(25 mM Tris, 130 mM glycine, 10 % methanol).  
2.5.3 Immunoblotting 
Quality of the protein transfer was analyzed by Ponceau staining, and the membranes 
were blocked in blocking solution (1x PBS or TBS, 0.04 % Tween 20, 3-5 % w/v dried 
skimmed milk) for 30 minutes at room temperature and on a shaking platform, 
followed by overnight incubation with the primary antibody (diluted in blocking 
buffer) at 4 oC. Next day, membranes were washed with PBS or TBS + 0.04 % Tween 
3 times for 5 minutes each, before being incubated with secondary antibody (diluted 
in blocking buffer) for 40 minutes at room temperature. Membranes were washed with 
PBS or TBS + 0.04 % Tween 3 times before protein visualisation by 
chemiluminescence using an ECL detection kit (SuperSignal West Pico or 
SuperSignal West Femto, Pierce) according to the manufacturer’s instructions. 
Finally, membranes were exposed to X-ray films (Agfa Healthcare), which were 





Primary and secondary (HRP-conjugated) antibodies used in this study: 
Antibody Species Dilution Source 
Anti-Mad2 Sheep 1:1000 Hardwick lab 
Anti-FLAG M2 Mouse 1:1000 Sigma-Aldrich 
Anti-Cdc20Slp1 Rabbit 1:1000 Matsumoto lab 
Anti-tubulin (TAT1) Mouse 1:1000 Keith Gull 














1;5000 GE Healthcare 
 
 
2.5.4 In vitro kinase assays 
Fission yeast Bub1 and MCC (mitotic checkpoint complex) proteins, which were 
purified from insect cells (See chapter 4.1), were washed twice with 1 x kinase buffer 
(50 mM Hepes pH 7.5, 10 mM MgCl2, 0.5 mM DTT). 25 l of kinase reaction buffer 
(12.5 l 2x kinase buffer (100 mM Hepes, pH7.5, 20 mM MgCl2, 1 mM DTT), 0.5 l 
P32 gamma-ATP, 0.5 l 1 mM ATP, made up with substrate (MCC) and kinase (Bub1) 
in a final volume of 25 l was then incubated at 30C for 30 mins. Reactions were 
stopped by adding 2xSDS sample buffer, boiled and resolved in an SDS-PAGE gel. 
Then the gel was stained with Coomassie Blue, dried and phosphorylation signals were 
detected by exposing the gel to Typhoon phosphoimager. Cold kinase assays were 





2.5.5 Mass-spectrometry  
Cross-linking fission yeast MCC 
Recombinant MCC was expressed in insect cells and the cell lysate was incubated with 
Strep magnetic beads to immobilize the MCC. Cross-linking was performed using two 
different cross-linkers: BS3 or EDC, each of them requiring different buffer 
conditions. Therefore, beads solution was split into two; one half was resuspended in 
HEPES (pH 8.0) for cross-linking with BS3, and the other half in MES (pH 6.0) for 
cross-linking with EDC. Cross-linking reactions were carried out on the beads by 
Angel Chen (from Juri Rappsilber lab), followed by trypsin digestion and mass 
spectrometry. Cross-linking data was visualized using Xi Network Viewer (Generated 
by Juri Rappsilber lab). 
 
2.5.6 APC/C ubiquitination assays 
Fission yeast genes E1 (Uba1) and E2s (Ubc1, 4 and 11) inserted in pMAL and 
pET16b vectors respectively were kindly provided by Hiro Yamano. These vectors 
were used to express the proteins in BL21 RIL cells. MBP-Uba1 and His-tagged E2s 
were then affinity purified using either amylose (NEB) or talon resins (Clonetech). 
MBP-Uba1 was further purified by size exclusion chromatography using a Sephadex 
S200 column. Full-length APC/C activator Cdc20Slp1 and radiolabelled [Met 35S] 
APC/C substrate, securincut2 were produced by in vitro translation using the TNT 
Quick Coupled Transcription/Translation kit (Promega) according to manufacturer’s 
instructions using 1μg of pHY22-Cdc20Slp1 and pHY22-securincut2 plasmids also 
provided by Hiro Yamano. Lid1-TAP APC/C was affinity purified using IgG agarose 
beads (GE Healthcare) from S. pombe cells carrying the ts slp1-362 mutation to isolate 







In vitro APC/C ubiquitination assays were carried out following a method based on 
assays previously described for budding, fission yeast and human proteins (Foster & 
Morgan, 2012; Hwang et al., 1998). In brief, 0.05 mg/ml Uba1, 0.5mg/ml E2s (ubc1, 
ubc4 and ubc11) and 0.3 mM ATP were mixed with 1.5 mg/ml wild-type mono-
ubiquitin (Sigma Aldrich), 2µM ubiquitin aldehyde (Boston Biochem) in a 
ubiquitination buffer containing 25 mM HEPES pH 7.5, 100 mM KCl, 3mM ATP, 2.5 
mM MgCl2, and 0.2 mM DTT. The ubiquitination mix was incubated at 23 °C for 20 
min. 0.5 µM APC/C, 4 µl and 2 µl of Cdc20Slp1 and securincut2 respectively were then 
added to the mix in a total reaction volume of 20 µl.  Reactions were carried out at 23 
°C for 45 min and stopped by adding 4xSDS sample buffer. Samples were subjected 
to SDS-PAGE electrophoresis and visualised by radiography using the Typhoon 
phosphoimager.  The ubiquitination of securincut2 by APC/C was quantified using the 
ImageQuant software (GE Healthcare) to analyse the decrease in intensity of the 















Chapter 3: Roles of Bub1 kinase activity in the spindle 
assembly checkpoint 
3.1 Overview 
During mitosis, equal chromosome segregation is crucial to maintain chromosomal 
stability throughout the cell division cycle. A cellular surveillance mechanism, known 
as the spindle assembly checkpoint (SAC) ensures chromosomal stability  by delaying 
chromosome segregation (anaphase onset), until all sister kinetochores attain bi-
orientation (Conly L. Rieder et al., 1995). 
Bub1 kinase is one of the upstream enzymes of SAC signalling. Studies in various 
model organisms have reported two sets of Bub1 functions based on its structural 
domains: 
1. Non-kinase related functions (mediated by the N-terminal and middle regions 
of Bub1), which are mainly functionaing as a scaffold at the unattached 
kinetochores to recruit downstream SAC proteins (Klebig et al., 2009; 
Rischitor et al., 2007; Shepperd et al., 2012a; Vanoosthuyse et al., 2004; 
Mathijs Vleugel et al., 2013). 
2. Functions mediated by Bub1 kinase activity. Observations in various species 
have suggested two major roles for Bub1 kinase activity:  
(i) Ensuring chromosome bi-orientation by recruiting the Shugoshin 
protein (Sgo2 in fission yeast) to inner centromere through direct 
phosphorylation of H2A (Kawashima et al., 2010). 
(ii) Delaying premature anaphase onset (underlying mechanisms are 
currently unclear) to provide time for chromosome bi-orientation, 
which is the main focus of this chapter. 
Unlike its chromosome bi-orientation roles described above, roles of Bub1 kinase 
activity for the SAC response are less well-understood. Even though its downstream 
pathways remain to be discovered, several lines of evidence have demonstrated the 
requirement of Bub1 kinase activity for a robust SAC response.  
Several studies suggested that whilst the Bub1 kinase activity is not essential for the 




perturbation through nda3-KM311 tubulin mutation or high dose of nocodazole), it is 
essential for the SAC response to a few unattached kinetochores (generated by low 
dose nocodazole) or lack of tension at sister kinetochores (generated by cohesion 
mutants) in budding yeast (Fernius & Hardwick, 2007), fission yeast (Kawashima et 
al., 2010) and Xenopus egg extracts (Chen, 2004). In addition, in fission yeast cells 
(Yamaguchi et al., 2003) that are exposed to an-anti microtubule drug (75µg/ml 
microtubule depolymerising drug carbendazim, CBZ) during synchronous mitosis, the 
ability of the ‘kinase-dead’ Bub1 mutant to delay anaphase onset is 25-30% less than 
that of wild type Bub1. Compared to nda3-KM311 cold sensitive mutation, 
carbendazim (CBZ) treatment has been reported to cause relatively subtle spindle 
damage, as cells exposed to CBZ have been reported to retain short microtubule stubs 
associated with their spindle pole bodies (Petersen & Hagan, 2003). On the basis of 
these observations, we hypothesize that the SAC roles of Bub1 kinase activity may 
become more important to delay anaphase onset in response to relatively subtle and 
short spindle perturbation, rather than prolonged spindle damage. 
The ‘kinase-dead’ Bub1 mutant (bub1-K762R), that was constructed by Yamaguchi 
and colleagues, has been reported to retain residual kinase activity in vitro and in vivo 
(Kawashima et al., 2010). On the other hand, Kawashima and colleagues have 
demonstrated that mutating the catalytic site (D900N) of Bub1 in addition to mutating 
its ATP binding motif (K762R) abolishes its kinase activity (Kawashima et al., 2010). 
In this chapter, we aim to investigate roles of Bub1 kinase activity in SAC response 
using the bub1-K762R D900N allele (hereafter referred to interchangeably as bub1-
kd) (Kawashima et al., 2010) and analysing its ability to: 
- (i) Arrest at metaphase in response to relatively severe (nda3-KM311 tubulin 
mutation) spindle damage (ii) recover from the SAC arrest upon re-
polymerization of microtubules, and progress into anaphase. 
- (i)Arrest at metaphase in response to relatively subtle (carbendazim treatment) 
spindle damage (ii) recruit two of the MCC components (Mad2 and Mad3) to 




3.2 Analysis of Bub1 kinase function in response to microtubule 
depolymerisation by nda3-KM311 allele 
3.2.1 Analysis of Bub1 kinase function in maintaining SAC arrest at metaphase 
In order to examine abilities of wild type, bub1-kd (Figure 3.1A) and bub1 null cells 
to arrest at metaphase in response to depolymerised microtubules, we used the nda3-
KM311 cold sensitive tubulin mutation, by which microtubules are depolymerised at 
the restrictive temperature (18°C), and thereby the SAC is activated. Strains were 
grown overnight at the permissive temperature (30°C) to mid-logarithmic phase, and 
then shifted to the restrictive temperature (18°C) for 9 hours. Cell samples were 
collected 6 hours and 9 hours after the temperature shift, fixed in methanol and stained 
with DAPI to visualise DNA. In addition to scoring condensed DNA, we monitored 
localisation of polo kinase (Plo1-GFP) at spindle poles, which is another indication of 
a metaphase arrest (Bahler et al, 1998a; Mulvihill et al, 1999). 
During the nda3-KM311 block cells exhibited characteristics of three types of cell 
cycle stages (Figure 3.1D): the first type is late G2 cells, which have uncondensed 
DNA and relatively weak Plo1-GFP signal gradually accumulating on their spindle 
poles; the second type is metaphase arrested cells with condensed DNA and strong 
Plo1-GFP signal on spindle poles; the third type is the cut (cell untimely torn) cells, in 
which cells exit mitosis forming septa without symmetrical segregation of their sister 
chromatids. The cut phenotype correlates with defects in the SAC response, as in this 
case cells do not have a robust checkpoint machinery to delay mitotic exit when the 
spindle formation is perturbed (Yanagida, 1998). 
Figure 3.1B and C show that after spending 6 hours with depolymerised microtubules, 
52% of the wild type cells arrested at metaphase, 48% remained at late G2, and only 
1% exhibited cut phenotype. 
On the other hand, bub1 null cells did not arrest at metaphase at all, however exhibited 
41% cut and 59% late G2 phenotype. This result was expected since bub1 null cells 
are known to be SAC deficient (Vanoosthuyse et al., 2004).  
Despite having a fully functional Bub1 N-terminus, less bub1-kd cells arrested at 




after 6 hours of nda3-KM311 block, 11% of the bub1-kd cells exhibited cut phenotype. 
In other words, 11% of the bub1-kd cells leaked through the metaphase arrest and 
exited mitosis without accurate chromosome segregation. 
After 9 hours, Figure 3.1B displays that the difference between the abilities of wild 
type and bub1-kd in arresting at metaphase became more significant. While 76% of 
wild type cells arrested at metaphase, only 54% of bub1-kd cells were able to arrest. 
Furthermore, as shown in Figure 3.1C-D, bub1-kd cells exhibited the cut phenotype 
more frequently (12%) than wild type cells did (2%). In the absence of Bub1 protein, 
premature mitotic exit was even more frequent, which was indicated by 58% cut 
phenotype observed in bub1 null cells. 
These results suggest that the non-kinase region of Bub1 (N-terminal and the middle 
region) is essential for the SAC response, however its C-terminal kinase activity is still 
required for SAC maintenance during a prolonged and severe spindle perturbation 





























9 hours in nda3-KM311 block
bub1∆
D
Figure 3.1 Bub1 kinase activity is required for maintaining the SAC in nda3-KM311 block
  
(A) Cartoon illustrating S. pombe bub1 kinase-dead (kd) allele, in which the function of C-termi-
nal kinase domain is abolished through two point mutations: K762R (ATP binding site) and 
D900N (catalytic site). (B) Wild type, bub1-kd and bub1∆ cells bearing nda3-KM311 cold 
sensitive tubulin mutation were grown at the permissive temperature (30°C) and shifted to the 
restrictive temperature (18°C) for 9 hours. Cell samples were collected 6 hours and 9 hours 
after the temperature shift, fixed in methanol and stained with DAPI to visualize DNA. Graph 
plotting percentage of cells arrested at metaphase with condensed DNA and Plo1-GFP locali-
zation at their spindle pole bodies (SPBs). 9 hour results are the mean values of two independ-
ent experiments with the error bars represent standard error of the mean (SEM) (n=100 cells 
per time point). (C) Distribution of the cells described in B in terms of their cell cycle stage: late 
G2 cells (green) with uncondensed DNA and relatively weak or absent Plo1-GFP signal; 
metaphase arrested cells (blue) with condensed DNA and strong Plo1-GFP signal; cut cells 
(cell untimely torn) (orange) which exit mitosis forming septa, without equal chromatid segre-
gation. (D) Representative images from 9 hours of nda3-KM311 block, displaying the distribu-
tion of the cells in terms of their cell-cycle stage. Scale bar represents 5 microns.        








3.2.2 Analysis of Bub1 kinase function in recovering from the SAC arrest at 
metaphase 
In the previous section we demonstrated that Bub1 kinase function was important to 
fully activate the SAC response and arrest cells at metaphase when spindle formation 
was perturbed by nda3-KM311 cold sensitive mutation. In its absence (in the case of 
bub1-kd), higher frequency of ‘cut’ phenotype was observed, in which the cells exited 
mitosis without ensuring equal segregation of their chromosomes. 
In this section, we address whether Bub1 kinase activity has a role in recovering from 
the SAC-mediated metaphase arrest, upon formation of the spindle. To analyse this, 
we released wild type and bub1-kd cells (in the same experiment described in Figure 
3.1) from 6 hours of nda3-KM311 block at 18℃, shifting them back to the permissive 
temperature (32℃) to allow re-polymerisation of microtubules. Then we collected cell 
samples 10, 20 and 30 minutes after the temperature shift, and fixed them in methanol 
to process as described previously (Figure 3.1).  
Following the release from metaphase arrest we observed that the cells exhibited 
characteristics of various cell-cycle stages (Figure 3.2A). The first type is late G2 cells, 
which have uncondensed DNA and relatively weak Plo1-GFP signal gradually 
accumulating on their spindle poles. The second type is metaphase arrested cells with 
condensed DNA and strong Plo1-GFP signal on spindle poles. Metaphase cells consist 
of two subtypes; the cells displaying overlapped Plo1-GFP signals (one spot) on two 
spindle poles that are very close to each other early in metaphase and the cells 
displaying separated Plo1-GFP signals late in metaphase (two spots). The third 
category is anaphase cells, which have their sister chromatids equally separated, and 
pulled to the opposite poles by re-polymerised microtubules. The fourth is ‘cut’ cells, 
which exit mitosis forming septa, without equal segregation of their sister chromatids, 
and become aneuploid. 
On the basis of these criteria, Figure 3.2C shows that 10 minutes after the release from 
metaphase arrest 37% of initially arrested wild type cells exited mitosis by either 
progressing into normal anaphase (25%) or cut phenotype (12%) (mitotic exit without 




initially arrested bub1-kd cells exited mitosis, 30% of it progressing into normal 
anaphase and 21% exhibiting cut phenotype.  
After 30 minutes (Figure 3.2C), 81% of initially arrested wild type cells exited mitosis, 
with 74% normal anaphase and 7% cut phenotype. However, after 30 minutes 
percentage of mitotic exit was 93% for bub1-kd cells, exhibiting 68% normal anaphase 
and 25% cut phenotype. 
In order to compare mitotic exit rates of wild type and bub1-kd cells when spindle 
reformed, we plotted trend lines out of ‘% of initially arrested cells which exited 
mitosis upon microtubule re-polymerisation’ data. Linear regression analysis of these 
lines demonstrated that SAC recovery (mitotic exit) rates of wild type and bub1-kd 
cells were not significantly different from each other, indicated by the result that 
neither the slopes (stability of a certain recovery rate), nor the elevations (recovery 
rates themselves) are significantly different. 
In summary, (Figures 3.1A and B) upon re-polymerization of microtubules initially 
well-arrested wild type cells progressed into a normal anaphase with a low frequency 
of cut phenotype. On the other hand, bub1-kd cells did not only slip through the SAC 
arrest (with more frequent cut phenotype) throughout the nda3-KM311 block, but also 
exhibited an increasing number of cut phenotype during the recovery from the SAC 
mediated arrest.  
These results suggest that, Bub1 kinase function is important for both preventing 
premature mitotic exit when the spindle formation is perturbed, and ensuring equal 























Figure 3.2 Bub1 kinase activity is required to ensure equal chromosome segregation 
(A) Cells from the same experiment described in Figure 3.1 were blocked for 6 hours at 18°C 
with depolymerized microtubules through nda3-KM311 tubuline mutation. Immidiately after 
taking the 0 minute samples, cells were shifted to the permissive temperature (32°C) to allow 
re-polymerization of microtubules, and subsequent recovery from the SAC. Cell samples were 
taken at each 10 minutes for 30 minutes after the release from nda3-KM311 block, fixed in 
methanol, and stained with DAPI (purple) to visualize DNA, along with Plo1-GFP localisation at 
SPBs (green). Pictures demonstrate representative cell-cycle stages of the cells 0, 10, 20 and 
30 minutes after the release. Observed mitotic stages are annotated with dashed rectangles as 
follows: cells at late G2 (green); metaphase cells with one (light blue) or two (dark blue) 
Plo1-GFP spots at SPBs; cut cells (yellow); and anaphase cells (red). Scale bar represents 5 
microns. (B) Graph displaying the relative percentage of each cell-cycle stage for each strain 
throughout 30 minutes after the release (n=100 cells) (C) Graph plotting the percentage of 
metaphase cells at time=0, which progressed into anaphase or cut 0, 10, 20, 30 min after the 
release, using the following formula: 
     %    (anaphase cells + cut cells at 0, 10, 20 or 30 min) - (cut cells at 0 min)
              metaphase cells at 0 min
Linear regression analysis of the trend lines was performed using GraphPad Prism software:
* indicates lines with slopes that are not significantly different from each other; § indicates lines 
with elevations that are not significantly different from each other. 




3.3 Analysis of Bub1 kinase function in response to microtubule 
depolymerisation by an anti-microtubule drug 
In the preceding two sections, we have investigated possible roles of Bub1 kinase 
activity in activating (when microtubules depolymerized) and inactivating (when 
microtubules re-polymerized) the SAC, by employing nda3-KM311 cold sensitive 
tubulin mutation. Using the nda3-KM311 allele has multiple advantages and related 
downsides.  
First, it provides a switch-like control on the polymerization of microtubules, which is 
reversible by switching between restrictive (18℃) and permissive (32℃) temperatures. 
However, S. pombe cells grow very slowly at 18℃. Therefore, once an asynchronous 
culture is shifted to 18℃, the whole population may not enter mitosis and be blocked 
at metaphase. This was observed in the previous experiment, in which 47% and 16% 
of the wild type cells were in late G2 after 6 and 9 hours of nda3-KM311 block 
respectively. Second, because it is a genetic tool, spindle perturbation through nda3-
KM311 is much more penetrant than those obtained from anti-microtubule drugs. This 
is particularly useful to rule out possible outcomes of residual microtubule 
polymerization. On the other hand, this ‘absolute’ microtubule depolymerisation 
mediated by nda3-KM311 results in activation of a very strong SAC response. In other 
words, a prolonged nda3-KM311 block leaves all the kinetochores unattached for a 
considerably long period of time (6-9 hours), which leads to constant formation of high 
quantities of MCC. This is a condition, in which contributions from more subtle 
elements of the SAC machinery might be overlooked in the presence of excessive 
amount of MCC. Bub1 kinase activity may be playing such a subtle role in maintaining 
the SAC, compared to the direct involvement of MCC components (Cdc20, Mad2 and 
Mad3). Thus, in this section we investigate Bub1 kinase activity by employing a more 
subtle spindle perturbation that is mediated by an anti-microtubule drug called 
carbendazim (CBZ) (Petersen & Hagan, 2003). This way, we aim to dissect the roles 
of Bub1 kinase function under conditions where it might become more important for 





To do this, we employ temperature sensitive cdc25-22 mutant, which allows blocking 
the cells at G2 and releasing them into mitosis synchronously. To arrest cells in 
mitosis, they are treated with 100µg/ml CBZ 20 minutes after the G2 release (Note 
that cells have been observed not to enter mitosis if CBZ is added before 20 minutes, 
Jonathan Millar laboratory personal communication). 
3.3.1 Analysis of mitotic progression rate and kinetochore localization of MCC 
components in the presence of an anti-microtubule drug 
In the previously described nda3-KM311 time courses we used bub1 null allele as a 
negative control to examine bub1-kd allele in the context of the SAC. Although bub1-
kd cells were not able to activate the SAC at wild type levels, they were not as defective 
as bub1 null cells either. These results suggest that the N-terminal regulatory region of 
Bub1 is essential for the SAC, however C-terminal kinase function is still required for 
its maintenance during a prolonged spindle perturbation mediated by nda3-KM311 
mutation. 
In this section, we investigate Bub1 kinase activity using sgo2 null (Shugoshin2) as a 
control allele. S. pombe Sgo2 is required for loading the Aurora B complex 
(chromosome passenger complex) to centromeres, where it destabilizes erroneous 
attachments, and thereby activates the SAC (Vanoosthuyse, Hardwick, 2007). Bub1 
kinase has been shown to recruit Sgo2 to centromere through direct phosphorylation 
of H2A-S121(Kawashima et al., 2010). It has also been observed that the centromeric 
localization of Sgo2 is abolished in H2A-S121A and bub1-kd cells, which impairs the 
recruitment of Aurora B. Moreover, sgo2 null cells largely reproduced the defects of 
bub1-kd and H2A-S121A cells in ensuring accurate chromosome segregation, and 
delaying anaphase in the absence of sister chromatid cohesion. However, in an nda3-
KM311 block sgo2 null cells activated the SAC like wild type cells did (Vanoosthuyse, 
Hardwick, 2007), whereas bub1-kd cells were more defective in that regard 
(Kawashima et al., 2010). This suggests that Bub1 kinase might have other substrates 
which are involved in the maintenance of the SAC response. Considering that sgo2 
null phenocopies H2A-S121A (lack of H2A phosphorylation by Bub1), it can serve as 
an ideal separation-of-function allele which would help distinguish from other possible 




In order to investigate roles of Bub1 kinase function in regulating the progression rate 
of a mitosis with destabilized microtubules, wild type, bub1-kd and sgo2 null cells 
bearing cdc25-22 mutation were grown at 25°C to mid-log phase, and shifted to 36°C 
(restrictive temperature for the cdc25-22 allele). After 4 hours at 36°C, cells were 
synchronously released from G2 phase into mitosis by shifting them back to the 
permissive temperature (25°C). Cells were treated with the anti-microtubule drug 
(CBZ) 20 minutes after the release. Samples were collected at 30 minute time points 
for 150 minutes, fixed in methanol, and then stained with calcofluor to detect septa. 
Septation was scored as a readout of anaphase onset/ mitotic exit (Yanagida, 1998), in 
order to determine mitotic progression rate. In addition, two of the MCC components 
Mad2-GFP and Mad3-GFP were visualized, as they are known to localise at 
kinetochores in metaphase arrested cells (S. Heinrich et al., 2012). Although the delay 
of anaphase onset (manifested as the absence of septation) and the kinetochore 
localization of MCC components are related events both occurring at the metaphase 
arrest, they might be regulated by different pathways. To be able to separately evaluate 
these pathways we scored kinetochore localisation of Mad2 and Mad3 only in the 
population of non-septating cells.  
30 minutes after the G2 release (10 minutes after the CBZ treatment) all three strains 
(wild type, bub1-kd and sgo2 null cells) arrested at metaphase with a low septation 
index (15-20%) (Figure 3.3A). Consistent with this, all three strains displayed 
kinetochore localization of Mad2 and Mad3 in roughly half (wild type 55%; bub1-kd 
46%; and sgo2 null; 54%) of their non-septating cells (Figure 3.4B). 
60 minutes after the G2 release bub1-kd cells deviated from wild type and sgo2 null 
cells. While wild type and sgo2 null cells maintained a relatively robust SAC arrest 
indicated by only 41-45% septation, more than half of bub1-kd cells (66%) septated, 
as they could not delay anaphase onset (Figure 3.3A). Consistent with the maintenance 
of a SAC arrest, 90% of the non-septating wild type cells had Mad2 and Mad3 foci at 
unattached kinetochores. Although their SAC arrest (45% septation) was as robust as 
that of wild type cells (41% septation), a relatively small proportion of non-septating 











Figure 3.3 Bub1 kinase activity is required to delay premature anaphase in response 
to the microtubule drug CBZ
(A) Cdc25-22 temperature sensitive cells (wild type, bub1-kd and sgo2∆) were grown at the 
permissive temperature (25°C) until mid-log phase, then shifted to the restrictive temperature 
(36°C) for 4 hours to block in G2. Once all cells were blocked at G2-phase, they were shifted 
back to the permissive temperature (25°C) to be released into a synchronous mitosis 
(time=0). 20 minutes after the release, cells were treated with the microtubule depolymeris-
ing drug, 100 µg/ml carbendazim (CBZ) to activate the SAC response. Samples were 
collected at each 30 minutes time point. Graph plotting percentage of cells that formed 
septum (exited mitosis) throughout 150 minutes (n=100 cells). Results are the average of 
two independent experiments, and the values are expressed as mean ± SEM. (B)  Repre-
sentative images from 60 minutes after release into mitosis, displaying septation (in red) by 
calcofluor staining and Mad2-GFP, Mad3-GFP localisation (in green) at kinetochores. 
Scale-bar represents 5 microns. 











Figure 3.4 Bub1 kinase function is required to maintain the kinetochore localization of 
MCC components in response to CBZ
(A) Representative images at 120 minutes after release into mitosis, from the same experi-
ment described in Figure 3.3, displaying septation (in red) by calcofluor staining and 
Mad2-GFP, Mad3-GFP localisation (in green) at kinetochores. Scale-bar represents 5 
microns. (B) Graph plotting percentage of non-septating cells with Mad2-GFP and 
Mad3-GFP localized at kinetochores 30, 60, 90 and 120 min after the release into mitosis. 
(n= 30-80 cells).  





Strikingly at 60 minutes, only 14% of non-septating bub1-kd cells displayed robust 
Mad2 and Mad3 localisation to unattached kinetochores (Figures 3.3B and 3.4B). 
At the 90 minutes time point, abilities of wild type (56% septation) and sgo2 null cells 
(68% septation) to delay anaphase onset became slightly different. On the other hand, 
a considerable proportion of bub1-kd cells (87% septation) slipped through the SAC 
arrest, and progressed into anaphase. Kinetochore localization of MCC components 
was observed in 94% of non-septating wild type cells, whereas that became even less 
frequent in sgo2 null (33%) and remained low in bub1-kd cells (20%) (Figure 3.4B). 
Towards the end of the time course at 120 minutes, almost all of the bub1-kd cells 
exited mitosis (90% septation), whereas wild type (67% septation) and sgo2 null (77% 
septation) cells were more proficient at delaying anaphase onset. Despite the similar 
metaphase arrest profiles of wild type and sgo2 null cells, their MCC kinetochore 
localization frequencies appeared to be dramatically different. Mad2 and Mad3 
kinetochore foci were completely abolished in sgo2 null and bub1-kd cells, whereas it 
was observed in 94% of the non-septating wild type cells (Figure 3.4 A and B) 
These data suggest that at the early stages (30 minute) of a mitosis challenged with 
CBZ, Bub1 kinase activity is largely dispensable for both delaying anaphase onset and 
recruiting MCC components to kinetochores. However, at the later stages (60 minutes 
onward) it is required to maintain the SAC activity, to be able to sustain both the 
kinetochore recruitment of the MCC components and the anaphase delay. On the other 
hand, Bub1-mediated phosphorylation of H2A (Sgo2+) is not strictly required for 
either SAC activation or maintenance, as sgo2 null cells exhibited a similar mitotic 
progression to wild type cells. However, although the SAC response was intact without 
it, the Bub1-H2A-Sgo2-Aurora B pathway appears to play a role in the kinetochore 
localization of the MCC components, given sgo2 null cells became gradually defective 







Taken together, Bub1 kinase activity appears to be required for at least two main 
aspects of the SAC response:  
1) Localization of Mad2, Mad3 (maybe even Cdc20) at unattached 
kinetochores, where they assemble to form MCC. This role of Bub1 kinase 
function appears to be partially mediated through the Bub1-H2A-Sgo2-
Aurora B pathway. 
2) Arresting at metaphase to delay anaphase onset, and provide cells time to 
correct erroneous microtubule-kinetochore attachments. This role of Bub1 
kinase function appears to be largely mediated by another substrate(s) of 




















3.3.2 Analysis of MCC formation in an unperturbed mitosis 
In the preceding section we proposed that Bub1 kinase activity maintains the anaphase 
delay in response to spindle perturbation through an unknown substrate(s) (and/or its 
autophosphorylation). Since this substrate(s) does not appear to be in the Bub1-H2A-
Sgo2-Aurora B pathway, we hypothesize that it may be directly involved in the 
inhibition of APC/C.  
Considering that the mitotic checkpoint complex (MCC) is the ultimate effector of the 
SAC (London & Biggins, 2014b; Sudakin et al., 2001), we addressed whether the 
Bub1 kinase activity has a role in MCC formation. To analyse that, wild type, bub1-
kd and mps1-kd cells bearing cdc25-22 mutation were grown at 25°C, and shifted to 
36°C. After blocking cells at G2 phase for 4 hours, they were shifted back to 25°C to 
be released into an unperturbed mitosis (time 0). Cell samples were collected at 15 
minute time points for 135 minutes. Then the samples were lysed, subjected to anti-
FLAG (Cdc20) immunoprecipitation and processed for SDS-PAGE/western blotting, 
in which they were probed for two of the MCC components (Mad2 and Mad3). Note 
that, we used the SAC deficient Mps1 (Mph1 in fission yeast) kinase-dead (mps1-kd) 
allele as a negative control, because the kinase activity of Mps1 is required for MCC 
formation (unpublished data) and MCC-APC/C interaction (Zich et al., 2012). 
Figure 3.5A shows that, consistent with the previous observations, MCC formation 
was somewhat compromised in mps1-kd cells, whereas bub1-kd cells exhibited MCC 
formation similar to wild type levels. It is worth to note that the mitotic appearance of 
Cdc20 (Stephanie Heinrich et al., 2013) was observed to be slightly delayed in bub1-
kd cells (appearing at 45 minutes) compared to wild type (appearing at 30 minutes) 
(Figure 3.5B). This suggests that Bub1 kinase activity may be required for a timely 
mitotic entry after the G2 phase block. 
These results suggest that unlike Mps1 kinase activity, Bub1 kinase activity is not 
necessary for MCC formation in an unperturbed mitosis. 
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Figure 3.5 Bub1 kinase activity is not necessary for MCC formation in an unper-
turbed mitosis
Wild type, bub1-kd (kinase-dead Bub1) and mps1-kd (kinase-dead Mps1) cells were blocked 
in G2-phase for 4 hours through cdc25-22 temperature sensitivity, and then released into an 
unperturbed mitosis at 0 minute. Cells were harvested at each 15 minutes time point 
throughout 135 minutes. Coimmunoprecipitation (IP) analysis of the MCC formation is shown. 
Cdc20 (FLAG) was immunoprecipitated from cell extracts. Levels of  Mad3 (GFP) and Mad2 
coimmunoprecipitated with Cdc20 (FLAG) were analyzed by immunoblotting using anti-GFP 
and anti-Mad2 antibodies. Tubulin (TAT1) levels were analyzed as loading control. Cdc20 





3.3.3 Analysis of MCC-APC/C interaction in the presence of an anti-microtubule 
drug 
We demonstrated that bub1-kd cells can form MCC efficiently, therefore suggested 
that Bub1 kinase activity is not necessary for MCC formation in an unperturbed 
mitosis. However, formation of the MCC at wild type levels may not be sufficient to 
delay anaphase, considering the SAC maintenance defects of bub1-kd cells we 
previously observed in the presence of spindle damage (Figures 3.1, 3.3 and 3.4). Thus, 
we hypothesize that Bub1 kinase activity may have a role in MCC binding to the 
APC/C in response to spindle perturbation. 
To determine that, wild type and bub1-kd cells bearing cdc25-22 mutation were grown 
at 25°C, and shifted to 36°C. After blocking cells at G2 phase for 4 hours, they were 
shifted back to 25°C to release them into a synchronous mitosis (time 0), which was 
followed by CBZ treatment 20 minutes after the release. Cell samples were collected 
at 15 minute time points for 135 minutes. Then the samples were lysed, subjected to 
anti-TAP (APC4) immunoprecipitation and processed for SDS-PAGE/western 
blotting, in which they were probed for two of the MCC components (Mad2 and 
Mad3). 
As demonstrated in Figure 3.6, Mad2 and Mad3 began binding the APC/C at 30 
minutes after destabilisation of microtubules (20 minutes) in both wild type and bub1-
kd cells, though amount of MCC components interacting with APC/C was less in bub1-
kd cells. After 30 minutes, wild type cells maintained a detectable MCC-APC/C 
interaction until 120 minutes time point, whereas it was abolished at 60 minutes in 
bub1-kd cells. 
Considering that the MCC-APC/C interaction is the ultimate inhibitory mechanism of 
the SAC (London & Biggins, 2014b), these results are consistent with our previous 
findings (Figures 3.1 and 3.3) that bub1-kd cells are not able to maintain an anaphase 
delay in response to microtubule depolymerisation. Thus, we conclude that Bub1 
kinase activity contributes to the maintenance of anaphase delay, largely stabilizing 












Figure 3.6 Bub1 kinase activity is required to maintain the MCC-APC/C interaction
in response to the microtubule drug CBZ
Wild type and bub1-kd cells were blocked in G2-phase for 4 hours through cdc25-22 temper-
ature sensitivity, and then released into mitosis at 0 minute. At 20 minutes, cells were treated 
with the microtubule depolymerising drug CBZ to activate the SAC response. Cells were 
harvested at each 15 minutes time point throughout 135 minutes. Coimmunoprecipitation (IP) 
analysis of MCC-APC/C interaction is shown. Apc4 (TAP) was immunoprecipitated from cell 
extracts. Levels of  Mad3 (GFP) and Mad2 (GFP) coimmunoprecipitated with Apc4 (TAP) 
were analyzed by immunoblotting using anti-GFP antibody. Apc4 levels were analyzed as 
loading control. Mad3 (GFP) and Mad2 (GFP) are commonly detected as two bands due to 






In this chapter we investigated roles of fission yeast Bub1 kinase activity in SAC 
signalling under various spindle perturbation conditions: (i) severe (nda3-KM311 
tubulin mutation) or (ii) subtle (carbendazim treatment) microtubule depolymerisation. 
3.4.1 Bub1 kinase activity is important but not necessary for the SAC response to 
prolonged spindle damage 
In response to a prolonged exposure (9 hours) to severe (nda3-KM311 tubulin 
mutation) microtubule depolymerisation we observed that the kinase-dead Bub1 
mutant (bub1-K762R D900N) failed to maintain the SAC mediated metaphase arrest 
at wild type levels (22% less mitotic index than wild type), while exhibiting 
characteristics of the ‘cut’ phenotype (untimely mitotic exit with missing or aberrant 
chromosome segregation) more frequently (10% more than wild type), though not as 
frequently as bub1 null exhibited (56% more than wild type). 
Our observations are consistent with previous findings of (Kawashima et al., 2010), 
who constructed the kinase-dead Bub1 mutant allele (bub1-K762R D900N) that we 
have used in this study. (Kawashima et al., 2010) reported that in a 10 hours long nda3-
KM311 block, bub1-K762R D900N cells are 10% less efficient than wild type and sgo2 
null cells in arresting at metaphase. (comparable SAC proficiencies of wild type and 
sgo2 null has been also reported by (Vanoosthuyse, Prykhozhij, & Hardwick, 2007)). 
This suggests, Kawashima and colleagues indicated that bub1-K762R D900N was not 
as SAC defective (10%) as we observed (22%). This phenotypical difference might 
have been due to using different criteria for scoring metaphase arrested cells. 
(Kawashima et al., 2010) have reported that they score all the cells displaying Plo1-
GFP foci at spindle poles as metaphase arrested. However, weak yet detectible Plo1 
localization in late G2 cells has been observed before, in which DNA is not condensed 
yet and exhibits the interphase-like morphology (crescent shape, with faint ribosomal 
DNA in the middle, see Figure 3.1D ) (Mulvihill, Petersen, Ohkura, Glover, & Hagan, 
1999). Therefore, in order to distinguish the genuine metaphase-arrested cells from the 
late G2 cells, we score only the ones (as metaphase arrested), which have both strong 




Taken together, these results confirm that the non-kinase region of Bub1 (N-terminal 
and the middle region) is essential for the SAC response to severe spindle damage. 
However, although not essential, C-terminal kinase activity of Bub1 is still required 
for SAC maintenance. 
3.4.2 Bub1 kinase activity is necessary for chromosome bi-orientation 
We next sought to determine whether Bub1 kinase activity has a role in recovering 
from the SAC-mediated metaphase arrest, upon reformation of the spindle. To 
examine this, we allowed re-polymerization of initially perturbed microtubules in the 
same experiment described in Figure 3.1, and analysed the abilities of wild type and 
bub1-K762R D900N cells to silence their SAC response and progress into anaphase. 
Wild type and bub1-kd cells exited mitosis with similar rates (bub1-kd cells were 
slightly faster though), thus their abilities to recover from SAC recovery were 
comparable (Figure 3.C). However, while most of the wild type cells were progressing 
into a normal anaphase, bub1-K762R D900N cells exhibited an increasing frequency 
of cut phenotype during their recovery from the SAC arrest (Figure 3.2A and B). These 
observations are consistent with previous fission yeast studies which have reported 
that upon recovery from an nda3-KM311 arrest, Bub1 kinase-dead cells (both bub1-
K762R D900N (Kawashima et al., 2010) and bub1-K762M (Vanoosthuyse et al., 
2009)) exhibit lagging chromosomes frequently, similar to sgo2 null cells. The latter 
study (Vanoosthuyse et al., 2009) analysed chromosome bi-orientation of the bub1-
K762M allele by monitoring the segregation of GFP-marked chromosome 2, which we 
should also carry out (ideally by live imaging) in order to accurately analyse the ability 
of bub1-K762R D900N allele in chromosome bi-orientation. 
To sum, these results confirm that Bub1 kinase activity is necessary for bi-orientation 
and accurate segregation of chromosomes, and this role of Bub1 appears to be largely 





3.4.3 Bub1 kinase activity is necessary to maintain anaphase delay and 
kinetochore recruitment of SAC proteins in response to the anti-microtubule 
drug CBZ 
After confirming the published roles of Bub1 kinase activity (contributing to anaphase 
delay and playing a key role in chromosome bi-orientation) in response to prolonged 
spindle damage (nda3-KM311), we set out to determine whether it is also required 
under relatively subtle spindle perturbation. To analyse this, we monitored mitotic 
progression rates and the kinetochore recruitment of MCC components in wild type, 
bub1-kd (bub1-K762R D900N) and sgo2 null cells, which all bear cdc25-22 mutation 
and were exposed to microtubule depolymerising drug carbendazim (CBZ) 20 minutes 
after the release from G2 phase. 
Abilities of wild type and sgo2 null cells in delaying anaphase onset in response to 
spindle damage were comparable throughout the mitosis, whereas bub1-K762R 
D900N cells failed to maintain metaphase arrest, and they progressed into premature 
anaphase (Figure 3.3). Our results are in agreement with those of another fission yeast 
study (Yamaguchi et al., 2003). Yamaguchi and colleagues have reported that both the 
bub1-K762R allele and a Bub1 truncation allele lacking the entire kinase domain failed 
to delay anaphase onset in response to CBZ treatment. We observed that the bub1-
K762R D900N mutant was capable of arresting like wild type and sgo2 null early in 
mitosis (soon after the CBZ treatment), whereas after 60 minutes it leaked through the 
SAC arrest 25-30% more frequently than wild type and sgo2 null cells did. Even 
though Yamaguchi and colleagues employed a different method to synchronize the 
cells in G2 phase (a Cdk1 temperature sensitive mutant), their results were consistent 
with ours. Similarly, their kinase-inactive Bub1 alleles were also able to arrest at 
metaphase soon after the CBZ treatment, however at later stages they failed to maintain 
that arrest, and entered anaphase 25% more frequently than wild type (Yamaguchi et 
al., 2003).  
Taken together, soon after the CBZ treatment (30 minutes after the G2 release) Bub1 
kinase activity is largely dispensable for delaying anaphase onset, whereas at the later 
stages of mitosis (60 minutes onward) it becomes necessary to maintain the SAC 




Sgo2-Aurora B pathway, because the absence of sgo2 does not significantly affect the 
mitotic progression rate, unlike the lack of whole Bub1 kinase activity does (Figure 
3.3). Consequently, substrate(s) of Bub1 kinase, in addition to H2A, may be 
responsible for its anaphase delay role. 
In addition to its role in delaying anaphase onset, we analysed the role of Bub1 kinase 
activity in recruiting MCC components (Mad2 and Mad3) to kinetochores 
independently from its anaphase delay role. As we previously demonstrated in Figure 
3.3, the bub1-K762R D900N (bub1-kd) mutant has less cells arrested at metaphase. 
Therefore the bub1-kd mutant is expected to have a very low percentage of Mad2 and 
Mad3 kinetochore recruitment (within the whole bub1-kd population), which would 
be surely affected by its low mitotic index. However, this does not necessarily mean 
that the sub-population of bub1-kd cells, that are still arrested at metaphase (much 
fewer than wild type though), are defective in recruiting Mad2 and Mad3, in case its 
anaphase delay role is independent of the kinetochores (for instance, it may be 
mediated through a catalytic APC/C inhibition, via direct phosphorylation of it or one 
of its activators). In order to dissect these two possible roles of Bub1 kinase activity, 
we scored kinetochore localisation of Mad2 and Mad3 only in the population of non-
septating cells (presumably arrested at metaphase). 
Soon after the addition of CBZ (30 minutes after the G2 release), all three strains (wild 
type, bub1-kd and sgo2 null cells) were able to recruit Mad2 and Mad3 to kinetochores 
at similar levels. However, later in mitosis (60 minutes onward) kinetochore 
recruitment abilities of bub1-kd and sgo2 null cells gradually decreased (bub1-kd being 
more severe), while wild type cells maintained the kinetochore recruitment of Mad2 
and Mad3 even at 120 minutes (where bub1-kd and sgo2 null cells had no detectable 
kinetochore foci) (Figure 3.4). These results suggest that, soon after the CBZ treatment 
(30 minutes after the G2 release) Bub1 kinase activity is largely dispensable for the 
kinetochore recruitment of MCC components, whereas at the later stages of mitosis 
(60 minutes onward) it becomes more important to maintain their recruitment. This 
role of Bub1 appears to be partly mediated through the Bub1-H2A-Sgo2-Aurora B 
pathway, because the absence of sgo2 compromises Mad2 and Mad3 kinetochore 
localization 60 minutes onward, and becomes as defective as the lack of Bub1 kinase 




may be working in parallel with the Bub1-H2A-Sgo2-Aurora B pathway in performing 
the kinetochore recruitment (of the MCC components) role of Bub1 kinase activity.  
On the basis of these observations, we propose a working model for the roles of Bub1 
kinase activity in maintaining anaphase delay and kinetochore recruitment of MCC 
components in response to spindle damage (Figure 3.7). Soon after the CBZ treatment, 
its high concentration in the cells is presumably sufficient to depolymerise 
microtubules efficiently. This probably generates many unattached kinetochores. This 
experimental condition may mimic the cellular conditions in early prometaphase, in 
which most or all of the kinetochores are unattached (Chen, 2004; Pablo Lara-
Gonzalez, Westhorpe, & Taylor, 2012). In the presence of relatively more unattached 
kinetochores, Bub1 “non-kinase activity” (kinetochore scaffolding) may suffice to 
recruit MCC components (Mad2, Mad3 and even Cdc20), and thereby promote the 
formation of “enough MCC molecules”, that would efficiently inhibit Cdc20 even 
without Bub1 kinase activity. Although the two possible pathways mediating Bub1 
kinase activity ((i) the H2A-Sgo2-Aurora B pathway and (ii) the additional “unknown” 
pathway) both contribute to the SAC response to a certain extent, they are largely 
dispensable under these conditions to maintain an average anaphase delay              
(Figure 3.7A). 
On the other hand, in late prometaphase cells (mimicked by later stages of the time 
course, in which the CBZ concentration is probably lower due to being pumped out by 
cells (Goffeau et al., 1997)) probably fewer unattached kinetochores left. Under these 
conditions, lower number of unattached kinetochores may not be sufficient to stimulate 
enough MCC formation through the stoichiometric non-kinase activity of Bub1. 
Therefore, the sub-stoichiometric (catalytic) kinase activity of Bub1 may become more 
important for the few unattached kinetochores to maintain the “wait anaphase” signal 
until all kinetochores attach to microtubules (Figure 3.7). 
This hypothesis is consistent with our observation that 30 and 60 minutes after the 
release into mitosis with CBZ (soon after the CBZ treatment), the ability of sgo2 null 
cells to delay anaphase was identical to that of wild type, whereas at later stages (90 
and 120 minutes) it slightly decreased (Figure 3.3A). This supports the notion that 






























































Figure 3.7 Speculative model for the regulation of SAC signalling by multiple 
factors in response to various degrees of spindle damage
Schematics illustrating the regulation of SAC response by multiple mechanisms, which are related 
to different structural domains of Bub1: C-terminal kinase domain (blue); N-terminal and middle 
non-kinase region (grey). Description boxes above the schematics denote: (1) various degrees of 
spindle damage that cells were exposed to in the time course experiments: prolonged mitotic arrest 
via the nda3-KM311 tubulin mutation (relatively severe damage), early stages of exposure to the 
anti-microtubule drug CBZ when its at high concentrations in cells (relatively severe damage) and 
late stages of exposure to the anti-microtubule drug CBZ when its at relatively low concentrations in 
cells due to being pumped out over time(relatively subtle damage); (2) stages of prometaphase in 
an unperturbed mitosis mimicked by relatively severe damage (early prometaphase) or relatively 
subtle damage (late prometaphase) on the spindle; (3) hypothetical amounts of unattached kineto-
chores in early prometaphase (more) or  late prometaphase (fewer). (A) In the presence of “more” 
unattached kinetochores (either in early prometaphase of an unperturbed mitosis or in a mitotic 
time course experiment in which cells are challenged by nda3-KM311 or CBZ) the “non-kinase 
region” of Bub1 may be sufficient to promote “enough MCC molecules” ([MCC] indicates MCC 
concentration) to maintain the SAC response. Although the two possible pathways mediating Bub1 
kinase activity, (i) the H2A-Sgo2-Aurora B pathway and (ii) the additional “unknown” pathway, both 
contribute to the SAC response to a certain extent, they are largely dispensable under these 
conditions. (B) In the presence of “fewer” unattached kinetochores (in late prometaphase of an 
unperturbed mitosis or in the later stages of a mitotic time course experiment in which cells have 
pumped out most of the CBZ), the “non-kinase region” of Bub1 may not be sufficient anymore to 
produce “enough MCC molecules”, therefore Bub1 kinase activity may be required to promote 
(catalytically) the assembly of “enough MCC molecules” to maintain the SAC response.      
nda3-KM311 early stages ofexposure to CBZ
late stages of
exposure to CBZ
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delay at early stages, it becomes important, but not sufficient, to maintain the delay at 
later stages presumably through its contribution by (i) correcting erroneous 
attachments, and thereby generating more unattached kinetochores, and (ii) promoting 
recruitment of Mps1 to those unattached kinetochores (Figure 3.7). These roles of the 
H2A-Sgo2-Aurora B pathway are not sufficient, as there appears to be other roles (a 
parallel pathway) of Bub1 kinase activity that may be complementary to them (bub1-
kd is significantly more SAC defective than sgo2 null, Figure 3.3A). 
This model is also in agreement with our findings in the nda3-KM311 experiment 
(Figure 3.1B). In the presence of highly penetrant microtubule depolymerisation 
(similar to the early stages of CBZ treatment), Bub1 kinase function was not as 
important as it was in the late stages of CBZ treatment (Figure 3.3A). In addition, other 
nda3-KM311 experiments in fission yeast have demonstrated that the H2A-Sgo2-
Aurora B pathway is dispensable to maintain a robust metaphase arrest (Kawashima 
et al., 2010; Vanoosthuyse et al., 2007). This is sensible because when microtubules 
are depolymerised by nda3-KM31, presumably there are not enough intact 
microtubules (or only negligible amounts) in the cell to cause stochastic attachment 
errors. Under these conditions, “the error correction” role of the H2A-Sgo2-Aurora B 
pathway will be dispensable and is expected to contribute less to the SAC response.  
In addition, our model is in agreement with observations in Xenopus egg extracts 
(Chen, 2004). Even though Bub1 kinase activity is dispensable in the presence of high 
dose nocodazole (when the “non-kinase Bub1 activity” is sufficient), it is required to 
maintain the SAC mediated metaphase arrest in the presence of low dose nocodazole. 
This suggests that the kinase activity of Bub1 probably does not function as an on-off 
switch of the SAC; instead, it modulates the strength of the SAC signal generated from 
each kinetochore, and appears to become more important for the maintenance of the 
SAC when the number of unattached kinetochores are presumably lower in the cell 
(mimicked by low dose of nocodazole). We hypothesize that Bub1 kinase activity may 
contribute to the maintenance of the “wait anaphase” signal through two likely 
mechanisms, which are not mutually exclusive: 
(i) promoting MCC formation and/or MCC-APC/C interaction  




3.4.4 Bub1 kinase activity is not necessary for MCC assembly, yet essential to 
maintain MCC-APC/C interaction 
We next sought to determine the inhibitory mechanism underlying the anaphase delay 
role of Bub1 kinase activity. We hypothesize that although the exact pathway is not 
known, it probably links Bub1 activity to the most downstream SAC effector, MCC, 
and its ultimate target, APC/C.  
To test this, we analysed MCC formation in wild type and bub1-kd, and mps1-kd cells 
in an unperturbed mitosis. Results indicated that unlike Mps1 kinase activity, Bub1 
kinase activity is not necessary for MCC formation in an unperturbed mitosis (Figure 
3.5). However, this result is not sufficient conclude that MCC can assemble 
independent of Bub1 kinase activity, as we have tested the contribution of Bub1 
activity to the SAC only in the presence of spindle damage. Therefore this experiment 
needs to be repeated in the presence of CBZ in order to reproduce the same conditions 
in which Bub1 kinase activity has been important for the SAC response. 
Next, we hypothesize that Bub1 kinase activity may have a role in MCC binding to 
the APC/C in response to spindle perturbation. Analysis of wild type and bub1-kd cells 
in the presence of CBZ demonstrated that Bub1 kinase activity is essential to maintain 
MCC-APC/C interaction (Figure 3.6). 
Considering that the MCC-APC/C interaction is the ultimate inhibitory mechanism of 
the SAC (London & Biggins, 2014b), these results are consistent with our previous 
findings (Figures 3.1 and 3.3) that bub1-kd cells are not able to maintain an anaphase 
delay in response to microtubule depolymerisation. Thus, we conclude that Bub1 
kinase activity contributes to the maintenance of anaphase delay, largely stabilizing 
MCC-APC/C interactions probably through the phosphorylation of its unknown 







Chapter 4: In vitro analysis of Bub1 kinase activity and 
interactions between the MCC components 
4.1 Overview 
In chapter three, we confirmed the requirement for Bub1 kinase activity for a robust 
SAC response to spindle damage, which has been reported by studies in budding yeast 
(Fernius & Hardwick, 2007; Roberts et al., 1994), fission yeast (Kawashima et al., 
2010; Yamaguchi et al., 2003) and Xenopus egg extracts (Chen, 2004). We 
demonstrated that Bub1 kinase activity may contribute to the SAC response through 
another pathway that works parallel to the Bub1-H2A-Sgo2-Aurora B pathway. The 
upstream component of such a pathway is likely to be a substrate of Bub1 kinase, as 
our observations have suggested roles for its kinase activity (in addition to 
phosphorylating H2A) in maintaining kinetochore localization of the MCC 
components, MCC-APC/C interaction and ultimately anaphase delay in response to 
spindle perturbation. However, such a substrate of Bub1 other than H2A had not been 
implied until a report published in 2004 (Tang, Shu, et al., 2004). Tang and colleagues 
identified Cdc20 as a substrate of Bub1, and reported that Bub1-mediated 
phosphorylation of Cdc20 is required for a robust SAC response in response to spindle 
damage. In addition, they further supported this hypothesis by crystalizing the C-
terminal kinase domain of Bub1, and demonstrating that Bub1 has a considerable 
specificity toward Cdc20 (Kang et al., 2008). 
Considering our observations that Bub1 kinase activity promotes MCC-APC/C 
binding (Figure 3.6), we suggest that the unknown substrate of Bub1 may have a direct 
role in maintaining MCC-APC/C interaction in fission yeast. On the basis of human 
studies (Kang et al., 2008; Tang, Shu, et al., 2004; Yu & Tang, 2005), we hypothesize 
that maintenance of the SAC response through Bub1-mediated Cdc20 phosphorylation 








In this chapter we aim to investigate this possibility by: 
1. Purifying recombinant MCC components from insect cells, which will be used 
as substrates in a Bub1 kinase assay to analyse whether fission yeast Cdc20 (or 
other MCC components) are phosphorylated by Bub1 in vitro.  
2. If phosphorylation takes place, identifying phosphorylated sites by mass 
spectrometry. 
3. Analysing interactions between the recombinant MCC components to predict 
the roles of putative phosphorylation sites in the regulation of the SAC. Using 
this estimation to focus on the phosphorylation sites, which are more likely to 
be important for the SAC activity. 
4. Engineering the cdc20+ gene at its endogenous locus (inserting an antibiotic 
resistance marker and an internal epitope tag) for using in subsequent 
experiments. 
5. Generating phosphorylation mutants of Cdc20 to analyse its regulation through 















4.2 Identification of Bub1 kinase substrates in vitro 
4.2.1 Purification of Bub1 kinase and its putative substrates from insect cells 
Previously in our lab there have been attempts to purify recombinant S. pombe Bub1 
kinase and Cdc20 from competent E. coli cells (BL21) (data not shown). However, 
these attempts resulted in production of insoluble proteins. Although E. coli is a cheap 
and versatile host to produce recombinant proteins, it is likely that S.pombe Bub1 and 
Cdc20 proteins have particular requirements for chaperone systems or post-
translational modifications that E. coli cannot support. Therefore, their recombinant 
production necessitates a eukaryotic expression system. The baculovirus/ insect cell 
system has recently become a method of choice in many laboratories for producing 
eukaryotic proteins. There are a number of reasons for that. First of all, large proteins 
with several hundred kilodalton molecular weight can be produced and authentically 
processed in insect cells, which contributes to their solubility. Moreover, this system 
does not require strict safety measures in the laboratories, as baculoviruses do not 
replicate in eukaryotic cells other than their insect cells hosts. Furthermore, subunits 
of multi-protein complexes can be simultaneously produced by infecting insect cells 
with a mixture of baculoviruses, each of which carries the gene encoding a particular 
subunit (Berger, Fitzgerald, & Richmond, 2004; Trowitzsch, Bieniossek, Nie, 
Garzoni, & Berger, 2010). 
 
On the basis of these technical advantages, in this study we employed the baculovirus/ 
insect cell system to purify S. pombe Bub1 kinase and the mitotic checkpoint complex, 
which consists of Cdc20, Mad2 and Mad3 (Figure 4.1A), to be used in the subsequent 
experiments. Figure 4.2A summarises early steps of the protocol from cloning of the 
recombinant genes into a transfer vector to the first infection of insect cells. First, we 
cloned Bub1 or MCC components into a transfer vector (pFL) that is compatible with 
the baculovirus/ insect cell system Figure 4.2A and B. The transfer vector contains 
multiple baculovirus promoters (polyhedron and p10) followed by multiple cloning 
sites, consisting of several restriction enzyme sites. Using conventional cloning, 
coding sequences of Bub1 or the MCC components were inserted, whose expression 
would be driven by separate baculovirus promoters. BUB1 gene was cloned in full 

























Figure 4.1 Baculovirus transfer vectors cloned with MCC ∆N-term or Bub1  
(A) Schematic illustrating pFL baculovirus transfer vectors cloned with genes of the 
MCC ∆N-term components: Cdc20 ∆N, lacks its first 86 aminoacids and carries an N-termi-
nal tag; Mad3 is full length and wild type; Mad2 double mutant (dm), bears two mutations, 
one (L12A) prevents it from dimerizing, and the other one (R133A) locks it into the closed- 
conformation. Sequence of the tag at the N-terminus of Cdc20 ∆N consists of 8xHis, two 
strep-tag II and a TEV protease recognition site. Dark blue boxes indicate baculovirus 
promoters, red boxes indicate terminator sequences and orange boxes indicate Tn7 
transposon elements required for the transfer of recombinant genes into baculovirus 
genome. (B) Schematic illustrating pFL baculovirus transfer vectors cloned with genes of 
either of the following full length and N-terminally tagged Bub1 proteins: wild type Bub1 
or Bub1 kinase-dead. The dark blue box indicates the baculovirus promoter, the red box 
indicates the terminator sequence, orange boxes indicate Tn7 transposon elements 
required for the transfer of recombinant genes into baculovirus genome. recombinant genes 
into baculovirus genome. Vector maps were constructed in and exported from Lasergene 
Seqbuilder Software.    
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Figure 4.2 Purification of recombinant S. pombe SAC proteins from insect cells
(A) Schematic illustrating the early steps of producing recombinant proteins using 
baculovirus/ insect cell system. Genes of the recombinant proteins are cloned into a 
transfer plasmid (pFL), which is then used to transform bacterial cells containing the 
baculovirus genome (bacmid, indicated by the red rectangle and depicted in detail) in 
the form of a BAC. Once the recombinant genes are integrated into the bacmid, it is 
isolated and used in the transfection of insect cells. (B) Timetable for recombinant 
protein production in insect cells. Schematics in A and B were adapted from Trowitzsch 
et al. 2010 (C) Coomassie staining of purified recombinant mitotic checkpoint complexes 
(MCC); N-terminally truncated (MCC ∆N-term) and full length (MCC FL). (D) Coomassie 
staining and immunoblot (anti-Strep antibody) detection of purified recombinant Bub1 





bub1-kd (Figure 4.1B). As for the MCC components (Figure 4.1A), MCC ΔN-term, 
containing a wild type Cdc20 ΔN that lacks its first 86 aminoacids, was cloned. By 
doing so, we aimed to compare MCC ΔN-term and full length MCC (provided by 
David Barford) to analyse whether the N-terminus of Cdc20 is phosphorylated by 
Bub1. MCC ΔN-term also contains (Figure 4.6A) a wild type full length Mad3 and a 
double mutant Mad2. The two mutations in the MAD2-dm gene prevent Mad2 from 
dimerizing (L12A) and lock it into the closed-conformation (R133A) that is active 
during the SAC response (Westhorpe et al., 2011). (The transfer vector containing 
MCC ΔN-term components was provided by David Barford, which was also used to 
purify the MCC and determine its crystal structure (Chao et al., 2012b). They used an 
N-terminally truncated Cdc20 because full length Cdc20 did not crystallize). Both 
Cdc20 and Bub1 carry an N-terminal tagging cassette that consists of eight tandem 
histidines, two strep-tag II and a TEV protease recognition site (Figure 4.1).  
 
As illustrated in Figure 4.2A, the transfer vector also contains Tn7L and Tn7R 
sequence elements of the Tn7 transposon system flanking the foreign genes, which is 
later used in their integration into a baculoviral genome. Baculoviral genomic DNA 
(bacmid) isolated from native virus is engineered into an artificial bacterial 
chromosome (BAC) carried by competent E. coli cells. Integration of foreign genes 
into this BAC is accomplished in vivo via a Tn7 attachment site embedded in a lacZa 
gene on the BAC. A helper plasmid in the competent E. coli cells provides the Tn7 
transposon enzyme complex for catalysing the transposition event (Berger et al., 
2004). 
 
Therefore, we transformed the competent E. coli cells, which contain baculovirus 
genome, with the transfer vector cloned with BUB1 gene or the genes of MCC 
components. After a series of selections, Baculoviral genomic DNA (>130 kb) was 
purified from the correct E. coli transformants and used in the first round of infecting 
(transfection) insect cells (Figure 4.2A and B). In the transfection, purified bacmid was 
fused with a lipid-based transfection reagent and mixed into media of Sf9-type 
(Spodoptera frugiperda) insect cells that were cultured as monolayer in 6-well plates. 




burst insect cells, and are released into the insect cell growth medium. To monitor 
recombinant protein expression, a YFP gene is embedded in the bacmid, whose 
expression is controlled by the same promoter as that of the recombinant genes. Thus, 
two days after the transfection we monitored expression of our S. pombe genes using 
YFP expression as a readout. The first generation of baculoviruses were harvested 
from the medium and the extracts of remaining insect cells were analysed by 
immunoblotting to probe for Bub1 and MCC components. First generation 
baculoviruses were then used to infect a larger insect cell culture (50-100 ml) that was 
grown in suspension. After 3-4 days, expression levels were monitored as described 
above, and the second generation of baculovirus was obtained, which is expected to 
be concentrated enough to perform a large scale protein production. Ultimately, a 
larger culture (300-400 ml) was infected with baculovirus, followed by lysis of insect 
cells and purification of recombinant S. pombe proteins using Strep magnetic beads. 
 
As displayed in Figure 4.2C, S. pombe MCC ΔN-term was purified at comparable 
concentration to that of the full length MCC. Figure 4.2D shows that wild type and 
kinase-dead versions of Bub1 were also purified at similar concentrations. Here, it is 
worth mentioning that a proportion of recombinant Bub1 is cleaved into two 
fragments. Since Bub1 was tagged at its N-terminus, the cleaved C-terminus, which 
bears the kinase domain, was not retained. Nevertheless, a band corresponding to the 
size of full length Bub1 was excised, and the presence of intact Bub1 was confirmed 
by mass spectrometry identification (collaboration with Juri Rappsilber’s lab) for both 
wild type and kinase-dead versions. This was also confirmed by immunoblotting with 
anti-strep antibody, which detected N-terminally tagged intact Bub1 and N-terminal 
half of Bub1 cleavage product (Figure 4.2D). 
In summary, the kinases (wild type and kinase-dead Bub1) and the substrates (MCC 







4.2.2 In vitro Bub1 kinase assay 
Initially, to test kinase functions of recombinant wild type and kinase-dead Bub1 
proteins, we performed a preliminary kinase assay using an established substrate of 
Bub1, S. pombe H2A (Kawashima et al., 2010) (provided by Robin Allshire ). Kinase 
assays were carried out with γ−32P-ATP, run on SDS protein gels and phosphorylation 
was visualized by autoradiographs. Figure 4.3A demonstrates that H2A and Bub1 
itself were phosphorylated only by wild type Bub1, whereas kinase-dead Bub1 was 
unable to phosphorylate either of them. This confirms that Bub1 kinase function has 
been completely abolished in the kinase-dead allele (Kawashima et al., 2010)  and also 
suggests that our recombinant Bub1 preparations do not appear to contain any insect 
cell-originated contaminant kinases. 
Next we carried out a Bub1 kinase assay using MCC ΔN-term and MCC FL as 
substrates. As displayed in Figure 4.3B, both full length and N-terminally truncated 
Cdc20 (Cdc20 ΔN-term) proteins were phosphorylated by the wild type Bub1 kinase, 
however not by kinase-dead Bub1. The N-terminus of Cdc20 has been found to be 
phosphorylated by Cdk1 in X. laevis (S50/T64/T68/ T79/S114/S165) (Labit et al., 
2012) and Bub1 in H. sapiens (S41, S72, S92, S153, T157, S161) (Tang, Shu, et al., 
2004). Our phosphorylation of N-terminally truncated Cdc20 suggests that Bub1 is 
able to phosphorylate downstream of the first 86 amino acids of Cdc20 as well. 
Moreover, Figure 4.3B confirms the Bub1 autophosphorylation observed in the 
previous experiment (Figure 4.3A). In addition to the autophosphorylation of Bub1 N-
terminal cleavage product, somewhat slowly migrating Mad3 appears to be 
phosphorylated by wild type Bub1 too (more visible in the MCC ΔN-term lane). On 
the other hand, Mad2 does not appear to be phosphorylated by Bub1 in vitro, although 
it has been reported as a substrate of S. pombe Mph1 (Mps1 in budding yeast and 
higher eukaryotes) (Zich et al., 2012). 
These data confirms that S. pombe Bub1 kinase auto-phosphorylates efficiently 
(Kawashima et al., 2010) and demonstrates that it phosphorylates Cdc20 directly. 
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Figure 4.3 Bub1 kinase autophosphorylates and phosphorylates Cdc20 in vitro
(A) S. pombe H2A was incubated with recombinant S. pombe Bub1 (wild type or 
kinase-dead) in the presence of γ−32P-ATP. Protein loading was examined through 
Coomassie Blue (CB) staining, and incorporation of the radioactive phosphate group 
was visualized through autoradiography (32P). (B) Recombinant S. pombe MCC∆N-term 
and full length MCC (FL) were incubated with recombinant S. pombe Bub1 (wild type or 
kinase-dead) in the presence of γ−32P-ATP. Protein loading was examined through 
Coomassie Blue (CB) staining, and incorporation of the radioactive phosphate group 
was visualized through autoradiography (32P). Asterisk denotes phosphorylated Bub1 
N-terminal cleavage product.   
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4.2.3 Identification of in vitro phosphorylation sites using mass spectrometry 
In the previous section we demonstrated that Cdc20 is an in vitro substrate of Bub1. 
We observed that Bub1-mediated phosphorylation modified middle and/or C-terminal 
regions of Cdc20, as well as its N-terminal 86 amino acids that has been reported to 
be phospho-regulated in vitro and in vivo in other model organisms (Labit et al., 2012; 
Tang, Shu, et al., 2004). 
In vivo phosphorylation of S. pombe Cdc20 had been analysed in our lab before by 
Sjaak van der Sar. Sjaak purified Mad3 and Apc4 proteins from either cycling or 
mitotically arrested (through nda3-KM311 cold sensitive tubulin mutation) cells, and 
identified phosphorylated sites of their interactors by mass spectrometry analysis (in 
collaboration with John Yates’ lab in Scripps Research Institute). These analyses 
showed that Cdc20 is phosphorylated at 10 serine or threonine residues in vivo (Figure 
4.4A).  
In this section, we aim to identify in vitro phosphorylated sites of Cdc20 by Bub1, and 
indicate which of those sites were previously found to be phosphorylated in vivo. For 
this purpose, we repeated the previously described Bub1 kinase assay (Figure 4.3B) 
using Cdc20 (full length or ΔN-term) and Bub1 kinase (wild type or kinase-dead) in 
the presence of non-radioactive ATP, and then identified in vitro phosphorylated sites 
by mass spectrometry analysis (in collaboration with Juri Rappsilber’s lab). As listed 
in Figure 4.4A, wild type Bub1 was found to phosphorylate 14 sites of Cdc20 in vitro, 
5 of which were also identified as in vivo phosphorylated sites in mitotically arrested 
cells. On the other hand, none of the Cdc20 sites were found to be phosphorylated by 
the kinase-dead Bub1, which confirms that the in vitro phosphorylation of Cdc20 was 
specific to Bub1. All together 19 different sites were indicated to be phosphorylated in 
vivo and/or in vitro, and 15 of them cluster around the N-terminal C-box motif. Several 
of these may be Cdk1 sites (S11, S28, T31, S76), as they are followed by a proline. 
(Figure 4.4B). The C-box motif has been reported to be required for APC/C activation 
(David Barford, 2011). Moreover, a study in X. laevis showed that Cdk1-mediated 
phosphorylation of the Cdc20 sites near the C-box (the majority of them are upstream 
the C-box) inhibits APC/C activation by Cdc20 (Labit et al., 2012). On the other hand, 




(Figure 4.3B), that lacks its N-terminal 86 amino acids, and starts from the C-box motif 
(included). This suggests that only five sites (S167, T359, T380, S399, S482) account 
for this signal. Importantly, one of these five sites (serine 482) was also identified as 
an in vivo phosphorylated residue in mitotically arrested cells, which is in very close 
proximity to the IR motif (I487 and R488). The IR motif has been shown to be required 
for Cdc20-APC/C interaction and subsequent activation of the APC/C (Izawa & Pines, 
2012). Thus, phospho- modification of a nearby residue like serine 482 may be 
regulating Cdc20 activity. 
Bub1, Cdk1 and Cdc20 proteins have several domains that are largely conserved from 
yeast to human. In order to determine which of the phosphorylation sites that we 
identified are well-conserved, we aligned the orthologs of Cdc20 protein from three 
fission yeast species (S. pombe, S. octosporus, S. japonicus), one budding yeast 
(S.cerevisiae) and two metazoans (H. sapiens, X. laevis) using ClustalWS algoritm in 
Jalview software. As demonstrated in Figure 4.5, four (S28, T31, S76 and S482) of the 
five residues, which were phosphorylated both in vitro by Bub1 and in vivo in mitosis, 
appear to be well-conserved at least among four of the six species. This strengthens 
the possibility that phospho- modification of these residues may play key roles in the 
regulation of Cdc20 throughout evolution.   
In order to further narrow down the phosphorylated sites of Cdc20 with possible 
regulatory roles, we next determined the interacting sites of MCC components (Cdc20, 






Phosphorylated residue Peptides identified in vitro Identified in vitro Identified in vivo Cell cycle stage (in vivo )
S7 MEIAGNSSTISPTFSTPTK +
S8 MEIAGNSSTISPTFSTPTK +
S11 MEIAGNSSTISPTFSTPTK + + mitotic arrest and interphase
S15 MEIAGNSSTISPTFSTPTK +
S28 NLVFPNSPITPLHQQALLGR + + mitotic arrest
T31 NLVFPNSPITPLHQQALLGR + + mitotic arrest
S59 data N/A + mitotic arrest and interphase
T67 IDVVNTDWSIPLCGSPR +
S70 IDVVNTDWSIPLCGSPR +
S76 IDVVNTDWSIPLCGSPR + + mitotic arrest and interphase
S93 data N/A + mitotic arrest
T97 data N/A + mitotic arrest
S104 data N/A + mitotic arrest





























Figure 4.4 Cdc20 is phosphorylated in vivo during mitosis and in vitro by Bub1 
(A) Table listing the phosphorylated sites of Cdc20; in vitro by Bub1(red), in vivo in 
mitotically arrested or cycling cells (blue) and both in vitro and in vivo (purple). High-
lighted residues in the identified peptides correspond to the in vitro phoshorylated sites.
(B) Cartoon illustrating distribution of the phosphorylated sites of Cdc20 along with its 
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Figure 4.5 In vivo and in vitro phosphorylated Cdc20 sites are well-conserved
Alignment of Cdc20 orthologs from three fission yeast species (S. pombe, S. octospo-
rus, S. japonicus), one budding yeast (S. cerevisiae) and two metazoans (H. sapiens, X. 
laevis) using ClustalWS algoritm in Jalview software. Red (in vitro by Bub1), blue (in 
vivo in mitotically arrested cells) and purple (in vitro and in vivo) dots indicate the phos-
phorylated sites. Purple dashed rectangles denote well-conserved residues that are 
phosphorylated in vitro and in vivo. Red dashed rectangles annotate two domains of 
Cdc20 that are required for APC/C activation: C-box and IR-motif. The green dashed 






4.3 Analysis of interactions between the recombinant MCC 
components: Cdc20, Mad2 and Mad3 
As described in section 4.3.1 (Figure 4.6A), from insect cells we purified recombinant 
S. pombe MCC (MCC ΔN-term) that consists of; wild type Cdc20 ΔN-term (with an 
N-terminal strep-tag), lacking the first 86 amino acids; wild type full length Mad3; 
double mutant Mad2, that is prevented from dimerizing (L12A) and locked into the 
closed-conformation (R133A). Although, soluble Mad2 and Mad3 proteins have been 
efficiently purified from E. coli in our lab, Cdc20 has been insoluble in every attempt. 
This was the main reason for purifying the S. pombe MCC from insect cells, which 
provide a eukaryotic post-translational folding machinery. Therefore, before using 
recombinant MCC ΔN-term in crosslinking mass spectrometry (CLMS) analysis, we 
examined whether its components folded properly and assembled a functional 
complex, by testing its functionality as an APC/C inhibitor in vitro.  
4.3.1 In vitro analysis of recombinant MCC as an APC/C inhibitor 
An in vitro APC/C ubiquitination assay has been optimized (and carried out in this 
experiment) by Konstantinos Paraskevopoulos in our lab (Foe et al., 2011; Van 
Voorhis & Morgan, 2014). In this assay, we test the ability of APC/C (an E3 ubiquitin 
ligase) to add poly-ubiquitin chains to Securin, which is one of its mitotic targets (D. 
Barford, 2011). Moreover, this assay allows us to analyse the abilities of recombinant 
SAC proteins to inhibit APC/C activity in vitro (P. Lara-Gonzalez et al., 2011). In this 
experiment, we used wild type APC/C purified from the Cdc20-362 S. pombe strain, 
in which the temperature sensitive mutant Cdc20 was not able to bind APC/C 
(Matsumoto, 1997). This provides an APC/C preparation free from endogenous 
Cdc20. S. pombe full length Cdc20 was in vitro translated to be used as an APC/C 
activator. As the APC/C substrate, S. pombe Securin was translated in vitro, and 
radiolabelled with 35S-methionine. As for the APC/C inhibitor proteins; full length 
Mad3 (wild type) and Mad2 (double mutant, see the description above) were purified 
from E. coli. In addition to single or double permutations of Mad2 and Mad3 proteins, 
we also used baculovirus produced MCC ΔN-term (described above) that contains 




Figure 4.6B and C show that Mad2 or Mad3 proteins partially inhibited APC/C activity 
to 77% and 55% respectively, when they were used alone. On the other hand, 
combination of Mad2 and Mad3 decreased the APC/C activity to 45%. Strikingly, 
MCC ΔN-term appeared to be the most potent inhibitor, as it almost completely 
abolished the APC/C activity (3%) towards Securin.  
To sum up, recombinant MCC ΔN-term efficiently inhibits APC/C activity in vitro. 
This confirms that post-translational folding machinery in insect cells was sufficient 
to produce a functional S. pombe MCC. Moreover, these data demonstrate that 
although apo-Cdc20 is an APC/C activator, its presence in the MCC has a significant 
contribution to the inhibition of APC/C, which is in line with findings from a human 
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Figure 4.6 Recombinant MCC efficiently inhibits 
APC/C activity in vitro
(A) Coomassie stained gel shows S. pombe mitotic 
checkpoint complex (MCC) purified from Sf9 insect 
cells. (Asterisks denote contaminants, which are likely 
to be insect cell chaperones). Cartoon illustrates 
important domains of the purified MCC components: 
Cdc20 ∆N, lacks its first 86 aminoacids and carries an 
N-terminal tag; Mad3 is full length and wild type; Mad2 
double mutant (dm), bears two mutations, one (L12A) 
prevents it from dimerizing, and the other one (R133A) 
locks it into the closed- conformation. Sequence of the 




















two strep-tag II and a TEV protease recognition site. (B) Autoradiography image shows 
results of an in vitro  ubiquitination assay. Mad2, Mad3 (purified from E.coli) and MCC ∆N 
(purified from insect cells) were tested for their abilities to inhibit APC/C (purified from 
S.pombe) and Cdc20 (S.pombe, in vitro translated) mediated ubiquitination of Securin (in vitro 
translated with 35S-Methionine). Controls were as follows: ‘-Cdc20’ was with APC/C and 
without Cdc20; ‘- APC’ was without APC/C and with Cdc20; +APC was with both APC/C and 
Cdc20. Inhibitors were added as 10, 50 or 100 times more concentrated than APC/C. Half of 
each reaction was taken immidiately after mixing APC/C, Cdc20 and the inhibitors (0 min) and 
the other half after incubation (40 min). Samples were run on SDS gels, dried and visualized 
to detect ubiquitinated Securin (C) Graph plots the results (1/10 APC/inhibitor molar ratio) of 
the ubiquitination assay quantified  by Image Quant software (measuring the signal decrease 
in the unmodified securin band). Results were normalized to the intensity of ubiquitinated-Se-
curin in +APC control lane, considering it as 100% APC/C activity. Experiments shown in B 
and C were carried out by Konstantinos Paraskevopoulos. 
-Cdc20 -APC






















4.3.2 Cross-linking mass spectrometry analysis of the interactions between the 
MCC components 
A previous study has resolved the crystal structure of S. pombe MCC (Chao et al., 
2012a). This finding has provided valuable insight into how Cdc20 is sequestered by 
Mad2 and Mad3, by revealing their key interacting domains. However, in order to 
optimize purification and crystallization steps Chao and his colleagues used ‘MCC 
ΔN-term ΔC-term’ comprising truncated components: Cdc20 ΔN-term lacking the 
first 86 amino acids (crystal structure lacks disordered last 22 amino acids 467-488 as 
well); Mad3 ΔC-term, lacking last 87 amino acids, 224-310; double mutant Mad2, that 
is prevented from dimerizing (L12A) and locked into the closed-conformation 
(R133A). Therefore, the crystal structure lacks some of the critical regulatory domains 
of Cdc20 (the N-terminus, where it is regulated by Cdk1 phosphorylation (Labit et al., 
2012); the IR motif at the C-tail) and the Mad3 C-terminus, including the second KEN 
box, that is involved in the inhibition of APC/C substrate recruitment (P. Lara-
Gonzalez et al., 2011). Considering that we have purified a recombinant MCC ΔN-
term, which includes Mad3 C-terminus, we next sought to determine the interactions 
between its components by performing cross-linking mass spectrometry analysis 
(CLMS) in collaboration with Juri Rappsilber lab following the protocol in (Barysz et 
al., 2015). By using this method, we aimed to reveal interactions between (or within) 
the regions of MCC components that are in close proximity, which will be covalently 
bound by either of the two cross-linkers: 
  
BS3   (bis(sulfosuccinimidyl)suberate) (11.4 Å spacer arm length) 
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride) 
(0 Å spacer arm length) 
 
For this purpose, we immobilized purified MCC ΔN-term on strep-magnetic beads 
through the strep-tag on the N-terminus of Cdc20 ΔN-term. This way it was more 
convenient to exchange the strep wash buffer with the buffers required by BS3 and 
EDC. Zhuo Angel Chen carried out the cross-linking reaction, mass spectrometry, and 





We identified two types of linkages from the CLMS data: 
1. Linkages between the regions of MCC components that were resolved in the 
crystal structure (Figure 4.7 and Table 4.1). 
2. Novel linkages between the regions of MCC components that were absent in 
the crystal structure (Figure 4.8 and Tables 4.2, 4.3). 
Linkages that can be compared to the crystal structure 
With the CLMS data, we plotted networks of cross-links and self-links between (or 
within) the MCC components (Figure 4.7) using XiNet Crosslink Viewer (Combe, 
Fischer, & Rappsilber, 2015). In the MCC crystal structure, Chao and his colleagues 
identified the major binding interfaces between Cdc20, Mad2 and Mad3, such as the 
first KEN box of Mad3 (KEN20) and its receptor in the WD40 domain of Cdc20, or 
the safety belt of Mad2 and the N-terminal Mad2 binding domain of Cdc20. In addition 
to these major regulatory contacts, the crystal structure reveals interactions between 
other regions of the MCC components, whose roles remain unknown. Therefore, we 
have annotated all of those interacting sites identified by the crystal structure in our 
CLMS data networks. 
Linkages mediated by the BS3 cross-linker are demonstrated in Figure 4.7A (network) 
and Figure 4.8 (on the crystal structure), and listed in Table 4.1. The most prominent 
cross-links are between the Mad2 binding domain of Cdc20 (K133, K140, K141) and 
two sites of Mad2 (residues K43 and K66) which have been shown to interact with 
Cdc20 in the crystal structure (Figure 4.8A). Moreover, self-links form between those 
two sites (K43 and K61) of Mad2. This suggests, that particular region of Mad2 might 
be folding onto itself to bind (and perhaps to wrap) the Mad2 binding domain of 
Cdc20.  
As for the Mad3 interactions, the N-terminus (K27) (near KEN20) and the middle 
region (K190, Y191) of Mad3 interact with the Mad2 binding domain of Cdc20 (K141) 
(Figure 4.7A, Figure 4.8B and Table 4.1). Furthermore, these two sites of Mad3 form 
a self-link. Taken together, these results imply that the sites of Mad2 and Mad3, which 
were found to interact with Cdc20, may be folding onto themselves in order to 




Barford, 2011). Thus, sequestration of the Mad2 binding domain of Cdc20 by Mad2 
and Mad3 may have a direct role in the inhibition of APC/C by MCC. Interestingly, a 
self-link within Cdc20 brings together its C-terminus region (K461) and an N-terminal 
region (T167), which is 27 amino acids downstream of its Mad2-binding domain 
(K140) (Figure 4.10). Because the C-terminal tail (last 22 amino acids) of Cdc20 is 
disordered, it was not resolved in the crystal structure. On that basis, assuming the last 
ordered (resolved) region of Cdc20 C-terminus (K461) folds onto the downstream 
(T167) of Cdc20’s Mad2-binding domain (K140), this flexible C-terminal tail is likely 
to interact with the Mad2-binding domain itself, as it is exactly at the sufficient length 
to reach there (K461 to R488, and T167 to K140). Such a folding would bring the C-
terminus of Cdc20 near its regulatory C-box motif, which may be required for APC/C 
activation (D. Barford, 2011). Moreover, the Mad2 binding domain of Cdc20 is also 
required for APC/C binding in humans (Izawa & Pines, 2012). This is intriguing 
because at the very end of its C-terminal tail Cdc20 has the IR motif (I487 and R488), 
which is also required for APC/C activation through interactions with its Cdc27 
subunit (da Fonseca et al., 2011). This implies that, the Mad2 and Mad3 proteins may 
be targeting multiple regulatory domains of Cdc20 (C-box, Mad2 binding domain and 
IR-motif) that are responsible for APC/C activation. 
Furthermore, linkages mediated by the EDC cross-linker are consistent with those 
identified through BS3 (Figure 4.7 A and Table 4.1). EDC cross-linking reproduced 
the interactions between the Mad2 binding domain of Cdc20 (K140, K141 and D144) 
and Cdc20 interacting sites of Mad2 (E40, K43 and E59). 
Taken together, linkages between the regions of MCC components that were resolved 
in the crystal structure are in line with the interactions revealed by the MCC crystal 
structure. In addition, our findings suggest that when Cdc20 functions as an activator 
of APC/C, its IR motif in the flexible C-terminal region may come closer to the N-
terminal C-box in order to synergistically activate APC/C. On the other hand, when 
the SAC is activated, MCC assembles in a way that Mad2 and Mad3 may sequester 
both C-box and IR-motif of Cdc20, in order to effectively block Cdc20’s binding to 
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Figure 4.7 Linkages between the regions of MCC components which were 
resolved in the crystal structure
(A) Schematic illustrating the linkage network between MCC ΔN-term components 
mediated by BS3 (bis(sulfosuccinimidyl)suberate) crosslinker. MCC ΔN-term compo-
nents: Cdc20 ΔN-term, lacking the first 86 amino acids; wild type full length Mad3; 
double mutant Mad2, that is prevented from dimerizing (L12A) and locked into the 
closed-conformation (R133A). C-alpha distances and Cdc20-Mad3, Cdc20-Mad2 
contacts were obtained from S. pombe MCC crystal structure (4AEZ.pdb). Different from 
the crystal structure, cross-linked MCC ΔN-term used here contains Mad3 C-terminus 
(last 87 amino acids; 224-310) and disordered C-tail region of Cdc20 (last 22 amino 
acids; 467-488). (B) Schematic illustrating the linkages between MCC ΔN-term compo-
nents mediated by EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride) 
crosslinker. Networks of cross-links and self-links were constructed using XiNet 
















Figure 4.8 MCC cross-linking data are consistent with the MCC crystal structure  
(A) Cartoon representation of the “MCC ∆N-term ∆C-term” crystal structure with the 
prominent BS3-mediated cross-links (indicated by dark blue lines) between its components: 
Cdc20 ΔN-term lacking the first 86 amino acids (crystal structure lacks disordered last 22 
amino acids 467-488 as well); Mad3 ΔC-term, lacking last 87 amino acids, 224-310; double 
mutant Mad2, that is prevented from dimerizing (L1 2A) and locked into the closed-confor-
mation (R133A). N-terminal end of Cdc20 ΔN-term starts with the C-box. Mad2 binding 
domain of Cdc20 is between K133 and K141. (B) Details of the linkages between Mad2 
(K43 and K66) and the Mad2 binding domain of Cdc20 (K133, K140 and K141), shown 
in A. (C) Details of the linkages between Mad3 (K27, K177, K190 and K191) and the 
Mad2 binding domain of Cdc20 (K140 and K141), shown in A. Lysines of the proteins 
are highlighted, between which the BS3 crosslinker formed covalent bonds. Cartoon 
representations were generated using X-link Analyser tool in UCSF Chimera Software.  















Protein 1 Linkage site 1 Protein 2 Linkage site 2 Match count C-α distance in 4AEZ (Å)
Mad2 E40 Cdc20 K140 1 10.2
Mad2 E40 Cdc20 K141 5 10.1
Mad2 K43 Cdc20 D144 1 13.4
Mad2 E59 Cdc20 K140 1 10.7
Mad3 K114 Mad3 D115 1 3.8
Mad3 S19 Mad3 E21 1 5.7
Mad3 E21 Mad3 S31 1 15.5
Mad3 T44 Mad3 E47 2 5.2
Cdc20 K133 Cdc20 D135 2 6.5
Linkages through BS3
Linkages through EDC
Protein 1 Linkage site 1 Protein 2 Linkage site 2 Match count C-α distance in 4AEZ (Å)
Mad2 K43 Mad2 K47 7 12.3
Mad2 K43 Mad2 K61 2 12.1
Mad2 K43 Cdc20 K133 2 C-α
Mad2 K43 Cdc20 K140 2 15.8
Mad2 K43 Cdc20 K141 5 16.8
Mad2 K43 Cdc20 K342 4 25.8
Mad2 K66 Cdc20 K133 2 11.3
Mad2 S92 Mad3 K190 1 15.3
Mad3 Y113 Mad3 K177 2 21.5
Mad3 K114 Mad3 K114 17 0
Mad3 K114 Mad3 K168 4 24.3
Mad3 K114 Mad3 K175 3 17.2
Mad3 K114 Mad3 K180 3 15.6
Mad3 K114 Mad3 K182 14 13.9
Mad3 K114 Mad3 K190 4 22.3
Mad3 K177 Mad3 K180 2 4.8
Mad3 K177 Mad3 K182 7 9.5
Mad3 K177 Cdc20 K141 1 21.5
Mad3 K190 Cdc20 K140 4 15.1
Mad3 K190 Cdc20 K141 9 12.6
Mad3 Y191 Cdc20 K141 1 13.5
Mad3 K27 Mad3 K190 5 16.5
Mad3 K27 Mad3 K61 1 27.3
Mad3 K27 Cdc20 K141 4 23.1
Mad3 K37 Mad3 K46 10 14.8
Mad3 K37 Mad3 K53 37 16.5
Mad3 K53 Mad3 K61 3 12.6
Mad3 K92 Cdc20 K461 3 15.7
Cdc20 K133 Cdc20 K133 2 0
Cdc20 K133 Cdc20 K141 3 24.5
Cdc20 T167 Cdc20 K461 1 9.5
Cdc20 S335 Cdc20 K342 1 17.1
Table 4.1 Linkages between the regions of MCC components which were resolved 
in the crystal structure
List of linkages between MCC ΔN-term components mediated through BS3 or EDC 
cross-linkers. C-alpha distances were obtained from S. pombe MCC crystal structure 
(4AEZ.pdb). Linkages listed in this table were identified between the regions of MCC Δ
N-term components which are present in the crystal structure. Within-length distances 
(~28Å for BS3; ~15Å for EDC) were calculated as follows: spacer arm length of the 






Novel linkages that can be complementary to (were absent in) the crystal 
structure 
In this subsection, we describe the CLMS data that indicates novel interactions of 
Mad3 C-terminus and Cdc20 C-tail, which were absent in the MCC crystal structure. 
Novel linkages mediated by the BS3 cross-linker are demonstrated in Figure 4.9A and 
listed in Table 4.2. We observed two major clusters of cross-links mediated by BS3. 
The first cluster is the cross-links between the Mad2 binding domain of Cdc20 (K133 
and K141) and the C-terminus of Mad3 (K271, K288 and K292). It is worth noting 
that K271 is the lysine of the C-terminal (second) KEN box of Mad3. It has been 
previously shown that fission yeast KEN271 (Sczaniecka et al., 2008), and its 
counterpart in budding yeast (Janet L. Burton & Solomon, 2007; King et al., 2007) are 
essential for a SAC response. In addition, a recent study has reported that the human 
counterpart of KEN271 is required for the inhibition of substrate recruitment to APC/C 
(P. Lara-Gonzalez et al., 2011).  
The second cluster of cross-links mediated by BS3 is the one between C-terminus of 
Mad3 (K271, K288 and K292) and the C-terminal tail of Cdc20 (K461, K472 and 
K479) (Figure 4.9A and Table 4.2). Importantly, the flexible C-terminal tail of Cdc20 
(K472 and K479) also forms self-links with the Mad2 binding domain of Cdc20 (K133 
and K141), which supports our hypothesis that the IR-motif in the C-tail may come 
closer to the N-terminal C-box (Figure 4.10).  
Taken together, the novel linkages mediated by BS3 suggest that the C-terminal Mad3 
KEN271 may be inhibiting substrate recruitment to APC/C, through its interaction 
with the Mad2 binding domain of Cdc20, where the C-box and IR-motif (which are 
responsible for substrate recruitment and APC/C activation) come closer (Figure 4.10). 
Novel linkages mediated by EDC cross-linker are consistent with those identified 
through BS3 (Figure 4.9B and Table 4.3), as numerous linkages show that C-terminus 
of Mad3 interacts with the C-terminal tail and the Mad2 binding domain of Cdc20. 
What is more, both the C-terminal Mad3 KEN271 and the C-terminal Cdc20 IR-motif 
(R488) interact with two very same regions of Mad2 N-terminus (K13) and C-terminus 




findings strengthen the possibility that Mad2 may cooperate with both the N-terminal 
KEN20 (see Figure 4.7A), and the C-terminal KEN271 (see Figure 4.9B) of Mad3 to 
sequester the C-box, and especially the IR-motif of Cdc20 for effective inhibition of 





















Novel linkages through BS3













Figure 4.9 Novel linkages between the regions of MCC components which were 
absent in the crystal structure
(A) Schematic illustrating novel linkages between MCC ΔN-term components mediated 
by BS3 (bis(sulfosuccinimidyl)suberate) crosslinker. MCC ΔN-term components: Cdc20 
ΔN-term, lacking the first 86 amino acids; wild type full length Mad3; double mutant 
Mad2, that is prevented from dimerizing (L12A) and locked into the closed-conformation 
(R133A). C-alpha distances and Cdc20-Mad3, Cdc20-Mad2 contacts were obtained 
from S. pombe MCC crystal structure (4AEZ.pdb). Different from the crystal structure, 
cross-linked MCC ΔN-term used here contains Mad3 C-terminus (last 87 amino acids; 
224-310) and disordered C-tail region of Cdc20 (last 22 amino acids; 467-488). The 
linkages illustrated in A and B represent interactions of these regions that are absent in 
the crystal structure. (B) Schematic illustrating novel linkages between MCC ΔN-term 
components mediated by EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydro-
chloride) crosslinker. Self-links identified by EDC cross-linking are not presented here, 
as BS3 self-link data are representative of both of them. Networks of cross-links and 
self-links were constructed using XiNet Crosslink Viewer (Combe, Fischer, & Rappsilber, 
2015).   
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Protein 1 Linkage site 1 Protein 2 Linkage site 2 Match count C-α distance in 4AEZ (Å)
Mad3 114 Mad3 237 1 N/A
Mad3 114 Mad3 253 3 N/A
Mad3 114 Mad3 259 4 N/A
Mad3 114 Mad3 292 2 N/A
Mad3 114 Cdc20 472 1 N/A
Mad3 114 Cdc20 479 2 N/A
Mad3 168 Mad3 234 2 N/A
Mad3 168 Cdc20 479 1 N/A
Mad3 234 Cdc20 461 1 N/A
Mad3 27 Mad3 234 2 N/A
Mad3 271 Mad3 288 4 N/A
Mad3 271 Cdc20 141 1 N/A
Mad3 271 Cdc20 461 7 N/A
Mad3 288 Mad3 292 2 N/A
Mad3 288 Cdc20 133 1 N/A
Mad3 288 Cdc20 342 2 N/A
Mad3 288 Cdc20 472 2 N/A
Mad3 288 Cdc20 479 1 N/A
Mad3 292 Mad3 309 2 N/A
Mad3 292 Cdc20 133 4 N/A
Mad3 292 Cdc20 141 3 N/A
Mad3 292 Cdc20 342 4 N/A
Mad3 292 Cdc20 472 5 N/A
Mad3 292 Cdc20 479 12 N/A
Mad3 37 Mad3 292 1 N/A
Mad3 53 Mad3 271 1 N/A
Mad3 92 Mad3 271 4 N/A
Cdc20 133 Cdc20 479 1 N/A
Cdc20 141 Cdc20 472 2 N/A
Cdc20 339 Cdc20 479 1 N/A
Cdc20 342 Cdc20 342 7 N/A
Cdc20 342 Cdc20 479 7 N/A
Cdc20 461 Cdc20 472 2 N/A
Cdc20 461 Cdc20 479 1 N/A
Linkages through BS3
Table 4.2 Novel linkages through BS3 between the regions of MCC compo-
nents which were absent in the crystal structure
List of novel linkages between MCC ΔN-term components mediated through BS3 
cross-linker. C-alpha distances are not available, as the linkages listed in this 
table were identified between the regions of MCC ΔN-term components which are 
absent in S. pombe MCC crystal structure (4AEZ.pdb). Those regions which were 
present only in the crosslinked MCC ΔN-term are as follows: Mad3 C-terminus 
(last 87 amino acids; 224-310) and disordered C-tail region of Cdc20 (last 22 
amino acids; 467-488).
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Protein 1 Linkage site 1 Protein 2 Linkage site 2 Match count C-α distance in 4AEZ (Å)
Mad2 108 Mad2 119 1 N/A
Mad2 11 Mad2 179 2 N/A
Mad2 13 Mad2 110 2 N/A
Mad2 13 Mad3 272 1 N/A
Mad2 13 Mad3 283 1 N/A
Mad2 13 Cdc20 469 1 N/A
Mad2 13 Cdc20 488 2 N/A
Mad2 177 Mad3 233 1 N/A
Mad2 177 Mad3 234 1 N/A
Mad2 177 Mad3 237 2 N/A
Mad2 177 Mad3 253 1 N/A
Mad2 177 Mad3 288 3 N/A
Mad2 177 Mad3 292 2 N/A
Mad2 177 Cdc20 472 3 N/A
Mad2 177 Cdc20 479 1 N/A
Mad2 179 Mad3 234 1 N/A
Mad2 179 Mad3 237 2 N/A
Mad2 179 Mad3 288 2 N/A
Mad2 179 Mad3 292 2 N/A
Mad2 179 Cdc20 472 1 N/A
Mad2 179 Cdc20 479 3 N/A
Mad2 66 Cdc20 469 1 N/A
Mad2 69 Cdc20 469 1 N/A
Mad3 101 Mad3 237 1 N/A
Mad3 101 Mad3 292 1 N/A
Mad3 168 Mad3 247 2 N/A
Mad3 168 Cdc20 469 2 N/A
Mad3 171 Mad3 239 3 N/A
Mad3 171 Mad3 288 1 N/A
Mad3 171 Mad3 292 1 N/A
Mad3 175 Mad3 247 1 N/A
Mad3 182 Cdc20 469 1 N/A
Mad3 21 Mad3 239 1 N/A
Mad3 233 Cdc20 138 1 N/A
Mad3 233 Cdc20 169 1 N/A
Mad3 234 Cdc20 135 2 N/A
Mad3 234 Cdc20 138 2 N/A
Mad3 234 Cdc20 436 2 N/A
Mad3 234 Cdc20 469 3 N/A
Mad3 237 Mad3 272 1 N/A
Mad3 237 Cdc20 135 4 N/A
Mad3 239 Mad3 247 2 N/A
Mad3 239 Mad3 249 1 N/A
Mad3 239 Mad3 254 1 N/A
Mad3 239 Cdc20 135 1 N/A
Mad3 239 Cdc20 138 1 N/A
Mad3 239 Cdc20 436 1 N/A
Mad3 239 Cdc20 469 1 N/A
Mad3 241 Mad3 254 4 N/A
Mad3 243 Mad3 254 1 N/A
Mad3 245 Mad3 254 1 N/A
Mad3 246 Mad3 254 2 N/A
Mad3 247 Mad3 288 2 N/A
Mad3 247 Cdc20 472 1 N/A
Mad3 249 Mad3 292 1 N/A
Mad3 251 Mad3 254 2 N/A
Mad3 254 Mad3 271 2 N/A
Mad3 254 Mad3 288 2 N/A
Mad3 254 Mad3 292 1 N/A
Mad3 271 Cdc20 135 2 N/A
Mad3 272 Mad3 288 1 N/A
Mad3 272 Mad3 292 1 N/A
Mad3 272 Cdc20 437 1 N/A
Mad3 283 Mad3 288 3 N/A
Mad3 283 Mad3 292 3 N/A
Mad3 283 Cdc20 133 6 N/A
Mad3 288 Cdc20 135 3 N/A
Mad3 288 Cdc20 436 2 N/A
Mad3 292 Cdc20 135 5 N/A
Mad3 292 Cdc20 138 2 N/A
Mad3 294 Cdc20 437 1 N/A
Mad3 46 Cdc20 469 1 N/A
Mad3 63 Mad3 292 1 N/A
Mad3 63 Cdc20 472 1 N/A
Mad3 69 Mad3 234 2 N/A
Mad3 69 Mad3 288 4 N/A
Mad3 69 Mad3 292 1 N/A
Mad3 69 Cdc20 472 2 N/A
Mad3 70 Mad3 239 1 N/A
Cdc20 135 Cdc20 472 1 N/A
Cdc20 135 Cdc20 479 1 N/A
Cdc20 138 Cdc20 472 2 N/A
Cdc20 141 Cdc20 469 1 N/A
Cdc20 169 Cdc20 472 1 N/A
Cdc20 342 Cdc20 469 1 N/A
Cdc20 436 Cdc20 472 5 N/A
Cdc20 458 Cdc20 472 1 N/A
Linkages through EDC
Table 4.3 Novel linkages through 
EDC between the regions of MCC 
components which were absent in 
the crystal structure
List of novel linkages between MCC 
ΔN-term components mediated 
through EDC cross-linker. C-alpha 
distances are not available, as the 
linkages listed in this table were 
identified between the regions of 
MCC ΔN-term components which 
are absent in S. pombe MCC crystal 
structure (4AEZ.pdb). Those regions 
which were present only in the 
crosslinked MCC ΔN-term are as 
follows: Mad3 C-terminus (last 87 
amino acids; 224-310) and disor-
dered C-tail region of Cdc20 (last 22 
















Figure 4.10 Mad2 and Mad3 may cooperate to sequester the APC/C activation 
domains of Cdc20
Cartoon representation of the “MCC ∆N-term ∆C-term” crystal structure with the prominent 
BS3-mediated cross-links (indicated by dark blue lines) between its components. Red lines 
denote the novel interactions between the Mad2 binding domain of Cdc20 (K133 and 
K141) and C-terminal tails of Cdc20 and Mad3 (which were absent in the crystal struc-
ture since they are disordered). Here Cdc20 K133 and K141 are linked (through red 
lines) to Cdc20 Y466 and Mad3 F220 (last ordered residues of Cdc20 and Mad3 C-ter-
mini) in order to show the direction of the novel interactions identified by cross-linking. 
Grey (Cdc20 C-tail) and orange (Mad3 C-tail) drawings emanating from the C-terminal 
ends (that were available in the crystal structure) of Cdc20 and Mad3 represent possible 
interactions of the flexible (disordered) C-terminal tails of Cdc20 and Mad3 respectively. 
Both C-tails were found to interact with the Mad2 binding domain of Cdc20 (K133, K140 
and K141) by cross-linking. KEN2 denotes the second KEN box (KEN271) of Mad3. IR 
denotes the IR-motif of Cdc20 (its last two residues) that is required for binding to and 
activation of APC/C. The yellow box denotes the conserved phosphorylation site of 
Cdc20, serine 482 (S482), that is 4 aminoacids upstream of the IR-motif. Cartoon 








4.4 Marking of cdc20+ gene with an antibiotic resistance and inserting 
an internal tag 
As described in the previous sections we have identified phosphorylation sites of 
Cdc20 and novel interactions between MCC components. In order to investigate roles 
of these sites in vivo, we needed a selection marker in its endogenous locus, so we 
would be able to select for the Cdc20 alleles that we will generate. We initially had an 
attempt to mark the cdc20 gene locus at its 5’ UTR with the hygromycin B resistance 
gene. However, this led to a severe benomyl and temperature sensitivity, which might 
be due to the presence of a non-coding RNA sequence at that region. In addition, 
modification of 5’ UTR might have affected a complex Cdc20 promoter. To test these 
possibilities, RNA levels of Cdc20 could be analysed performing reverse transcriptase 
polymerase chain reaction (RT-PCR). Therefore, we inserted the hygromycin B 
resistance gene at its 3’ UTR, 460 bp downstream of cdc20 stop codon (Figure 4.11A). 
Analysis of benomyl and temperature sensitivities indicated that marking cdc20 gene 
at its 3’ UTR does not cause any detectable phenotypes (data not shown). 
To be able to track the Cdc20 protein in our immunoprecipitation and immunoblotting 
experiments we needed to couple it with an epitope tag. Previously in our lab, Cdc20 
had been coupled with several tags (GFP, HA and myc) at its C-terminal end by 
Matylda Sczaniecka. These tags had been inserted between the IR motif and the stop 
codon of Cdc20, which has been reported to involve in APC/C activation. Subsequent 
functionality analyses indicated that tagging Cdc20 at its C-terminus led to benomyl 
sensitivity and inability to hold a fully functional checkpoint arrest upon 
depolymerisation of microtubules by nda3-KM311 cold sensitivity. This could be 
caused by a possible perturbation of the IR-motif function and Cdc20-APC/C 
interaction due to the location of the tag. On the other hand, N-terminal tagging did 
not seem to be a viable solution either, since at that region Cdc20 has been found to 
bear several regulatory phosphorylation sites (Labit et al., 2012) and the C-box (David 
Barford, 2011), which have been reported to have roles in the APC/C activation. 
Moreover, similar difficulties in tagging Cdc20Slp1 has been reported by other groups 




Cdc20 function. Thus we decided to use three tandem repeats of FLAG tag 
(DYKDDDDK; 1012 Da). Figure 4.111C illustrates the process of inserting an internal 
3xFLAG tag, which consists of three steps. First, we amplified from the genomic DNA 
a sequence cassette with flanking restriction enzyme sites, which consists of the cdc20 
ORF and its 3’UTR followed by the hygromycin resistance gene and 527 base pair-
long 3’UTR downstream of the resistance marker. This ~500 base pair sequence was 
aimed to serve during homologous recombination of the final product into the yeast 
genome. Then we inserted this sequence cassette into Gateway pDONR201 vector 
using conventional cloning. Second, we ordered a synthetic Cdc20 DNA (nucleotides 
1-363) sequence (5’ end of the ORF), which contains the internal 3xFLAG tag. This 
sequence was incorporated into cdc20 ORF using conventional cloning in the Gateway 
vector. Third, we released the whole sequencing cassette, including the internal 
3xFLAG tag inside cdc20 ORF using restriction enzyme digestion, and transformed it 
into haploid S. pombe cells, followed by selection of the right isolates through 
hygromycin B resistance, and further analysis by PCR amplification and DNA 
sequencing. 
Next, we analysed cdc20-FLAG cells in terms of benomyl and temperature sensitivity 
and observed that they grow similarly to untagged cdc20 cells. Moreover, analyses in 
terms of mitotic progression rate in an unperturbed mitosis (using cdc25-22 block in 
G2 phase and synchronous release into mitosis) and nda3-KM311 mediated SAC 
activation indicated that internal tagging of Cdc20 protein does not lead to a detectable 
defect unlike the previously tried C-terminal tags (data not shown). Thus, we conclude 
that the internal FLAG tag is a relatively physiological tool to examine Cdc20 












cdc20 ORF Hyg GG
3 x FLAG
ATG2.
cdc20 ORF Hyg GG 3 x FLAGATG3.
Figure 4.11 Marking of cdc20+ gene with an antibiotic resistance gene and inserting an 
internal tag
 
(A) Schematic illustrating the marking of 3’ UTR of cdc20 gene with Hygromycin B resistance
gene, using the ‘two-step PCR based gene modification’ method. (B) Alignment of Cdc20 
N-terminus from three fission yeast species (S. pombe, S. octosporus, S. japonicus), one
budding yeast (S.cerevisiae) and two metazoans (H. sapiens, X. laevis), performed in Jalview
software using ClustalWS algoritm. The internal tag (3 x FLAG) was inserted between two
valine residues (V64 and V65) flanking the gap (C) Schematic illustrating three-steps of inserting
an internal 3 x FLAG tag into Cdc20 ORF, and transformation of haploid fission yeast with the
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4.5 Generating phosphorylation site mutants of Cdc20 
In the previous sections, by performing kinase assays we identified Cdc20 as a 
substrate of Bub1 kinase in vitro (Figure 4.3B). Subsequently, mapping of Cdc20’s in 
vitro phosphorylated sites by Bub1 indicated that five of those sites (S11, S28, T31, 
S76 and S482) overlap with the in vivo phosphorylated sites of Cdc20 in mitotically 
arrested cells (Figure 4.4A). Alignment of the Cdc20 orthologs from three fission yeast 
species (S. pombe, S. octosporus, S. japonicus), one budding yeast (S.cerevisiae) and 
two metazoans (H. sapiens, X. laevis) indicated that four (S28, T31, S76 and S482) of 
these five residues are well-conserved among these species (Figure 4.5). This 
strengthens the possibility that phospho- modification of these residues may play a role 
in the regulation of Cdc20 throughout evolution. In order to investigate this possibility, 
we categorised the putative phosphorylation sites in two groups: N-terminal sites S28, 
T31, S76 and S59 (instead of S11 that is not well-conserved); and the C-terminal site 
S482. Initially, we began to examine the N-terminal phosphorylation sites by mutating 
them to alanine, generating the phospho-deficient cdc20 4A allele. Analysis of cdc20 
4A cells in mitosis under unperturbed conditions or spindle perturbation by CBZ 
demonstrated that cdc20 4A was not expressed at the endogenous levels (data not 
shown). Because this phenotype would make interpretation of the results difficult, we 
have decided to split the cdc20 4A allele by generating two cdc20 2A alleles (S28, T31 
and S59, S76), which will be studied in the future.  
 
I next chose to focus on the C-terminal site S482. There are four reasons that I chose 
to analyse the serine 482 site in particular: 
1. In the Cdc20 alignments, serine 482 appears to be fairly well-conserved among 
S. pombe, S. cerevisiae, X. laevis and H.sapiens (Figure 4.5 and Figure 4.12A), 
in which phospho-regulation of Cdc20 has been demonstrated before (Chung 
& Chen, 2003; Labit et al., 2012; Pan & Chen, 2004; Tang, Shu, et al., 2004; 
Vanoosthuyse & Hardwick, 2005; Yu & Tang, 2005). This suggests that 






2. Serine 482 is the only ‘in vivo and in vitro’ phosphorylated residue among the 
five sites of Cdc20 ΔN-term which were phosphorylated by Bub1 in vitro 
(Figure 4.3B). This increases the possibility that S482 may be phosphorylated 
by Bub1 in vivo. 
 
3. Serine 482 is only four residues away from the IR-motif (Figure 4.12A), that 
is required for APC/C activation (D. Barford, 2011). The study (Labit et al., 
2012) that demonstrated the Cdk1-mediated inhibition of X. laevis APC/CCdc20, 
attributed this regulation to the close proximity of the N-terminal 
phosphorylation sites to the C-box, which is the other APC/C activating 
domain of Cdc20 (David Barford, 2011). This implies that likewise the C-box 
motif, the IR-motif of Cdc20 may also be regulated by phosphorylation of a 
nearby residue, like serine 482. 
 
4. Cross-linking mass spectrometry analysis (Figures 4.10) showed that Mad2 
and Mad3 proteins interact with the C-terminus of Cdc20, and are therefore in 
close proximity (numerous linkages were observed to K479) to serine 482. This 
strengthens the possibility that C-terminus of Cdc20 may be phospho-regulated 
in the context of an active SAC, in which the activity of Bub1 kinase and the 
assembly of Mad2, Mad3 and Cdc20 (as the MCC) coincide. 
 
Therefore, to analyse lack of phosphorylation (phospho - deficiency) at this site we 
mutated this putative Bub1 site, serine 482, (or two adjacent serine residues as well; 
serine 482, serine 483 and serine 484) to alanine, in order to generate phospho – 
deficient mutants of Cdc20 C-terminal cdc20 S1A and cdc20 S3A (Figure 4.12B). In 
addition to mutating only serine 482, we mutated two adjacent serines as well, 
although they were not mapped. This was because of the high proximity of these three 
serines and the possibility that the mass spectrometry mapping could be misleading. 
Therefore, if any of these three sites is phosphorylated in vivo (and if this is important 




On the other hand, to analyse constitutive phosphorylation of serine 482, we mutated 
it to glutamate to generate a phospho – mimicking allele, cdc20 S3E. We generated 
another phospho – mimic mutant of Cdc20 as well, mutating serine 482 to aspartate 
(cdc20 S1D), that we examine in the last section of chapter 5. Besides the C-terminal 
phosphorylation site mutants, we also mutated arginine 488 of the IR motif to 
glutamate, in order to generate the cdc20 IE mutant (Figure 4.12B). 
In addition to investigating the function of the IR-motif in S. pombe, we used the 
Cdc20 IE allele as a control, which was thought to help us interpret the behaviour of 
our Cdc20 phosphorylation mutants with respect to the following aspects: 
 
1. Deletion of the IR motif or its mutation into IE have been reported to impair 
Cdc20’s activator function and MCC-APC/C interaction (Izawa & Pines, 
2012). In our case, substitution of serine(s) by alanine or glutamate/ 
aspartate in close proximity to the IR motif might affect Cdc20 functions 
in this regard. 
 
2. In the case of phospho – mimic mutations (cdc20 S3E and cdc20 S1D) 
additional negative charge(s) would be constitutively introduced in close 
proximity to the IR motif. Substitution of the arginine 488 by glutamate in 
the case of cdc20 IE may help us evaluate whether changes in charge impair 
functions of the C-terminus, regardless of their roles in phospho – 











Figure 4.12 Cdc20 C-terminal mutants and the bub1 kinase-dead (kd) mutant used in
this study.
(A) Allignment of Cdc20 C-terminus from three fission yeast species
(S. pombe, S. octosporus, S. japonicus), one budding yeast (S.cerevisiae) and two
metazoans (H. sapiens, X. laevis), performed in Jalview software using ClustalWS algoritm.
The red asterisk annotates serine 482 that was found to be phosphorylated in vitro by Bub1
and in vivo in mitotically arrested cells. (B) Schematic illustrating the C-terminal
pshosphorylation site mutants (phospho-deficient cdc20 S1A and cdc20 S3A;
phospho-mimicking cdc20 S3E and cdc20 S1D) and IR motif mutant (cdc20 IE) of Cdc20
with their mutated sites. (C) Schematic illustrating the kinase-dead mutant of Bub1 (bub1-kd)
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Chapter 5: Roles of Cdc20Slp1 phospho-regulation in the SAC 
5.1 Overview 
Phospho-regulation of Cdc20 by different kinases has been reported in different 
species. In Xenopus egg extracts, phosphorylation of Cdc20 by Cdk1 (D’Angiolella et 
al., 2003; Yudkovsky et al., 2000) and MAPK (Chung & Chen, 2003) is required for 
its interaction with the other two MCC components (Mad2 and Mad3/BubR1). 
Another Xenopus study has reported that phosphorylation of Cdc20 N-terminus by 
Cdk1 decreases it affinity for the APC/C in early mitosis, which is later (at metaphase- 
anaphase transition) reversed through its dephosphorylation by PP2A to promote 
Cdc20-APC/C binding, and thereby promote anaphase onset (Labit et al., 2012). In 
addition, phosphorylation of Cdc20 N-terminus by Bub1 has been reported in a human 
study for the first time (Tang, Shu, et al., 2004) suggesting that, this phosphorylation 
is required for a robust SAC response. Furthermore, the same group (Kang et al., 2008) 
has further supported this hypothesis by crystalizing the C-terminal kinase domain of 
Bub1, and demonstrating that Bub1 has a considerable specificity toward Cdc20 (see 
page 26 for details). 
In chapter three, we confirmed the observations of previous studies (Chen, 2004; 
Fernius & Hardwick, 2007; Kawashima et al., 2010; Roberts et al., 1994; Yamaguchi 
et al., 2003) that Bub1 kinase activity is necessary for bi-orientation and required to 
have a robust SAC response to spindle damage, in order to ensure accurate 
chromosome segregation. We demonstrated that Bub1 kinase activity contributes to 
delaying premature anaphase onset by maintaining kinetochore recruitment of the 
MCC components (Mad2 and Mad3), and MCC-APC/C interaction until the later 
stages of prometaphase. In addition, by using the sgo2 null strain, we attempted to 
separate possible SAC roles of Bub1 kinase activity from its relatively better 
established chromosome biorientation (and indirect SAC activation) role through the 
Bub1-H2A-Sgo2-Aurora B pathway. We observed that its roles in maintaining the 
MCC components on kinetochores (partly shared by the Bub1-Aurora B pathway), and 
sustaining a robust anaphase delay may be mediated by another substrate. 
In chapter four, we confirmed that S. pombe Bub1 auto-phosphorylates efficiently 




fission yeast Cdc20 directly (in vitro). Identification of the phosphorylated Cdc20 sites 
(in vitro by Bub1 and in vivo in mitotically arrested cells) revealed that this 
modification of fission yeast Cdc20 is not restricted to its N-terminal region, unlike it 
has been reported in Xenopus egg extracts (Labit et al., 2012) and allegedly in human 
cells (Tang, Shu, et al., 2004). Unlike Tang and colleagues proposed, mutating six N-
terminal Bub1 sites (to alanine) on human Cdc20 does not appear to abolish its Bub1 
mediated phosphorylation in vitro (see the residual phosphorylation signal of the 
“nonphosphorylatable” Cdc20 mutant in (Tang, Shu, et al., 2004)). This suggests that 
Bub1 may phosphorylate Cdc20 at its other regions which might be important for 
mitotic regulation.  
By using crosslinking mass spectrometry (CLMS) analysis, we confirmed already 
known interactions between the MCC components (Cdc20, Mad and Mad3) (Chang et 
al., 2015; Chao et al., 2012b; Izawa & Pines, 2012), and demonstrated new ones 
between the flexible C-terminal tails of Cdc20 and Mad3, which were not determined 
in the MCC crystal structure (Chao et al., 2012b). These novel interactions suggest 
that, Mad2 and Mad3 may inhibit APC/C activity by binding to the C-terminal tail of 
Cdc20 where the regulatory IR-motif (da Fonseca et al., 2011) and a highly conserved 
phosphorylation site, serine 482, (revealed in both in vitro and in vivo analyses) are 
found. In other words, sequestration of Cdc20 IR motif by Mad2 and Mad3 may inhibit 
the activation of APC/C by Cdc20. On the basis of these observations, we generated 
phosphorylation mutants of Cdc20, either refractory to C-terminal phosphorylation 











In this chapter, we aim to: 
1. Examine the mitotic behaviour of the C-terminal Cdc20 phosphorylation 
mutants to determine whether they still retain the mitotic functions of Cdc20 
under unperturbed conditions: (i) activating APC/C to promote anaphase onset, 
(ii) maintaining MCC assembly and (iii) MCC-APC/C interaction. 
 
2. Analyse whether lack of C-terminal Cdc20 phosphorylation or its constitutive 
phosphorylation have any functional consequences on the abilities of cells in 
recruiting the MCC components to kinetochores and maintaining the MCC-
APC/C interaction, thus delaying anaphase onset in response to various degrees 
of spindle perturbation. In addition, we aim to assess the abilities of Cdc20 
phosphorylation mutants in satisfying the SAC (chromosome biorientation) 
and subsequently recovering from the SAC mediated metaphase arrest (SAC 
silencing), upon spindle reformation. 
 
3. Finally, combine the phospho-mimicking Cdc20 mutants with the bub1-kd 
mutant to analyse whether the constitutive phosphorylation of Cdc20 C-
terminus can rescue the SAC defects observed in the absence of Bub1 kinase 
activity. By performing this rescue experiment, we aim to provide in vivo 
evidence for the possibility that Bub1-mediated phosphorylation of Cdc20 (that 











5.2 Analysis of Cdc20 C-terminal phosphorylation mutants under 
unperturbed conditions  
In this section we aim to analyse whether the phospho-deficient (cdc20 S1A and cdc20 
S3A) or phospho-mimicking (cdc20 S3E) mutations affect its functions under 
unperturbed conditions. To determine this, we analyse the abilities of C-terminal 
Cdc20 phosphorylation mutants in progressing into anaphase, assembling the MCC 
and maintaining MCC-APC/C interaction in an unperturbed mitosis. 
5.2.1 Progression through an unperturbed mitosis 
In this experiment we aimed to analyse whether Cdc20 phosphorylation mutations 
(cdc20 S3E, cdc20 S1A and cdc20 S3A) affect its APC/C activator function. If this was 
impaired, then we would expect the cells to have defects in anaphase onset, despite the 
absence of any microtubule perturbation (Izawa & Pines, 2012; Nilsson et al., 2008).  
 
In order to track progression of the Cdc20 mutants through an unperturbed mitosis, 
temperature sensitive cdc25-22 mutant was used to synchronize cells in G2 phase. In 
addition, SAC deficient mad2 null allele (Vanoosthuyse et al., 2009) was used as a 
negative control and crossed with wild type and cdc20 S3E, to be able to test if the 
results depend on the presence of a functional SAC machinery. Cells were grown at 
25°C to mid-log phase, and then the temperature was shifted to 36°C (restrictive 
temperature for cdc25-22 allele), in order to arrest them in G2 phase. After 4 hours, 
cells were synchronously released into mitosis by shifting the temperature back to the 
permissive temperature of 25°C. Samples were collected at 15 minute time points for 
120 minutes, and fixed in methanol. Fixed samples were then stained with calcofluor 
to detect septation, which was scored as a readout of mitotic exit (Vanoosthuyse et al., 
2009; Yanagida, 1998). The Mad3-GFP fusion protein was also visualized as it is 
known to localise to kinetochores of prometaphase arrested cells (Rischitor et al., 







It is evident from the results (Figure 5.1A) that at 60 minutes, 80-90% of the cells from 
all strains exited mitosis (septated) without any detectable Mad3-GFP localization to 
kinetochores. As can be seen in Figure 5.1B, septation scores of all Cdc20 
phosphorylation mutants, both phospho-deficient and phospho-mimicking ones, are 
similar to that of wild type throughout the time course. At the end of two hours 90-
100% cells of all strains exited mitosis with an almost equal timing. Moreover, the 
mad2 null mutant and the mad2 null, cdc20 S3E double mutant do not significantly 
deviate from this mitotic timing. (Figure 5.1B). This result implies that the effect of a 
functional SAC machinery on the timing of an unperturbed mitosis is negligible 
(Movies have demonstrated that unperturbed mitosis is only 1-2 minutes shorted in the 
absence of Mad2, Kevin Hardwick personal communication).  
 
These results suggest that cdc20 S3E, cdc20 S1A and cdc20 S3A mutants can activate 
APC/C as efficiently as wild type cdc20 does. In other words the Cdc20 activator 
function is not significantly affected by either absent (cdc20 S1A and cdc20 S3A) or 



















60 minutes after release into mitosis
Figure 5.1 APC/C activating function of Cdc20 is not affected by either absent or constitutive
phosphorylation of its C-terminus in an unperturbed mitosis.
(A) Representative images from 60 minutes, displaying septation (in red) by calcofluor staining
and Mad3-GFP localisation (in green) in the cells expressing wild type cdc20, cdc20 S3E,
cdc20 S1A or cdc20 S3A, following 4 hours of cdc25-22 block at G2-phase and release into an
unperturbed mitosis (time zero). Scale-bar represents 5 microns (B) Graph plotting percentage
of cells that formed septum (exited mitosis) with respect to time. Results are the average of two





5.2.2 MCC formation in an unperturbed mitosis 
In the previous section we reported that mitotic progression rates of Cdc20 
phosphorylation mutants were comparable to that of wild type. This result was 
accompanied by the finding that mitotic progression of mad2 null double mutants were 
not significantly faster. In other words, although cells with a functional SAC 
machinery (+Mad2 strains) were able to form MCC, this did not delay their mitotic 
timing dramatically. We hypothesize that in an unperturbed mitosis, random 
microtubule-kinetochore attachment errors may still occur, which leads to MCC 
formation to a certain extent. However, those errors are likely to be corrected without 
a long delay, which leads to silencing of the SAC and subsequent disassembly of the 
MCC. Thus, in the next experiment, we aimed to analyse MCC formation in the cells 
expressing wild type cdc20 or cdc20 S3A in an unperturbed mitosis. Cells were 
released into a synchronous mitosis employing cdc25-22 temperature sensitivity as 
described previously. Cell samples were collected at 15 minute time points for 135 
minutes. Then the samples were lysed, subjected to anti-FLAG (Cdc20) 
immunoprecipitation and processed for SDS-PAGE/western blotting, in which they 
were probed for Cdc20, Mad2 and Mad3 to monitor MCC formation. 
As shown in Figure 5.2A, wild type cdc20 and cdc20 S3A total protein levels were 
largely similar overall, although there may be a slight delay in the decline of cdc20 
S3A levels compared to that of wild type cdc20. Nevertheless, Figure 5.2B shows that 
comparable amount of MCC components (Mad2 and Mad3) are pulled-down by wild 
type cdc20 and cdc20 S3A.  
These data suggest that lack of the phosphorylation of Cdc20 C-terminus (as in the 











Figure 5.2 MCC formation is not affected by the absence of Cdc20 C-terminus
phosphorylation in an unperturbed mitosis
(A) Total levels of Cdc20 (FLAG) and Mad3 (GFP) were analyzed by immunoblotting in whole
cell extracts from cells blocked at G2-phase (cdc25-22), and released into unperturbed mitosis
for 135 minutes. Mad3 levels were used as loading control. (B) Coimmunoprecipitation (IP)
analysis of mitotic checkpoint complex (MCC) formation. Cdc20 (FLAG) was immunoprecipitated
from the extracts described in A. Levels of Mad3 (GFP) and Mad2 coimmunoprecipitated with
Cdc20 (FLAG) were analyzed by immunoblotting. Cdc20 (FLAG) commonly appears as two
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5.2.3 MCC-APC/C interaction in an unperturbed mitosis 
Having shown previously that phosphorylation of Cdc20 C-terminus affects neither 
the mitotic progression rate nor the MCC formation abilities of cells significantly, next 
we sought to determine whether it influenced their MCC-APC/C interaction. To 
analyse that we employed cdc25-22 temperature sensitivity assay that enables us to 
release cells into an unperturbed mitosis. Cell samples were collected at 15 minute 
time points for 135 minutes. Then the samples were lysed, subjected to anti-TAP 
(APC4) immunoprecipitation and processed for SDS-PAGE/western blotting, in 
which they were probed for MCC components. 
As Figure 5.3A shows that total levels of wild type cdc20 and cdc20 S3A were fairly 
similar despite cdc20 S3A being slightly more stabilised towards the end of mitosis. 
This subtle stabilisation of cdc20 S3A levels is consistent with the previous finding 
(Figure 5.2A).  
As for the MCC-APC/C interaction, Figure 5.3B displays that comparable amounts of 
Cdc20, Mad2 and Mad3 bound to APC/C in wild type cdc20 and cdc20 S3A cells.  
This result is consistent with the previous findings that wild type cdc20 and cdc20 S3A 
cells progress through mitosis with almost the same rate (Figure 5.1B) as they form 
similar amounts of MCC (Figure 5.2B). 
To sum up, lack of Cdc20 phosphorylation at its C-terminus (as in the case of cdc20 
S3A) does not significantly affect MCC formation, MCC-APC/C interaction or the 
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Figure 5.3 MCC-APC/C interaction is not affected by the absence of Cdc20 C-terminus
phosphorylation in an unperturbed mitosis
(A) Total levels of Cdc20 (FLAG) and Apc4 (TAP) were analyzed by immunoblotting in whole
cell extracts from cells blocked at G2-phase (cdc25-22), and released into unperturbed mitosis
for 135 minutes. Apc4 levels were used as loading control. (B) Coimmunoprecipitation (IP)
analysis of MCC-APC/C interaction. Apc4 (TAP) was immunoprecipitated from the extracts 
described in A. Levels of Cdc20 (FLAG), Mad3 (GFP) and Mad2 coimmunoprecipitated with
Apc4 (TAP) were analyzed by immunoblotting. Apc4 levels were used as loading control.
Cdc20 (FLAG) commonly appears as two bands due to the cleavage of Cdc20 (FLAG) fusion









5.3 Analysis of Cdc20 C-terminal phosphorylation site mutants in the 
context of the SAC activated by an anti-microtubule drug 
Our previous findings show that C-terminal phospho-modification of Cdc20 does not 
appear to affect cells’ mitotic timing, MCC formation and MCC-APC/C interaction in 
an unperturbed mitosis. In this section we aim to investigate whether this is also true 
in the context of a perturbed mitosis with destabilised spindle microtubules, activating 
the SAC. To investigate this, we released cells into a synchronous mitosis, employing 
cdc25-22 temperature sensitivity followed by treatment with the microtubule 
depolymerising drug carbendazim (CBZ) at 20 minutes after the release. Using this 
method, we aim to determine whether C-terminal phospho-modification of Cdc20 is 
involved in the regulation of mitotic progression rate and MCC-APC/C interaction, 
when the SAC is activated by depolymerised microtubules.  
 
5.3.1 Analysis of mitotic timing and Mad3 kinetochore localisation in 
the presence of an anti-microtubule drug 
Following their release into synchronous mitosis with CBZ treatment, cell samples 
were collected at 15 minute time points for 150 minutes, and fixed in methanol. Later, 
fixed cells were stained to detect septa, which was visualised by microscopy along 
with Mad3-GFP localisation at unattached kinetochores. 
Figure 5.4A and B demonstrate that after 60 minutes into mitosis, 56% of wild type 
cells exited mitosis (indicated by septation), and the remaining 44% still arrested at 
metaphase through the SAC response activated upon microtubule depolymerisation. 
However, this arrest did not occur anymore when Mad2 is deleted, as indicated by 94 
% septation index of the mad2 null strain. This result suggests that the observed 
metaphase arrest depends on a functional SAC machinery in the presence of spindle 
damage, which is abolished by deletion of Mad2 (Vanoosthuyse et al., 2009). Septation 
indexes of the phospho-deficient Cdc20 mutants cdc20 S1A and cdc20 S3A were 
similar to that of wild type, being 51% and 47% respectively. This result indicates that 
there is only a slight delay in the mitotic progression of phospho-deficient Cdc20 




On the other hand, phospho-mimicking Cdc20 mutant cdc20 S3E displayed a 
dramatically lower septation index (13%) (and higher arrest profile (87%)). 
Importantly, when Mad2 was deleted, cdc20 S3E cells were not able to delay anaphase 
onset anymore, as indicated by a very high septation index (88%) exhibited by cdc20 
S3E, mad2 null cells.  
Figure 5.4B shows that the relative proportions of mitotic progression rates indicated 
at 60 minutes (Figure 5.4A) were largely maintained by the strains throughout the time 
course. At 150 minutes, ~80% of wild type and phospho-deficient Cdc20 cells (cdc20 
S1A and cdc20 S3A) septated, whereas the septation index of phospho-mimic Cdc20 
mutant cdc20 S3E was as low as 39%. This excessive arrest phenotype of cdc20 S3E 
was reversed in the absence of Mad2, indicated by 98% septation index of cdc20 S3E, 
mad2 null cells, which is almost identical to that of wild type, mad2 null strain (100%). 
In addition to examining mitotic exit, we monitored localisation of Mad3-GFP to 
unattached kinetochores, which is another indicator of metaphase arrest. To be able to 
separately evaluate abilities of cells to regulate either mitotic timing (indicated by 
septation index) or localisation of MCC components to unattached kinetochores 
(indicated by Mad3-GFP foci), we scored Mad3-GFP kinetochore localisation only in 
the population of non-septating cells.  
Figure 5.5 displays that at 30 minutes 66% of the non-septating wild type cells 
exhibited Mad3-GFP kinetochore foci, which was followed by phospho-deficient cells 
cdc20 S1A (54%) and cdc20 S3A (64%) with similar scores. However, only 17% of 
non-septating wild type, mad2 null cells could display kinetochore foci, suggesting that 
Mad2 is required to maintain the recruitment of MCC components to unattached 
kinetochores in wild type cells. On the other hand, non-septating cdc20 S3E cells 
exhibited a significantly high percentage of Mad3-GFP kinetochore foci (86%). 
Interestingly unlike wild type, mad2 null, removal of Mad2 from cdc20 S3E cells did 
not abolish kinetochore localisation of Mad3-GFP at 30 minutes, which is indicated 
by fairly high percentage of kinetochore foci exhibited by cdc20 S3E, mad2 null cells 
(64%). This result suggests that, cdc20 S3E phospho-mimicking mutation can rescue 
the Mad3 recruitment defect in the absence of Mad2, and restores it almost to the wild 




time course, as at 60 minutes the percentage of Mad3- GFP kinetochore foci in cdc20 
S3E, mad2 null cells (4.5%) became as low as that in wild type, mad2 null cells (5%), 
and eventually both of them became zero at 90 and 120 minutes (Figure 5.5B).  
This suggests that although cdc20 S3E mutation promotes kinetochore localisation of 
Mad3 at early stages of metaphase (30 min), Mad2 is still required in a functional SAC 
to maintain Mad3 recruitment until the later stages of mitosis (60, 90, 120 min). As for 
the other strains, Figure 5.5B shows that non-septating wild type, cdc20 S1A and cdc20 
S3A cells exhibited Mad3 foci similar to each other throughout the time course, 
indicated as ~80% (60 min), ~90% (90 min) and ~60% (120 min). On the other hand 
the ability of cdc20 S3E maintain Mad3 at kinetochores remained higher than that of 
others, especially towards the end of time course (94% at 120 min). 
These results suggest that in the presence of a microtubule depolymerising drug 
(CBZ), lack of C-terminal Cdc20 phosphorylation (as in the case of cdc20 S1A and 
cdc20 S3A) does not significantly affect either the mitotic timing or the recruitment of 
Mad3. On the other hand, constitutive phosphorylation of Cdc20 C-terminus 
(mimicked by cdc20 S3E) leads to an significantly strong metaphase arrest that is 
dependent on Mad2 protein.  
Moreover, constitutive phosphorylation of the Cdc20 C-terminus (mimicked by cdc20 
S3E) not only enhances the kinetochore localisation of Mad3 throughout mitosis, but 
also rescues the defect of mad2 null allele in this regard at the early (30 minutes), but 




















Figure 5.4 Mimicking constitutive phosphorylation of Cdc20 C-terminus results in a 
hyperactivated SAC response that is dependent on Mad2
(A) Representative images from 60 minutes, displaying septation (in red) by calcofluor staining
and Mad3-GFP localisation (in green). Scale-bar represents 5 microns. (B) Cells were blocked
in G2-phase for 4 hours through cdc25-22 temperature sensitivity, and then released into mitosis
at 0 minute. At 20 minutes, cells were treated with the microtubule depolymerising drug CBZ to
activate SAC response. Samples were collected at each 30 minutes time point. Graph plotting
percentage of cells that formed septum (exited mitosis) with respect to time. Results are the 
average of two experiments. Error bars representing standard error.
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Figure 5.5 Constitutive phosphorylation of Cdc20 C-terminus significantly increases
the frequency of Mad3 kinetochore recruitment
(A) Representative images from 30 minutes of the same experiment described in Figure 5.6,
displaying septation (in red) by calcofluor staining and Mad3-GFP localisation (in green).
Scale-bar represents 5 microns. (B) Graph plotting percentage of non-septating cells (still in






5.3.2 Analysis of the MCC-APC/C interaction in the presence of an 
anti-microtubule drug 
In the previous section we demonstrated that mitotic exit of cells is strongly delayed 
due to constitutive phosphorylation of Cdc20 C-terminus (mimicked by cdc20 S3E), 
whereas that is not significantly affected by the lack of this phosphorylation (as in the 
case of cdc20 S1A and cdc20 S3A). This reproducible anaphase delay is likely to be an 
outcome of strengthened APC/C inhibition, since this E3 ligase is the ultimate target 
of SAC (P. Lara-Gonzalez et al., 2011). Thus, we hypothesize that constitutive 
phosphorylation of the Cdc20 C-terminus (mimicked by cdc20 S3E) may lead to a 
stronger MCC-APC/C interaction, whereas lack of this phosphorylation (as in the case 
of cdc20 S1A and cdc20 S3A) is expected to result in an interaction similar to wild type 
levels. To investigate a possible link between Cdc20 C-terminal phospho-modification 
and MCC-APC/C binding, we carried out time course experiments as described in the 
previous section. Following the release into a synchronous mitosis with CBZ treatment 
(20 minutes after the release), cell samples were collected at 15 minute time points for 
150 minutes. Then the samples were lysed, subjected to anti-TAP (APC4) 
immunoprecipitation and processed for SDS-PAGE/western blotting, in which they 
were probed for MCC components. 
As displayed in Figure 5.6A, total levels of wild type Cdc20 and cdc20 S3A were 
almost identical in the presence of CBZ. Figure 5.6B shows that, this similarity was 
also observed in the amount of MCC components (Cdc20, Mad2 and Mad3) pulled-
down by APC4 in wild type and cdc20 S3A cells. Moreover, this result is supported 
by the observation (Figure 5.6A) that wild type and cdc20 S3A cells exhibited highly 
comparable Cyclin B levels throughout the time course.  
These results suggest that wild type and cdc20 S3A cells inhibited APC/C to a 
comparable extent by binding similar amounts of MCC to it, which is consistent with 
their comparable mitotic timing that we reported previously (Figure 5.4B). 
On the other hand, comparison of wild type and phospho-mimicking cdc20 S3E cells 
appeared to be rather different. Figure 5.7B demonstrates that, cdc20 S3E cells 
exhibited significantly high amount of MCC-APC/C binding compared to that in wild 




than it did in wild type cells. In wild type cells MCC components began disassembling 
from the APC/C at 60 minutes into mitosis, whereas in cdc20 S3E cells the decline of 
the MCC-APC/C interaction was not observed until the 120 minutes time point (Figure 
5.7B). 
As Figure 5.7A shows, wild type Cdc20 and cdc20 S3E levels were similar until 45 
minutes after release into mitosis. However, from 45 minutes onwards wild type Cdc20 
levels began to decrease, while cdc20 S3E levels increased until 90 minutes. Moreover, 
although Cyclin B degradation began at 15 minutes in both strains, cdc20 S3E cells 
stabilized their Cyclin B levels at a significantly higher level than wild type cells did 
until the end of the time course.  
These results suggest that upon microtubule depolymerisation beginning at 20 
minutes, cdc20 S3E cells activate a more potent SAC response than the wild type cells 
do, which probably leads to formation of more MCC molecules that inhibit the APC/C 
more efficiently. Due to this stronger inhibition, higher amounts of Cyclin B are 
stabilised in cdc20 S3E cells, which results in an extended metaphase arrest consistent 
with our previous findings (Figure 5.4B). In this case, the extended mitotic state of 
cdc20 S3E cells explains their relatively more stabilised Cdc20 levels, whose 
expression is sustained by Cdk1 in budding yeast mitosis (Liang et al., 2011; Vernieri, 
Chiroli, Francia, Gross, & Ciliberto, 2013). Taken together, our results suggest that 
the lack of C-terminal Cdc20 phosphorylation (as in the case of cdc20 S3A) does not 
appear to affect either MCC-APC/C interaction or mitotic timing significantly. 
However, constitutive phosphorylation of Cdc20 C-terminus (mimicked by cdc20 
S3E) leads to a stronger and longer MCC-APC/C interaction, which delays anaphase 
onset. This stronger MCC-APC/C interaction may be a direct result of higher amounts 
of MCC formed in cdc20 S3E cells, which can be tested by co-immunoprecipitation 
of Cdc20 S3E-FLAG and the other MCC components. In addition, in the previous 
section (Figure 5.5) we reported that cdc20 S3E allele rescued the kinetochore 
recruitment of Mad3 in the absence of Mad2 at the early stages of mitosis. In order to 
assess the Mad2 dependency for a tight MCC formation, this experiment should be 
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Figure 5.6 MCC-APC/C interaction is not affected by the absence of Cdc20 C-terminus
phosphorylation in response to the microtubule drug CBZ
(A) Total levels of tubulin (TAT1), Cdc20 (FLAG) and Cyclin B were analyzed by immunoblotting
in whole cell extracts at each 15 minute time points from cells blocked at G2-phase (cdc25-22),
and released into mitosis (0 minutes) followed by CBZ (100 µg/ml) treatment at 20 minutes.
TAT1 levels were used as loading control. Cdc20 (FLAG) commonly appears as two bands due
to the cleavage of Cdc20 (FLAG) fusion protein. (B) Coimmunoprecipitation (IP) analysis of
MCC-APC/C interaction. Apc4 (TAP) was immunoprecipitated from the extracts described in A.
Levels of Cdc20 (FLAG), Mad3 (GFP) and Mad2 coimmunoprecipitated with Apc4 (TAP) were
analyzed by immunoblotting. Apc4 levels were used as loading control. Mad3 (GFP) is commonly
detected as two bands due to the cleavage of the fusion protein. Results are representative of
two independent experiments.
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Figure 5.7 Constitutive phosphorylation of Cdc20 C-terminus enhances MCC-APC/C 
interaction in response to the microtubule drug CBZ
(A) Total levels of Apc4 (TAP), Cdc20 (FLAG) and Cyclin B were analyzed by immunoblotting
in whole cell extracts collected at each 15 minute time points from cells blocked at G2-phase
(cdc25-22), and released into mitosis (0 minutes) followed by CBZ (100 µg/ml) treatment at 20
minutes. Apc4 levels were used as loading control. (B) Coimmunoprecipitation (IP) analysis of
MCC-APC/C interaction. Apc4 (TAP) was immunoprecipitated from the extracts described in A.
Levels of Cdc20 (FLAG), Mad3 (GFP) and Mad2 coimmunoprecipitated with Apc4 (TAP) were
analyzed by immunoblotting. Apc4 levels were used as loading control. Mad3 (GFP) is commonly








5.4 Analysis of Cdc20 C-terminal phosphorylation mutants under 
nda3-KM311-mediated microtubule depolymerisation 
In the preceding sections, we described how phospho-modification of the Cdc20 C-
terminus can affect MCC formation, MCC-APC/C interaction, kinetochore 
localisation of MCC components and progression rate in an unperturbed mitosis. In 
addition, to examine the same cellular events in the context of an activated SAC, we 
treated cells with the microtubule depolymerising drug carbendazim (CBZ). For both 
of these experiments, we used cdc25-22 temperature sensitivity to be able to arrest the 
cells in G2-phase, and release them into a synchronous mitosis. As described in the 
third chapter, there is another method of enriching cells in mitosis that employs the 
nda3-KM311 cold sensitive allele, by which microtubules are completely 
depolymerised, thereby the SAC is activated upon shifting cells to the restrictive 
temperature. In this section we present experiments in which we examined the mitotic 
behaviour of Cdc20 C-terminal phosphorylation mutants along with bub1-kd and bub1 
null alleles with regards to their abilities to activate and recover from the SAC, using 













5.4.1 Metaphase arrest mediated by nda3-KM311 
In order to examine abilities of the Cdc20 C-terminal mutants and the Bub1 mutants 
to arrest at metaphase in response to depolymerised microtubules, we carried out nda3-
KM311 time course experiments. Cells were grown overnight at the permissive 
temperature (30°C), and the next day log phase cultures were shifted to the restrictive 
temperature (18°C) for 9 hours. Cell samples were collected 6 hours and 9 hours after 
the temperature shift, fixed in methanol and stained with DAPI to visualise DNA. In 
addition to scoring condensed DNA, we monitored localisation of polo kinase (Plo1-
GFP) to spindle poles, which is another indication of metaphase arrest (Bahler et al, 
1998a; Mulvihill et al, 1999). Cdc20 C-terminal mutants examined in this experiment 
were phospho-deficient cdc20 S3A, phospho-mimic cdc20 S3E and cdc20 IE alleles 
(where the arginine of the C-terminal IR motif is mutated to glutamate); Bub1 mutants 
were bub-kd and bub1 null (negative control) alleles. 
 
After spending 6 hours with depolymerised microtubules (Figure 5.8), 52% of wild 
type cells arrested in metaphase, followed by cdc20 S3A with a similar arrest profile 
(49%). As expected from the negative control, bub1 null cells did not arrest at all, since 
they are known to be defective in the SAC response. Bub1-kd cells exhibited a lower 
arrest profile (44%) than the wild type cells did. On the other hand, higher (62%) 
proportion of cdc20 S3E cells arrested in metaphase. Interestingly, cdc20 IE cells also 
appeared to arrest with a rather high percentage (61%).  
 
After 9 hours, (Figure 5.8) arresting proportions of wild type (76%), cdc20 S3A (76%) 
and became comparable, that were higher than cdc20 IE (68%) cells. On the other 
hand, Cdc20 S3E cells (84%) were observed to have the highest arrest frequency than 
the other strains. However, bub1-kd cells exhibited a significant arrest defect (54%) 







These results suggest that, in a prolonged and relatively more penetrant spindle 
perturbation (6-9 hours), constitutive phosphorylation of Cdc20 C-terminus 
(mimicked by cdc20 S3E) leads to a strengthened SAC arrest, although the difference 
is not as big as in the case of a less penetrant spindle perturbation by CBZ treatment 
for a relatively short period (130 min) (Figure 5.4B). Lack of C-terminal Cdc20 
phosphorylation (as in the case of cdc20 S3A) results in a slightly weaker SAC arrest 
than wild type cells only after 6 hours, but not 9 hours. On the other hand, lack of the 
Bub1 kinase activity (as in the case of bub1-kd) compromises the SAC response 
significantly, especially after 9 hours of spindle damage. This result is consistent with 
previous observations in fission yeast (Kawashima et al., 2010; Yamaguchi et al., 
2003). 
 
Interestingly, cdc20 IE cells arrested more frequently than wild type cells after 6 hours, 
although cdc20 IE mutation was expected to impair the Cdc20-APC/C interaction as 
it has been reported in human cells (Izawa & Pines, 2012). This might have been due 
to two possibilities; (i) cdc20 IE mutation either leads to a more potent SAC response 
or (ii) it impairs the activator function of Cdc20 so that the cdc20 IE cells cannot 
progress into anaphase.  
 
To determine this we analysed the amount of Mad3 that is bound to the APC/C in wild 
type, cdc20 S3E and cdc20 IE cells, which were blocked at metaphase for 6 hours by 
nda3-KM311 mutation. Figure 5.9A-B display that cdc20 S3E cells exhibited a slightly 
higher Mad3-APC/C interaction than wild type cells (the difference was much higher 
in response to CBZ), whereas it is noticeably lower in cdc20 IE cells. This result 
suggests that, the “strong arrest” phenotype of cdc20 IE cells observed in the previous 
experiment (Figure 5.8) is probably not due to a more potent SAC response. In 
contrast, a more likely explanation is that cdc20 IE mutation may impair the activator 
function of Cdc20, and this leads to a defective anaphase onset, which was manifested 
as a prolonged anaphase delay. In order to better understand functional consequences 
of the IR-motif mutation, the mitotic progression rate of cdc20 IE cells should be 
analysed in an unperturbed mitosis, to determine whether their ability to progress into 
anaphase is compromised.  
Figure 5.8 Constitutive phosphorylation of Cdc20 C-terminus slightly enhances SAC
activity in response to nda3-KM311 block
Graph plotting percentage of cells arrested at metaphase indicated by Plo1-GFP signal
at spindle pole bodies (SPBs) after 6 or 9 hours at the restrictive temperature (18°C) with
depolymerised microtubules (nda3-KM311 cold sensitivity). Results of wild type, bub1-kd and
cdc20 IE cells are the average of two independent experiments. Error bars representing
standard error.
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Figure 5.9 IR-motif of Cdc20 is required for an efficient Mad3-APC/C interaction
(A) Coimmunoprecipitation analysis of Mad3-APC/C interaction in cells arrested
at metaphase for 6 hours through nda3-KM311 allele. Mad3-APC/C interactions
of wild type, cdc20 S3E and cdc20 IE cells were compared by immunoprecipitating Apc4 
(TAP), immunoblotting against Mad3 (GFP). (B) Graph displaying the quantification of the 
results in A. APC/C-bound Mad3 intensities were measured by Image J and normalized to 





5.4.2 Recovery from nda3-KM311-mediated metaphase arrest 
Having compared the Cdc20 C-terminal phosphorylation mutants and bub1-kd allele 
in terms of their abilities to arrest at metaphase in response to depolymerised 
microtubules, in this section we investigate how efficiently these mutants are able to 
extinguish the SAC-mediated ‘wait anaphase’ signal, and progress into anaphase upon 
re-polymerisation of microtubules. In order to examine this, we released the cells from 
the same experiment described in the previous section, from 6 hours of metaphase 
arrest at 18℃ by shifting them back to the permissive temperature (32℃) to allow re-
polymerisation of microtubules. Then we collected cell samples at 10, 20 and 30 
minutes after the release, and fixed them in methanol to process as described 
previously. Following the release from metaphase arrest we observed that cells 
exhibited characteristics of various cell cycle stages (Figure 5.10A). The first type is 
late G2 cells, which have uncondensed DNA and relatively weak Plo1-GFP signal 
gradually accumulating on their spindle poles. The second type is metaphase arrested 
cells exhibiting condensed DNA and strong Plo1-GFP signal on spindle poles. This 
category consists of two subtypes; (i) early metaphase cells displaying overlapped 
Plo1-GFP signals (appear as one spot) on two spindle poles that are very close to each 
other and (ii) late metaphase cells displaying separated Plo1-GFP signals (appear as 
two spots). The third category is anaphase cells, which have their sister chromatids 
symmetrically separated, and pulled to the opposite poles by anaphase spindles. The 
forth and the last category is ‘cut’ (cell untimely torn) cells, which form septa without 
symmetrical segregation of their sister chromatids, and become aneuploidy eventually 
(Yanagida, 1998). 
On the basis of these criteria, (Figure 5.10 C) 10 minutes after the release 37% of 
“initially (at time zero) arrested wild type cells” exited mitosis by either progressing 
into normal anaphase (25%) or exhibiting cut phenotype (12%) (Figure 5.10 A and B). 
However, after 10 minutes 51% of “initially arrested bub1-kd cells” exited mitosis with 






30 minutes after the release (Figure 5.10C), 81% of initially arrested wild type cells 
exited mitosis, with 74% normal anaphase and 7% cut phenotype. However, after 30 
minutes percentage of mitotic exit was as high as 93% for bub1-kd cells, exhibiting 
68% normal anaphase and 25% cut phenotype. 
Phospho – deficient Cdc20 S3A cells exhibited a fairly comparable SAC recovery 
pattern to wild type cells at the early stages after the release. Figure 5.10C plots that 
10 minutes after the release, 31% of the initially arrested Cdc20 S3A cells exited 
mitosis, by either progressing into normal anaphase (25%) or cut phenotype (6%). 
After 30 minutes, 92% of initially arrested Cdc20 S3A cells exited mitosis, with 83% 
normal anaphase and 9% cut phenotype. Although, frequency of cut phenotype was 
comparable to that of wild type (7%), Cdc20 S3A cells progressed into anaphase faster 
than wild type (74%) at the later stages of the release from nda3-KM311 block (Figure 
5.10 B).  
Phospho – mimetic Cdc20 S3E cells recovered from the SAC slightly slower than wild 
type cells did (Figure 5.10 B and C). 10 minutes after the release, 21% of initially 
arrested Cdc20 S3E cells exited mitosis (wild type 37%), almost of them progressing 
into normal anaphase (20%). After 30 minutes, mitotic exit index of initially arrested 
Cdc20 S3E cells was 77% which became similar to that of wild type (81%). Strikingly 
20% of those cells exhibited cut phenotype (wild type 7%), which largely accounts for 
this increase in the mitotic exit, whereas the cells progressing into a normal anaphase 
were only 57% of it. 
On the other hand, Cdc20 IE cells exhibited a rather different SAC rescue pattern. 
Figure 5.10B shows that, Cdc20 IE cells exhibited an arrest profile (63%) as high as 
Cdc20 S3E cells did (62%) immediately before the release. However, unlike Cdc20 
S3E cells, a considerable portion of Cdc20 IE cells remained arrested at metaphase 
even at 10 (54%), 20 (45%) and 30 minutes (43%) after the release. Consistent with 
this, as low as 36% of initially arrested Cdc20 IE cells could exit mitosis at 30 minutes 
time point (Figure 5.10C), which is significantly lower than the SAC recovery rates of 





In order to compare the mitotic exit (SAC recovery) rates of these strains when spindle 
reformed, (other than Cdc20 IE, that was significantly slower than the others) we 
plotted trend lines out of ‘% of initially arrested cells which exited mitosis upon 
microtubule re-polymerisation’ data (Figure 5.10 C). Linear regression analysis 
demonstrates that slopes and elevation (magnitude) values of the lines plotting mitotic 
exit rates of wild type, bub1-kd and cdc20 S3A cells are not significantly different from 
each other. In other words, the variance of mitotic exit rates among their own time 
points (0, 10, 20, 30 minutes) (represented by the slope of a line) and the levels of 
mitotic exit rates relative to each other (represented by the elevation of a line) were 
both statistically indistinguishable. On the other hand, the line plotting the mitotic exit 
rate of Cdc20 S3E cells has the same slope as the other three above, but with a lower 
elevation value. This suggests that Cdc20 S3E cells were able to maintain ‘a constant 
rate of recovery from the SAC’ (represented by the slope) as efficiently as wild type, 
bub1-kd and cdc20 S3A cells. However, that “constant rate” of SAC recovery was 
lower for Cdc20 S3E cells (represented by the elevation) than the other three. 
Taken together, these data suggest that the SAC recovery rate does not appear to be  
significantly affected by either lack of C-terminal Cdc20 phosphorylation by 
presumably Bub1 kinase (as in the case of cdc20 S3A) or lack of the whole Bub1 kinase 
function (as in the case of bub1-kd), albeit it is faster than wild type in both cases. 
However, constitutive phosphorylation of Cdc20 C-terminus by Bub1 kinase 
(mimicked by cdc20 S3E) slightly slows down the SAC recovery rate, yet does not 
impair the activation of APC/C by Cdc20, which takes place when the spindle reforms. 
This result is in line with our previous findings that cdc20 S3E retains its Cdc20 
function as an APC/C activator (It progresses through mitosis similar to wild type in 
an unperturbed mitosis (Figure 5.1) or when the SAC was shut down (mad2 null) in 
the presence of CBZ (Figure 5.4)). 
In contrast, mutation of the arginine residue of the Cdc20 IR motif to glutamate (as in 
the case of cdc20 IE) dramatically delays the SAC recovery. This result suggests that 
the cdc20 IE allele fails to fully perform the APC/C activator function of Cdc20, 


















Figure 5.10 Constitutive phosphorylation of Cdc20 C-terminus does not impair Cdc20 
function, yet slows down the SAC recovery 
(A) Cells from the same experiment described in Figure 3.1 were blocked for 6 hours at 
18°C with depolymerized microtubules through nda3-KM311 tubuline mutation. Immidiately 
after taking the 0 minute samples, cells were shifted to the permissive temperature (32°C) to 
allow re-polymerization of microtubules, and subsequent recovery from the SAC. Cell 
samples were taken at each 10 minutes for 30 minutes after the release from nda3-KM311 
block, fixed in methanol, and stained with DAPI (purple) to visualize DNA, along with 
Plo1-GFP localisation at SPBs (green). Pictures demonstrate representative cell-cycle 
stages of the cells 0, 10, 20 and 30 minutes after the release. Observed mitotic stages are 
annotated with dashed rectangles as follows: cells at late G2 (green); metaphase cells with 
one (light blue) or two (dark blue) Plo1-GFP spots at SPBs; cut cells (yellow); and anaphase 
cells (red). Scale bar represents 5 microns. (B) Graph displaying the relative percentage of 
each cell-cycle stage for each strain throughout 30 minutes after the release (n=100 cells) 
(C) Graph (dashed lines) plotting the percentage of metaphase cells at time=0, progressed 
into anaphase or cut 0, 10, 20, 30 min after the release, using the following formula: 
     %    (anaphase cells + cut cells at 0, 10, 20 or 30 min) - (cut cells at 0 min)
              metaphase cells at 0 min
Linear regression analysis of the trend lines (solid lines) was performed using GraphPad 
Prism software:
* indicates lines with slopes that are not significantly different from each other; § indicates 
lines with elevations that are not significantly different from each other. 




5.4.3 Turnover rates of Cdc20 phospho – mutants during nda3-KM311-mediated 
metaphase arrest 
Above we described how C-terminal phosphorylation of Cdc20 may affect activation 
of and recovery from the SAC arrest. Abilities of cells to arrest at metaphase, or 
recover from that were not affected much by the lack of this phosphorylation (cdc20 
S3A). However, constitutive phosphorylation of Cdc20 C-terminus (cdc20 S3E) 
resulted in a more potent metaphase arrest and slower recovery from that. In order to 
address whether these C-terminal phosphorylation mutations affect levels of Cdc20 
during a SAC mediated arrest, we analysed turnover rates of Cdc20 during the nda3-
KM311 block. 
First, we analysed the phospho – deficient cdc20 S1A cells. Following 6 hours of nda3-
KM311 arrest as described before, we treated wild type and cdc20 S1A cells either with 
cycloheximide (CHX) or DMSO. Cycloheximide was used to inhibit synthesis of new 
proteins, and thereby to monitor the degradation rate of Cdc20. We collected cell 
samples immediately before and 15, 30, 45, 60 minutes after the treatment. Then the 
samples were lysed, processed for SDS-PAGE/western blotting, in which they were 
probed for Cdc20 and Bip1 (loading control). 
As demonstrated in Figure 5.11A, Cdc20 levels decreased only in the cycloheximide 
treated samples, which indicates that the decrease in the protein levels was due to the 
inhibition of protein synthesis and continued protein turnover. Quantification of the 
turnover rates shows that (Figure 5.11B) the degradation rates of wild type Cdc20 and 
cdc20 S1A proteins were almost identical when synthesis of new Cdc20 proteins was 
inhibited by cycloheximide. However, turnover dynamics of cdc20 S3E were rather 
different than that of cdc20 S1A. Figure 5.12 displays that the cycloheximide treatment 
affected levels of only wild type Cdc20, whereas Cdc20 S3E levels remained stable, 
which is similar to the DMSO treatment group. 
Taken together, these results suggest that during an nda3-KM311 arrest, lack of C-
terminal phosphorylation of Cdc20 does not significantly affect its turnover dynamics. 
On the other hand, constitutive phosphorylation of Cdc20 C-terminus stabilizes its 
turnover rate during the SAC arrest mediated by nda3-KM311. 
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Figure 5.11 Lack of Cdc20 C-terminus phoshorylation does not affect Cdc20 turnover
rate during metaphase arrest
(A) Wild type and cdc20 S1A cells were shifted to the restrictive temperature to arrest them for
6 hours in metaphase through nda3-KM311 allele. After 6 hours cell samples were taken
(0 minute), and immediately after the cells were treated with cycloheximide (CHX) to inhibit
protein synthesis, or with DMSO (negative control). Samples were taken at each 15 minutes
for one hour. Extracts from the lysed cells were immunoblotted with Cdc20 and Bip1 antibodies
(loading control) to analyse Cdc20 turnover rates. (B) Graph demonstrating Cdc20 turnover rates
quantified using ImajeJ software and normalized to Bip1 levels. All values were normalized to the
‘0 minute’ value of their CHX treatment group. Trendlines were plotted to demonstrate
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Figure 5.12 Constitutive phoshorylation of Cdc20 C-terminus decreases Cdc20 turnover
rate during metaphase arrest
(A) Wild type and cdc20 S3E cells were shifted to the restrictive temperature to arrest them for
6 hours in metaphase through nda3-KM311 allele. After 6 hours cell samples were taken
(0 minute), and immediately after the cells were treated with cycloheximide (CHX) to inhibit
protein synthesis, or with DMSO (negative control). Samples were taken at each 15 minutes
for 90 minutes. Extracts from the lysed cells were immunoblotted with Cdc20 and Mad2 antibodies
(loading control) to analyse Cdc20 turnover rates. (B) Graph demonstrating Cdc20 turnover rates
quantified using ImajeJ software and normalized to Mad2 levels. All values were normalized to the
‘0 minute’ value of their treatment group (CHX or DMSO). Trendlines were plotted to demonstrate






5.5 Can the Cdc20 C-terminal phospho-mimicking mutation rescue 
the SAC defects of bub1-kd allele? 
In the third chapter, we reported that cells expressing the kinase-dead mutant of Bub1 
(bub1-kd) are partially defective in arresting at metaphase and thereby delaying 
anaphase onset upon depolymerisation of their microtubules by either a microtubule 
poison (CBZ) or nda3-KM311 cold sensitive mutant. Furthermore, this SAC defect of 
bub1-kd cells is accompanied by significantly decreased kinetochore localisation of 
MCC components and defective MCC-APC/C interaction when their spindle is 
perturbed by CBZ.  
In the fourth chapter, we showed by in vitro kinase assays that the two point mutations 
in the bub1-kd allele completely abolish its kinase function, which accounts for the in 
vivo SAC defects of bub1-kd described above. Moreover, we demonstrated that Cdc20 
is a substrate of Bub1 kinase in vitro. Identification of in vitro phosphorylated sites of 
Cdc20 revealed that some of those sites overlap with the sites phosphorylated in vivo 
in mitotically arrested cells. Among those overlapping sites, particularly C-terminal 
serine 482 is well-conserved among fission yeast, budding yeast, X. laevis and 
H.sapiens. Moreover, cross-linking mass spectrometry results we described in the 
fourth chapter indicated that Mad2 and Mad3 proteins interact with C-terminus of 
Cdc20, which is in close proximity to Serine 482. Therefore, we mutated this putative 
Bub1 site, (or adjacent two serine residues as well; serine 482, serine 483 and serine 
484) to generate phospho – deficient (cdc20 S1A and cdc20 S3A) and phospho – 
mimicking (cdc20 S3E) mutants of Cdc20. In the previous sections of this chapter, we 
showed that the phospho – deficient mutants of Cdc20 (cdc20 S1A and cdc20 S3A) 
behave similarly to wild type in terms of their mitotic progression, MCC formation, 
MCC-APC/C interaction, Cdc20 turnover rate and kinetochore localisation of the 
MCC components during unperturbed and perturbed (through CBZ or nda3-KM311) 
mitoses. On the other hand, the phospho – mimicking mutant (cdc20 S3E) behaves 
rather differently under the conditions activating the SAC, although it is similar to wild 
type during unperturbed mitosis. Upon depolymerisation of microtubules by CBZ, 
cells expressing cdc20 S3E arrest at metaphase for much longer, which is accompanied 




Moreover, this acquired SAC potency of cdc20 S3E correlates with a stronger and 
longer MCC-APC/C interaction in mitosis.  
On the basis of these findings, we hypothesize that cdc20 S3E, which mimics C-
terminal phosphorylation of Cdc20, may rescue the SAC defects of bub1-kd, if this 
site of Cdc20 is modified by Bub1 kinase in vivo.  
First, in order to address this possibility more accurately, we generated another 
phospho – mimicking mutant of Cdc20 (cdc20 S1D) by mutating serine 482 to 
aspartate. Subsequently, we crossed the phospho – mimicking mutants (cdc20 S3E or 
cdc20 S1D) with bub1-kd, and analysed these double-mutants in a synchronous mitosis 
using cdc25-22 allele, in which microtubules were depolymerised by CBZ. Cell 
samples were collected at 30 minute time points for 150 minutes, and fixed in 
methanol. In order to determine their mitotic progression rate, fixed cells were stained 
with calcofluor to detect septa, or DAPI to detect DNA. Kinetochore localization of 
the MCC components was analysed visualising Mad3-GFP localisation at unattached 
kinetochores. As described in Chapter 3.3.1 (Figure 3.4B), to be able to evaluate the 
anaphase delay mechanisms, which may be independent of the kinetochore 
recruitment of MCC components, we scored kinetochore localisation of Mad3 only in 
the population of cells that arrested at metaphase exhibiting condensed DNA (similar 
to the non-septating cells we considered previously in Figure 3.4B). 
The strains used in this experiment are: wild type, cdc20 S1D, cdc20 S1D bub1-kd, 
cdc20 S3E, cdc20 S3E bub1-kd, bub1-kd* and wild type*. It should be noted that all 
the strains express Mad3-GFP; in addition bub1-kd* and wild type* strains express 
Mad2-GFP as well (annotated throughout the text with an asterisk). Moreover, mps1-
kd results from an independent experiment under identical conditions were used as a 
negative control, as mps1-kd is known to be defective in the SAC (Shepperd et al., 
2012b; Yamagishi et al., 2012; Zich et al., 2012)). 
30 minutes after the release into mitosis (10 minutes after the CBZ treatment) only a 
small portion of the strains progressed into anaphase, that is indicated by a low 
septation index (%5-10) (Figure 5.13 A). Consistent with this, all the strains had a high 
percentage (83-92%) of metaphase arrested cells displaying condensed DNA (Figure 




In order to analyse the abilities of the strains to recruit the MCC components to 
unattached kinetochores, regardless of their abilities to delay anaphase,  we scored the 
percentage of metaphase arrested cells, which also exhibit kinetochore foci of MCC 
components (Figure 5.14 A and D). Within the population of metaphase arrested ones, 
60-66% of wild type, bub1-kd* and wild type* cells recruited Mad3-GFP to 
kinetochores (bub1-kd* and wild type* cells recruited Mad2-GFP as well). Hereafter 
Mad3 and/or Mad2 localization will be referred to interchangeably as ‘kinetochore 
localization of the MCC components’ as their localization dependencies are very 
similar (S. Heinrich et al., 2012)). As expected, none of the mps1-kd cells could recruit 
the MCC components, although they were at metaphase like the other strains at this 
time point. On the other hand, both phospho – mimicking mutants (cdc20 S1D, cdc20 
S3E) and their double mutant alleles, which also bear bub1-kd mutation, (cdc20 S1D 
bub1-kd, cdc20 S3E bub1-kd) exhibited kinetochore foci of the MCC components 
more frequently (80-95%) than wild type and bub1-kd cells did (60%) (Throughout 
this experiment, cdc20 S1D phenocopied cdc20 S3E; and cdc20 S1D bub1-kd 
phenocopied cdc20 S3E bub1-kd. Therefore hereafter, the functional consequences of 
phospho – mimicking mutations will be described by referring to cdc20 S1D and cdc20 
S1D bub1-kd alleles). 
60 minutes after the release into mitosis, the septation indexes of the strains deviated 
from each other depending on their abilities to maintain the SAC response. Wild type 
strains (wild type and wild type*) maintained a robust SAC response indicated by 44% 
of septation (Figure 5.13 A and B). However, bub1-kd* cells could not delay anaphase 
onset, as 71% of them septated. The inability of bub1-kd cells to hold a robust arrest 
was similar to that of mps1-kd (87% septation). On the other hand, cdc20 S1D cells 
maintained a very strong SAC response, and only 10% of them septated. Strikingly, 
although cdc20 S1D bub1-kd cells lacked Bub1 kinase activity, they maintained a 
robust SAC response (only 25% septation) that was significantly stronger than that of 
















60 minutes after release into mitosis
Mad3-GFP
Figure 5.13 Mimicking the phosphorylation of a putative Bub1 site in Cdc20 C-terminus  
rescues the anaphase delay defect of bub1-kinase dead
(A) Cells were blocked in G2-phase for 4 hours through cdc25-22 temperature sensitivity, and 
then released into mitosis at 0 minute. At 20 minutes, cells were treated with the microtubule 
depolymerising drug CBZ to activate SAC response. Samples were collected at each 30 
minutes time point. Graph plotting percentage of cells that formed septum (exited mitosis) 
throughout 150 minutes. Mph1-kd result was taken (dashed black line) from another experi-
ment with the identical conditions. (B) Representative images from 60 minutes, displaying 
septation (in red) by calcofluor staining and Mad3-GFP localisation (in green). Scale-bar 
represents 5 microns. All of the seven strains express Mad3-GFP. The two strains (annotated 









30 minutes after release into mitosis
Mad3-GFPDAPI Merge
A
Figure 5.14 Mimicking the phosphorylation of a putative Bub1 site in Cdc20 C-terminus
rescues the Mad3 kinetochore localization defect of bub1-kinase dead
The strains are from the same experiment described in Figure 5.15. All of the seven strains
express Mad3-GFP. The two strains (annotated with an asterisk), bub1-kd* and wild type*,
express Mad2-GFP as well as Mad3-GFP. 
(A) Representative images from 30 minutes, displaying DNA (in purple) by DAPI staining
and Mad3-GFP (Mad3-GFP and Mad2-GFP in the cells annotated with *) localisation at
kinetochores (in green). Scale-bar represents 5 microns.
(B) Representative images from 60 minutes, displaying DNA (in purple) by DAPI staining
and Mad3-GFP (Mad3-GFP and Mad2-GFP in the cells annotated with *) localisation at
kinetochores (in green). Scale-bar represents 5 microns.
(C) Graph plotting ‘percentage of metaphase cells’ (indicated by scoring condensed DNA)
at 30 and 60 minutes after release into mitosis.
(D) Graph plotting ‘percentage of metaphase cells exhibiting Mad3-GFP kinetochore foci at

















As for the proportions of the cells arresting at metaphase with condensed DNA 60 
minutes after the release into mitosis, 45-47% of the wild type strains were observed 
to have condensed DNA (Figure 5.14 B and C). It should be noted that at 60 minutes 
the wild type strains had 56% non-septating cells (44% septation), which are expected 
to arrest at metaphase. This slight discrepancy suggests that there were cells, which 
de-condensed their DNA, but have not fully septated yet.  
Consistent with its inability to delay anaphase onset, only 21% of bub1-kd* cells had 
condensed DNA, which was closer to that of the SAC deficient mps1-kd (1%). In 
contrast, phospho – mimicking cdc20 S1D (87%) and double mutant cdc20 S1D bub1-
kd (65%) strains had more cells with condensed DNA, which is in line with their lower 
septation indexes (Figure 5.14 B and C). 
As for the proportions of metaphase arrested cells displaying kinetochore foci of the 
MCC components at 60 minutes, Figure 5.14 B and D demonstrate that the Mad3 
localization increased in wild type strains (93-97%) to the levels of the phospho – 
mimicking mutant cdc20 S1D (100%). However, the double mutant cdc20 S1D bub1-
kd (84%) was not able to recruit Mad3 as efficiently as wild type, although it had more 
metaphase arrested cells with condensed DNA. On the other hand, even though bub1-
kd recruited the MCC components to kinetochores at wild type levels at 30 minutes, at 
60 minutes the proportion of (metaphase arrested) bub1-kd cells exhibiting 
kinetochore foci dropped to as low as 17%. This defect of bub1-kd appears to be close 
to that of the SAC deficient mps1-kd, in which no kinetochore localization of the MCC 
components was observed. 
 
At the later stages of mitosis, differences between septation indexes of the strains 
largely followed the proportions observed at 60 minutes (Figure 5.13 A): wild type 
strains (with or without Mad2-GFP expression) were similar, and ~85% of them 
septated at 150 minutes. Bub1-kd remained as the highest septating strain throughout 
the time course, and exhibited a very high septation index (95-98%) 120 minutes 
onward, which was identical to that of the SAC deficient mps1-kd (97% at 120 
minutes). On the other hand, phospho – mimicking cdc20 S1D cells maintained their 
strong metaphase arrest throughout mitosis, and only 56% of them septated at 150 




septation index than wild type throughout the mitosis, it septated (86%) at wild type 
levels at 150 minutes. 
 
These data suggest that at the early stages (30 minute) of a mitosis challenged with 
CBZ, Bub1 kinase function is not essential for (initial activation of the SAC) either 
delaying anaphase onset or kinetochore recruitment of MCC components. However, 
at the later stages (60 minutes onward) Bub1 activity is required to maintain a robust 
SAC response, to be able to delay premature anaphase and sustain localization of the 
MCC components at unattached kinetochores of metaphase arrested cells.  
In chapter three we proposed that the role of Bub1 kinase activity to delay premature 
anaphase appeared to be only partially mediated through the Bub1-H2A-Sgo2-Aurora 
B pathway, as the sgo2 null cells exhibited a similar septation index to wild type when 
microtubules were depolymerized. We hypothesized that this role of Bub1 kinase 
activity may be mediated through phosphorylating Cdc20, and thereby inhibiting the 
APC/C. Indeed, here we demonstrate that mimicking the constitutive phosphorylation 
of Cdc20 C-terminus (which was phosphorylated in vitro by Bub1) rescued the 
anaphase delay defect observed in the absence of Bub1 kinase activity and brought it 
at least to the wild type levels (as in the case of the double mutant cdc20 S1D bub1-
kd). According to these findings we conclude that the anaphase delaying role of Bub1 
kinase activity may be largely mediated through the phosphorylation of Cdc20 C-
terminus (serine 482). 
In addition, we also suggested in Chapter three that the role of Bub1 kinase activity to 
recruit Mad2, Mad3 (maybe even Cdc20) to unattached kinetochores appears to be 
partly mediated through the Bub1-H2A-Sgo2-Aurora B pathway, since it was partially 
compromised in sgo2 null cells (27% less compared to wild type, see Figure 3.4) 60 
minutes after the release into the mitosis challenged with carbendazim. This implies 
that there may be another pathway(s) working in parallel with the Bub1-H2A-Sgo2-
Aurora B pathway in mediating the kinase activity of Bub1 towards kinetochore 







Consistent with this possibility, mimicking Bub1 kinase activity on Cdc20 C-terminus 
was able to significantly rescue the Mad3 kinetochore localization defect in the 
absence of Bub1 kinase function (cdc20 S1D bub1-kd) to a level slightly below (13% 
less than wild type) that of wild type at the same time point (60 minutes). Note that the 
double mutant could not rescue the kinetochore recruitment of Mad3 at exact wild type 
levels probably because in cdc20 S1D bub1-kd cells both H2A-S121 (Bub1-H2A-
Sgo2-Aurora B pathway) and other putative phosphorylation sites of Cdc20 failed to 
be phosphorylated, which may further contribute to the kinetochore localisation of 
Mad3. On the basis of these findings we conclude that Cdc20 C-terminus (serine 482) 
and H2A C-terminus (serine 121) may be the two main mediators of Bub1 kinase 
activity for promoting the kinetochore recruitment of MCC components when the 


















Chapter 6: Final discussion 
In chapter three, we investigated the roles of Bub1 kinase activity in maintaining the 
SAC response. In chapter four, we demonstrated that fission yeast Cdc20Slp1 is an in 
vitro substrate of Bub1, and identified its phosphorylated sites. In addition, we 
revealed novel interactions between the MCC components that may be relevant to the 
regulation of the SAC through Cdc20 phosphorylation. In chapter five we investigated 
possible roles of fission yeast Cdc20Slp1 C-terminal phosphorylation (that we identified 
in the chapter four) in mitosis. For this purpose, we analysed the phosphorylation 
mutants of Cdc20, either refractory to C-terminal phosphorylation (phospho-deficient) 
or mimicking constitutive phosphorylation of this site (phospho-mimicking) under 
various mitotic conditions given below: 
1. In an unperturbed mitosis, to determine whether the phosphorylation mutants 
of Cdc20 retain their mitotic functions in the absence of spindle damage: 
 APC/C activation and subsequent anaphase onset  
 MCC assembly 
 MCC-APC/C interaction 
 
2. In the presence of prolonged spindle damage mediated by the cold sensitive 
tubulin mutant nda3-KM311, to examine whether the phosphorylation mutants 
of Cdc20 are capable of: 
 Maintaining a robust metaphase arrest mediated by the SAC 
 Recovering from the SAC arrest upon reformation of the spindle, and 
segregating their chromosomes equally 
 
3. In the presence of spindle damage caused by the microtubule depolymerising 
drug carbendazim (CBZ), to examine whether the phosphorylation mutants of 
Cdc20 are capable of: 
 Recruiting the MCC components (Mad2 and Mad3) to kinetochores 
 Maintain MCC-APC/C interaction 





4. In the absence of Bub1 kinase activity, to determine whether the phospho-
mimicking Cdc20 mutant can rescue the SAC defects observed in the absence 
of Bub1 kinase activity (which would provide in vivo evidence for a potential 
Bub1- Cdc20 pathway, in addition to the existing Bub1-H2A-Sgo2-Aurora B 
pathway) 
 
6.1 Cdc20 C-terminal phosphorylation mutants retain their mitotic 
functions in an unperturbed mitosis 
Phosphorylation of Cdc20 has been implicated to affect its mitotic functions, 
independent of the SAC. In Xenopus egg extracts, Cdk1 mediated phosphorylation of 
Cdc20 N-terminus blocks its binding to and activation of the APC/C, by inhibiting the 
interaction of Cdc20 C-box (N-terminal APC/C interaction domain) with Apc8. This 
phosphorylation needs to be reversed by PP2A for anaphase onset (Labit et al., 2012).  
APC/C activation and anaphase onset 
Another conserved APC/C interaction domain of Cdc20 is the C-terminal IR-motif, 
whose mutation compromises the Cdc20- APC/C interaction (Izawa & Pines, 2012). 
Our mutated sites are in close proximity to the IR-motif (4 amino acids upstream of 
the IR). This raises the possibility that our C-terminal phosphorylation mutations 
might affect the Cdc20 function mediated by the IR-motif.  
In order to determine whether the C-terminal phosphorylation mutations on Cdc20 
affect its APC/C activating function, we analysed abilities of the mutants in 
progressing into anaphase, assembling the MCC and maintaining MCC-APC/C 
interaction in an unperturbed mitosis. We demonstrated that the cells expressing 
phospho-deficient (cdc20 S1A and cdc20 S3A) or phospho-mimicking (cdc20 S3E) 
Cdc20 mutants are capable of activating APC/C, and promote anaphase onset as 
efficiently as wild type cells do. Thus we suggest that the APC/C activator functions 
of the Cdc20 C-terminal phosphorylation mutants are not affected by the mutations, 
despite their proximity to the regulatory IR-motif. To further conform this, we intend 
to express the Cdc20 mutants in vitro, and test them in in vitro APC/C assays to 





MCC formation and MCC-APC/C interaction 
In addition, we showed that the lack of Cdc20 C-terminus phosphorylation (as in the 
case of cdc20 S3A) does not significantly affect the MCC formation or the MCC-
APC/C interaction during an unperturbed mitosis. At the time we carried out these two 
assays, anti-Cdc20 antibody was not available. Therefore we used the internally 
FLAG-tagged cdc20 S3A strain to perform Cdc20-FLAG immunoprecipitations (to 
analyse MCC formation) or Cdc20-FLAG immunoblotting following Apc4 
immunoprecipitations (to analyse MCC-APC/C interaction).  
However, the internally FLAG-tagged cdc20 S3E strain has become available only 
recently. Though considering its comparable mitotic progression rate to that of wild 
type and phospho-deficient mutants, we expect the phospho-mimicking cdc20 S3E to 
exhibit similar MCC formation and MCC-APC/C interaction. Nevertheless, we will 
need to carry out these experiments using cdc20 S3E to be able to fully confirm that 
all of its mitotic functions are as intact as those of wild type and cdc20 S3A. 
6.2 Constitutive phosphorylation of Cdc20 C-terminus slightly 
enhances the SAC arrest in response to penetrant spindle damage 
(nda3-KM311) 
In chapter five, we confirmed that the non-kinase region of Bub1 (N-terminal and the 
middle region) is essential for the SAC response to severe spindle damage (bub1 null 
is SAC deficient) (Kadura, He, Vanoosthuyse, Hardwick, & Sazer, 2005; Kiyomitsu 
et al., 2007), and although not essential, its C-terminal kinase activity is required for 
maintaining a robust SAC (bub1-kd is compromised in the SAC ) (Figure 5.8) (Fernius 
& Hardwick, 2007; Kawashima et al., 2010; Yamaguchi et al., 2003). 
In addition, we demonstrated that constitutive phosphorylation of Cdc20 C-terminus 
(cdc20 S3E) leads to a slightly enhanced SAC arrest, whereas lack of this 
phosphorylation (cdc20 S3A) results in a slightly weaker SAC response than wild type 
cells (Figure 5.8, especially after 6 hours of nda3-KM311 block). These results are 
consistent with our hypothesis that Bub1 may be at least one of the kinases 
phosphorylating serine 482 (in vivo) in mitotically arrested cells (Figure 4.4), as well 




phosphorylation should phenocopy the lack of Bub1 kinase activity (toward serine 
482) to an extent, indicated by the slight SAC deficiency of cdc20 S3A. Moreover, 
constitutive phosphorylation of serine 482 indeed improved the SAC response, which 
strengthens the possibility that Bub1 may phosphorylate serine 482 to promote the 
SAC. 
On the other hand, introducing a negative charge on the regulatory IR-motif (cdc20 
IE) impaired the interaction between APC/C and Mad3. Even though a compromised 
MCC-APC/C interaction is expected to result in leakage through mitosis, cdc20 IE 
cells exhibited a mitotic index that is similar to wild type. Considering cdc20 IE cells 
are not expected to inhibit the APC/C efficiently, we hypothesized that their high 
mitotic index could be due to a compromised Cdc20 function, as an APC/C activator. 
In order to test this possibility we next analysed abilities of the C-terminal Cdc20 
mutants in activating the APC/C (recovering from the SAC) and promoting anaphase 
onset upon reformation of the spindle. 
 
6.3 IR-motif of Cdc20 is required for recovering from the SAC arrest 
(nda3-KM311) and progressing into anaphase 
Once the cells are released from a nda3-KM311 block, microtubules re-polymerize, 
chromosomes are bi-oriented (SAC is satisfied), and cells recover from the SAC 
(activating the APC/C), which results in progression into anaphase (Vanoosthuyse et 
al., 2009). However, this was not the case for cdc20 IE cells. Despite the spindle 
reformation (30 minutes after the release from metaphase arrest), a considerable 
portion of Cdc20 IE cells (43%) remained arrested at metaphase; in fact some them 
were even stuck at early metaphase indicated by Plo1-GFP localisation (“one spot”) to 
the spindle pole bodies which had not separated yet (Figure 5.10B) (Mulvihill et al., 
1999). This result suggests that the cdc20 IE mutant fails to fully perform its APC/C 
activating function, therefore is not able to trigger anaphase onset even after the re-
polymerisation of microtubules. To be able to further characterize roles of the IR-
motif, we need to analyse the mitotic progression rate of cdc20 IE cells in an 
unperturbed mitosis (using cdc25-22 mediated G2 arrest), to determine the degree of 




Constitutive phosphorylation of Cdc20 C-terminus slightly decreases the rate of 
SAC recovery 
Other C-terminal (phosphorylation) Cdc20 mutants recovered from the SAC more 
normally than the cdc20 IE cells did, yet with some variance depending on their 
mutation. 
Although the overall SAC recovery trends (Figure 5.10C displays the line representing 
the average mitotic exit at 10, 20 and 30 minutes) were comparable throughout the 
release, kinase inactive bub1-kd cells exited mitosis faster than wild type, especially 
at the later stages (30 minutes) of the release from metaphase. Interestingly, phospho-
deficient (at the C-terminus) cdc20 S3A cells phenocopied this, which is indicated by 
their slightly accelerated mitotic exit compared to wild type cells. According to this 
observation our hypothesis is as follows:  
Phosphorylation of SAC proteins (yet to be discovered) by Bub1 may promote SAC 
maintenance during spindle damage. Once the spindle reforms (and the SAC is 
satisfied), the sites phosphorylated by Bub1 may need to be dephosphorylated to 
recover from the SAC and activate APC/C (similar to the SAC silencing activity of 
PP1 (Liu et al., 2010; Meadows et al., 2011)). 
Accordingly, when the Bub1 kinase activity is absent (bub1-kd), it may be quicker to 
recover from the SAC arrest. Consistent with this hypothesis, lack of one of those 
Bub1 sites (as in the case of cdc20 S3A) may lead to a slightly accelerated SAC 
response (Figure 5.10C). If this hypothesis is true, then the phosphorylation and 
dephosphorylation of Cdc20 serine 482 may contribute to the regulation of SAC 
maintenance and the subsequent recovery from it respectively. Such a mechanism is 
not very unlikely, as threonine 79 (T79) of Xenopus Cdc20 has been shown to be in a 
dynamic state of phosphorylation and dephosphorylation mediated by Cdk1 and PP2A, 
respectively, which regulate the APC/C activation by Cdc20 in metaphase (Labit et 
al., 2012). In order to test whether the serine 482 phosphorylation has a key regulatory 
role in the context of SAC, we should analyse phosphatases, such as PP1 and PP2A, 





Consistent with this hypothesis, constitutive (non-reversible) phosphorylation of 
serine 482 (cdc20 S3E) resulted in a slightly slower SAC recovery (Figure 5.10C). 
This suggest that dephosphorylation of serine 482 is not essential for the mitotic exit 
upon spindle reformation, yet it contributes to the rate of SAC recovery. Intriguingly, 
at the later stages of the release from the arrest, cdc20 S3E cells exhibited the “cut” 
phenotype more frequently than wild type and cdc20 S3A cells did (Figure 5.10B). In 
other words, more cdc20 S3E cells failed to segregate their chromosomes equally 
before the septation began. This might be due to a possible defect in microtubule-
kinetochore attachment and/or chromosome bi-orientation caused by the non-
reversible phosphorylation of serine 482. Hypothetically, the phosphorylation of serine 
482 may be promoting the SAC, and thereby contributing to ensuring accurate 
chromosome segregation in the absence of kinetochore-microtubule attachments (or 
in the presence of spindle damage in our experiment). However, once microtubules 
attach to kinetochores (the spindle reforms, in our experiment), serine 482 may need 
to be dephosphorylated (that does not happen in Cdc20 S3E) to allow proper SAC 
recovery. Thus, the relatively slower and detectably inaccurate chromosome 
segregation in Cdc20 S3E cells suggest possible mechanisms for the regulation of SAC 
arrest and recovery through of phosphorylation and dephosphorylation of Cdc20 C-
terminus. 
 
Alternatively, slower SAC recovery (APC/C activation) might be due to a possible 
destabilisation of the cdc20 S3E levels, therefore depletion of the APC/C activator 
during the SAC arrest. We next analysed whether phospho-deficient or phospho-









Effects of constitutive phosphorylation of Cdc20 C-terminus on its levels during 
the SAC arrest mediated by nda3-KM311 
By inhibiting the biosynthesis of new Cdc20 (using the translation inhibitor 
cycloheximide) we showed that cdc20 S1A had the same turnover rate as the wild type 
Cdc20 (Figure 5.11), whereas the cdc20 S3E degradation rate appeared to be reduced 
during the nda3-KM311 block (Figure 5.12). On the other hand, the cdc20 S3E cells 
treated with DMSO had the same levels of cdc20 S3E as wild type Cdc20, suggesting 
that total cdc20 S3E levels (the net result of expression and degradation, which are not 
affected in DMSO) are similar to wild type. Thus, the relatively slow SAC recovery 
rate of cdc20 S3E cells was probably not due to destabilisation of the cdc20 S3E levels 
during the SAC arrest. Instead, the slower SAC recovery rate of cdc20 S3E cells may 
be related to their reduced degradation rate. MCC (comprising Cdc20, Mad2 and 
Mad3) has been reported to dynamically assemble and disassemble during the SAC 
arrest, through Cdc20 ubiquitination mediated by Apc15 in budding yeast (Foster & 
Morgan, 2012) and humans (Uzunova et al., 2012). Reduced degradation rate of cdc20 
S3E may have resulted from their reduced ubiquitination by the APC/C, which leads 
to a slower MCC disassembly during the SAC arrest. Accordingly, slower MCC 
disassembly would result in delayed APC/C activation, which may explain the SAC 
recovery delay of cdc20 S3E cells (Figure 5.10C).  
6.4 Constitutive phosphorylation of Cdc20 C-terminus enhances the 
SAC response to the microtubule depolymerising drug CBZ 
In addition to the spindle damage mediated by nda3-KM311 block, we tested the C-
terminal Cdc20 phosphorylation mutants also under the spindle damage caused by the 
microtubule depolymerising drug CBZ, in synchronous mitotic time courses (Figure 
5.4). As we discussed previously, while the nda3-KM311 cold sensitive mutation leads 
to a prolonged (9-10 hours (Kawashima et al., 2010)) and highly penetrant microtubule 
depolymerisation, CBZ concentrations in the cell probably reduce in time (due to the 
efflux pumps in yeast (Goffeau et al., 1997)) as even the fully SAC proficient wild 
type cells do not arrest in CBZ as long as in the nda3-KM311 block (Yamaguchi et al., 




mimic the early and late stages of metaphase arrest, in terms of the amount of 
unattached kinetochores in the cell. 
Soon after the CBZ treatment (at 30 minutes), both phospho-deficient (cdc20 S3A and 
cdc20 S1A) and phospho-mimicking (cdc20 S3E) cells arrested at metaphase like wild 
type (Figure 5.4B). At this early stage, phospho-deficient cells (cdc20 S3A and cdc20 
S1A) were capable of localizing Mad3 to kinetochores at wild type levels. In wild type 
cells, Mad3 recruitment was Mad2 dependent, as it was abolished when Mad2 was 
deleted (Figure 5.5A and B). On the other hand, significantly more cdc20 S3E cells 
exhibited Mad3 kinetochore foci than wild type. Interestingly, unlike wild type cells, 
cdc20 S3E cells were able to rescue Mad3 recruitment in the absence of Mad2, at the 
early (30 minutes), but not late (60 minutes) stages of mitosis (in Figure 5.5B, compare 
mad2 null strains: wild type Cdc20 and cdc20 S3E). This suggest that phosphorylation 
of Cdc20 C-terminus at early stages (which may be happening much later in wild type 
cells) might have strengthened the interaction between Mad3 and Cdc20, which 
presumably accounts for the enhancement (by cdc20 S3E) or the compensation of 
Mad2 deletion (by cdc20 S3E mad2 null) in terms of Mad3 kinetochore localization. 
However, constitutive phosphorylation of Cdc20 C-terminus is not sufficient, and 
requires Mad2, to maintain this interaction at later stages. Such an interaction between 
Mad3 and Cdc20 may be possible, as we identified cross-links between Cdc20 C-
terminus (K479, two residues upstream the mutated phospho-site serine 482) and 
Mad3 (mainly C-terminus, near its second KEN box) described in chapter four (Figure 
4.9 and 4.10). Thus a transient negative charge on Cdc20 C-terminus (by 
phosphorylation and subsequent dephosphorylation) may be regulating the recruitment 
of MCC components at different stages of mitosis.  
Later in mitosis (at 60 minutes), abilities of the phospho-deficient cells (cdc20 S3A 
and cdc20 S1A) to delay anaphase onset remained similar to that of wild type cells, 
suggesting that lack of Cdc20 C-terminus phosphorylation does not affect the SAC 
response significantly (Figure 5.4A and B). The delay of anaphase onset in response 
to spindle damage was Mad2 dependent, as the wild type cells could not delay 
anaphase anymore when Mad2 was deleted. On the other hand, significantly more 
cdc20 S3E cells delayed anaphase onset, which correlated with their more frequent 




was completely dependent on Mad2, as the deletion of Mad2 abolished their arrest, 
and cdc20 S3E mad2 null cells exited mitosis as frequently as mad2 null cells did 
(Figure 5.4A and B). This result further confirms that cdc20 S3E retains the APC/C 
activating function of Cdc20, as it is as efficient as wild type Cdc20 to progress into 
anaphase in the absence of a functional SAC machinery (mad2 null). In addition, this 
Mad2 dependency and the enhanced Mad3 recruitment (even in the lack of Mad2) of 
the phospho-mimicking cdc20 S3E mutant suggest that its strengthened SAC activity 
is probably mediated by the MCC, possibly through the direct inhibition of the APC/C. 
To gain more insight into interactions between the MCC components and how these 
interactions may contribute to their kinetochore recruitment, we intend to carry out 
several related experiments as follows: 
 Repeat the same experiment in Mad2-GFP, mad3 null background, to 
determine whether phosphorylation of Cdc20 C-terminus (cdc20 S3E) can 
enhance Cdc20-Mad2 interactions as well, and promote the kinetochore 
recruitment of Mad2. 
 
 Replace the internal FLAG tag of Cdc20 with a GFP tag, to analyse how 
phosphorylation of Cdc20 may affect its cellular localization, especially at the 
kinetochores.  
 
Mimicking the C-terminus Cdc20 phosphorylation enhances the MCC-APC/C 
interaction 
We next demonstrated that in the presence of spindle damage caused by CBZ, lack of 
C-terminal Cdc20 phosphorylation (as in the case of cdc20 S3A) does not affect the 
MCC-APC/C interaction significantly, whereas constitutive phosphorylation of Cdc20 
C-terminus (mimicked by cdc20 S3E) leads to a stronger and longer MCC-APC/C 
interaction. This result strengthens the possibility that the phosphorylation of Cdc20 
C-terminus contributes to the SAC response through the MCC mediated inhibition of 
the APC/C. As we discussed in section 5.3.2, this enhanced MCC-APC/C interaction 





 cdc20 S3E cells may form higher amounts of MCC, which saturate and 
efficiently inhibit the APC/C molecules, leading to the enhanced anaphase 
delay (Figure 5.4). This  mechanism is likely to occur, as the cells expressing 
cdc20 S3E have more abundant, and longer-lasting Mad3-GFP kinetochore 
localization, which may catalyse formation of more MCC molecules at the 
unattached kinetochores (presumably through more abundant Cdc20 and Mad2 
recruitment as well). We intend to test this hypothesis by performing co-
immunoprecipitation of Cdc20 S3E-FLAG and Mad2/ Mad3 to compare how 
efficiently the MCC is formed in this strain. 
 
 cdc20 S3E cells may have slower MCC disassembly, resulting in MCC 
accumulation, and thereby excessive APC/C inhibition. As described before, 
MCC has been shown to dynamically assemble and disassemble during the 
SAC arrest, through Cdc20 ubiquitination mediated by Apc15 in in budding 
yeast (Foster & Morgan, 2012) and humans (Uzunova et al., 2012), and p31 in 
humans (Miniowitz-Shemtov et al., 2012; Westhorpe et al., 2011). This can be 
investigated by (i) analysing how efficiently the C-terminal Cdc20 mutants 
(expressed in vitro) are ubiquitinated in APC/C assays (ii) analysing the 
biophysical features of MCC molecules produced in insect cells (including 
different Cdc20 mutants), to determine whether the reduced MCC disassembly 
is caused by tighter interactions (due to Cdc20 C-terminus phosphorylation) 
within the MCC. 
 
 cdc20 S3E cells may assemble more potent MCC molecules which inhibit 
APC/C more efficiently, regardless of their amounts. This possibility is also 
worth considering, as the enhanced APC/C inhibition in cdc20 S3E cells is 
strictly dependent on Mad2 (Figure 5.4). According to this hypothesis, cdc20 
S3E requires Mad2 and Mad3 molecules to form an MCC molecule that can 
inhibit APC/C more efficiently, presumably through increased affinity of C-
terminally phosphorylated Cdc20 (cdc20 S3E) towards the APC/C. In order to 
test this possibility, we intend to compare abilities of the MCC molecules, 




6.5 Mimicking phosphorylation of Cdc20 C-terminus by Bub1 rescues 
the SAC defects in the absence of Bub1 kinase activity 
Finally in the absence of Bub1 kinase activity (bub1-kd) we analysed cdc20 S3E and 
cdc20 S1D, mimicking constitutive phosphorylation of Cdc20 serine 482, that was 
identified as an in vivo phosphorylated site and an in vitro target of Bub1 kinase. 
(Hereafter we will refer to the cdc20 S1D allele to describe functional consequences 
of the phospho – mimicking mutation for two reasons: (i) the S1D mutation has 
successfully phenocopied the S3E mutation, (ii) the S1D mutation may be a more 
reliable allele as only this particular serine residue (S482D) was identified in the mass 
spectrometry analysis). 
We demonstrated that mimicking the constitutive phosphorylation of a putative Bub1 
site on Cdc20 (cdc20 S1D) significantly restored two prominent SAC defects in the 
cells, which lack Bub1 kinase activity and were exposed to a microtubule 
depolymerising drug: (i) delay of premature anaphase onset (Figure 5.13), (ii) 
kinetochore recruitment of the MCC components (Mad2, Mad3 and Cdc20) (Figure 
5.14). In order to further characterize this phenotype, we intend to clarify its certain 
aspects by carrying out a series of experiments in the future as follows: 
Is the compromised MCC-APC/C interaction in bub1-kd allele restored by cdc20 
S1D? 
We aim to address whether cdc20 S1D rescued the anaphase delay defect of bub1-kd 
(Figure 5.13), through restoring its highly defective MCC-APC/C interaction (Figure 
3.6). To determine this, we intend to repeat the synchronous mitotic time course 
experiment in the presence of CBZ. Considering the enhanced kinetochore recruitment 
of Mad3 in cdc20 S1D, bub1-kd cells, we expect them to exhibit also a stronger and 
longer-lasting MCC- APC/C interaction than bub1-kd cells. 
In addition, carrying out this experiment without CBZ may also provide insights into 
whether Bub1 kinase activity is required in an unperturbed mitosis, to maintain the 
relatively transient MCC-APC/C interaction observed in wild type cells (Zich et al., 
2012); moreover this experiment may reveal whether cdc20 S1D allele (that appeared 
to have a comparable progression rate to wild type in an unperturbed mitosis, similar 




Is the rescue phenotype (restored anaphase delay) dependent on kinetochores? 
Previously (in section 5.6.4) we discussed that the enhancement of anaphase delay and 
MCC-APC/C interaction observed in the phospho – mimicking Cdc20 mutants may 
have resulted from assembly of more MCC molecules at the kinetochores. Considering 
cdc20 S1D significantly restored the Mad3 localisation defect of the bub1-kd allele, 
we hypothesize that this recruitment, which may be mediated by Cdc20 C-terminal 
phosphorylation, might have an upstream role in its contribution to anaphase delay. To 
address this hypothesis, we aim to assess the dependency of this rescue phenotype on 
kinetochore recruitment of Mad2 and Mad3. For this purpose, we will repeat the same 
experiment (Figure 5.13 and 14) in bub3 null background, which abolishes the 
kinetochore recruitment of Bub1 and Mad3 (S. Heinrich et al., 2012; Shepperd et al., 
2012b; Yamagishi et al., 2012). 
 
Is Cdc20 phosphorylated by Bub1 at serine 482 in vivo? 
Although the mutated phospho – site in cdc20 S1D (serine 482) was identified as an 
in vivo phosphorylated site (in mitotically arrested cells) and an in vitro target of Bub1 
kinase, this possibility needs to be further analysed. In order to support the possibility 
that serine 482 is phosphorylated by Bub1 in vivo, we aim to perform several 
experiments as follows: 
 
a) Analyse Cdc20+ (wild type) proteins from Bub1+ (wild type) or bub1-kd cells 
to determine whether lack of Bub1 kinase activity leads to a mobility shift of 
Cdc20 on Phos-tag protein gels, which have been reported to improve the 
detection of minor mobility shifts resulted from phospho – modification 
(Godfrey, Kuilman, & Uhlmann, 2015). 
 
b) Purify Cdc20+ (wild type) proteins from Bub1+ (wild type) or bub1-kd cells, 
and identify which of the previously phosphorylated Cdc20 sites (by Bub1+) 






c) Purify the C-terminal Cdc20 phospho – deficient mutants (cdc20 S3A and 
cdc20 S1A) from insect cells and use them in an in vitro Bub1 kinase assay, to 
determine whether lack of Cdc20 phosphorylation by Bub1 at these specific 
sites decrease its total phosphorylation signals. Previously we have attempted 
to express these Cdc20 mutants in vitro in rabbit reticulocyte system, however 
the proteins were not pure enough to detect subtle changes in the 
phosphorylation signal (data not shown). 
 
d) Purify the C-terminal Cdc20 mutants (cdc20 S1D, cdc20 S3E, cdc20 S3A and 
cdc20 S1A) along with Cdc20+, to incubate with recombinant Mad2, Mad3 (to 
assemble the MCC) and Bub1+ kinase in vitro, and analyse their abilities to 
inhibit the APC/C activity (towards securin). This assay may provide direct 
evidence for whether Bub1 mediated Cdc20 C-terminal phosphorylation 
(either phosphorylation itself, or mimicking it via aspartate or glutamate 
mutations) inhibits APC/C directly. For this purpose, purification of the Cdc20 
mutants using in vitro in rabbit reticulocyte system may be sufficient, as the 
products of this system have been shown to work successfully in in vitro 
APC/C assays (Foe et al., 2011; Foster & Morgan, 2012).  
 
Does cdc20 S1D really rescue the bub1-kd phenotype or it has a dominant-positive 
effect on the SAC response? 
By performing the experiments listed above, we expect to provide further evidence for 
the our hypothesis that C-terminal Cdc20 may be regulated by Bub1 kinase activity; 
yet we will need to rule out the possibility that the rescue phenotype (cdc20 S1D, bub1-
kd) may be due to a dominant-positive effect of the cdc20 S1D allele rather than 
specifically restoring Bub1 kinase activity toward Cdc20 C-terminus. To investigate 
this possibility, we intend to determine whether the cdc20 S1D allele can restore the 








 bub1 null, is SAC deficient due to lack of its functions described in chapter 1. 
 mps1-kd, is severely defective in the SAC mainly because its kinase activity is 
required to localise the SAC proteins at kinetochores (London et al., 2012; 
Shepperd et al., 2012a; Yamagishi et al., 2012) and to promote the SAC 
response through Mad2 phosphorylation (Zich et al., 2012). 
 mad3 KEN271AAA, is a Mad3 allele that lacks its second KEN-box function, 
and is not able to maintain anaphase delay or MCC-APC/C interaction, 
although it can assemble the MCC efficiently (Sczaniecka et al., 2008). This 
allele would especially be useful to determine whether Cdc20 C-terminus 
phosphorylation (cdc20 S1D) promotes the MCC-APC/C interaction 
independently of MCC assembly. 
 
Understanding these aspects of Cdc20 C-terminus phosphorylation will hopefully 
strengthen our hypothesis that in addition to the Bub1-H2A-Sgo2-Aurora B pathway, 
a Bub1-Cdc20 mediated pathway may further promote the SAC response to ensure 















6.6 Relevance of Bub1 kinase activity and Cdc20 to therapeutic 
approaches 
Loss of Bub1 kinase activity has been reported to cause significant aneuploidy and 
male subfertility in mice (Ricke, Jeganathan, Malureanu, Harrison, & Van Deursen, 
2012). Together with several other studies, our findings imply that a possible Bub1-
Cdc20 pathway (in addition to the Bub1-Aurora B pathway) may contribute to 
genome stability in higher eukaryotes considering the observations as follows: 
 Bub1 kinase activity maintains the SAC response through direct 
phosphorylation of Cdc20 in humans (Tang, Shu, et al., 2004) 
 Human Bub1 has a considerable specificity toward Cdc20, through its 
extended substrate recognition loop in the non-kinase region (Kang et al., 
2008) 
 Phosphorylation of human Cdc20 by Bub1 in vitro is not restricted to its N-
terminus (Tang, Shu, et al., 2004), which suggests a possible phosphorylation 
of the C-terminus as well. 
 C-terminal phosphorylation site of Cdc20 (serine 482) is conserved among 
higher eukaryotes, including humans (Figure 4.5) 
 Mimicking C-terminal phosphorylation of fission yeast Cdc20 restores SAC 
related defects in the absence of Bub1 kinase activity (Figures 5.13 and 14) 
 
On the basis of these findings, investigation of Bub1 kinase activity towards Cdc20 in 
vertebrates may increase our understanding of the underlying mechanisms by which it 
ensures genome stability. Furthermore, these studies may lead to novel cancer 
therapeutic strategies, considering that targeting Cdc20 may be a better approach than 
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